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1. Summary	  
Pluripotency	   in	   the	   early	   embryo	   is	   defined	   as	   the	   capacity	   of	   a	   single	   cell	   to	  
generate	  all	   lineages	  of	   the	  adult	  organism.	   In	   vivo	   this	  property	   is	  possessed	  only	  
transiently	  by	  the	  cells	  of	  the	  epiblast,	  but	  it	  can	  be	  indefinitely	  “captured”	  in	  vitro	  by	  
deriving	   embryonic	   stem	   (ES)	   cells	   from	   the	   inner	   cell	   mass	   of	   the	   blastocyst.	   A	  
second	  property	  that	  characterizes	  ES	  cells	  is	  self-­‐renewal,	  the	  capacity	  to	  generate	  
more	  stem	  cells.	  Self-­‐renewal	  requires	  the	  coordination	  of	  cell	  proliferation	  and	  cell-­‐
fate	  choice	  (Orford	  and	  Scadden,	  2008).	  Originally,	  mouse	  ES	  cells	  were	  expanded	  on	  
mitotically	  inactivated	  fibroblasts,	  in	  a	  culture	  medium	  containing	  fetal	  bovine	  serum	  
and	   the	   leukemia	   inhibitory	   factor	   (LIF).	   Under	   these	   conditions	   ES	   cells	   are	  
metastable,	   since	   they	   show	   heterogeneity	   both	   in	  morphology	   and	   expression	   of	  
the	  core	  pluripotency	  factors	  Oct4	  and	  Nanog	  due	  to	  differentiation	  signals	  coming	  
from	  the	  serum	  components	  (Nichols	  and	  Smith,	  2009).	   In	  serum	  +	  LIF	  medium,	  ES	  
cells	   depend	  on	   the	   transcription	   factor	   and	  proto-­‐oncogene	  Myc	   for	   pluripotency	  
and	  self-­‐renewal	  (Smith	  et	  al.,	  2010).	  Myc	  proteins	  have	  been	  shown	  to	  repress	  the	  
expression	  of	   the	  primitive	  endoderm	  master	   regulator	  Gata6,	  and	  control	   the	  cell	  
cycle	  by	  regulating	  the	  mir-­‐17-­‐92	  miRNA	  cluster.	  The	  laboratory	  of	  Austin	  Smith	  has	  
recently	  shown	  that	  the	  culture	  in	  the	  absence	  of	  serum	  but	  in	  the	  presence	  of	  two	  
inhibitors	   (2i	   +	   LIF)	   of	   the	   Erk	   and	   glycogen	   synthase	   kinase-­‐3	   (GSK3)	   pathways	   is	  
sufficient	  to	  stabilize	  ES	  cells	  in	  a	  more	  naïve,	  so-­‐called	  ground	  state	  of	  pluripotency,	  
which	  more	  closely	  resembles	  the	  status	  of	  the	  inner	  cell	  mass	  of	  the	  blastocyst	  (Ying	  
et	  al.,	  2008).	  Since	  different	  culture	  environments	  impose	  distinctive	  transcriptional	  
and	   epigenetic	   properties	   on	  mouse	   ES	   cells	   (Marks	   et	   al.,	   2012),	  we	   re-­‐evaluated	  
the	   expression	   and	   requirement	   of	   the	   Myc	   proteins	   in	   the	   naïve	   state	   of	  
pluripotency.	  	  
Making	  use	  of	  ES	  cells	  expressing	  a	  Myc-­‐GFP	   reporter	   from	  the	  endogenous	  c-­‐myc	  
locus,	  we	  found	  that	  c-­‐Myc	  protein	  expression	  is	  significantly	  lower	  in	  naïve	  ES	  cells	  
compared	   to	   cells	   cultured	   in	   serum	   +	   LIF.	   When	   both	   c-­‐	   and	   N-­‐myc	   genes	   are	  
conditionally	   deleted	   (Myc	   dKO)	   using	   the	   Cre-­‐loxP	   system,	   naïve	   mouse	   ES	   cells	  
undergo	  cell	  cycle	  arrest.	  Although	  this	  type	  of	  cell	  cycle	  behavior	  with	  a	  decreased	  
Summary	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rate	  of	   cell	  division	   is	  often	  associated	  with	  differentiation,	  Myc	  dKO	  ES	   cells	   form	  
smaller	  but	  undifferentiated	  colonies.	  Most	  surprisingly,	  Myc	  dKO	  ES	  cells	  maintain	  
the	  expression	  of	  the	  core	  stem	  cell	  factor	  network	  including	  Oct4,	  Nanog	  and	  Sox2	  
both	  at	  the	  RNA	  and	  the	  protein	  level.	  To	  determine	  the	  molecular	  properties	  of	  Myc	  
dKO	  ES	  cells,	  we	  performed	  RNA-­‐seq	  analysis	  24	  and	  96	  hours	  after	  Cre	   induction.	  
Our	  results	  show	  that	  Myc	  is	  not	  exclusively	  regulating	  the	  cell	  cycle	  machinery	  but	  is	  
directly	   and	   indirectly	   involved	   in	   multiple	   aspects	   of	   ES	   cell	   metabolism.	   In	   the	  
absence	   of	   both	   Myc	   proteins,	   expression	   of	   genes	   controlling	   and	   executing	  
ribosomal	   biogenesis	   as	   well	   as	   protein	   and	   DNA	   synthesis	   is	   strongly	   down-­‐
regulated,	  leading	  to	  a	  state	  of	  “metabolic	  dormancy”.	  	  
The	   state	   of	   “metabolic	   dormancy”	   of	   ES	   cells	   in	   vitro	   resembled	   the	   state	   of	  
embryonic	   diapause	   in	   vivo.	   Diapause	   is	   a	   poorly	   understood	   phenomenon	   of	  
reversible	   arrest	   of	   embryonic	   development	   prior	   to	   implantation.	   In	   mice,	  
facultative	   diapause	   occurs	   to	   delay	   implantation	   of	   newly	   formed	   embryos	  when	  
the	  mother	   is	   feeding	   a	   previous	   litter.	  When	  we	   compared	   our	   data	   to	   reported	  
global	   gene	   expression	   profiling	   of	   diapause	   embryos	   (Hamatani	   et	   al.,	   2004),	   we	  
observed	   that	   dKO	   Myc	   ES	   cells	   possess	   surprising	   similarity	   with	   the	   dormant	  
blastocyst,	  characterized	  by	  reduced	  DNA	  synthesis	  and	  cell	  division,	   low	  metabolic	  
activity	  and	  activation	  of	  the	  insulin	  pathway	  (Given,	  1988;	  Hamatani	  et	  al.,	  2004).	  
These	   data	   suggest	   that,	   in	   the	   absence	   of	   differentiation	   cues,	   c-­‐Myc	   and	  N-­‐Myc	  
control	  the	  cell	  cycle	  of	  ES	  cells	  and	  the	  transcriptional	  networks	  responsible	  for	  the	  
entire	   metabolism	   and	   biosynthesis	   pathways	   while	   the	   pluripotency	   network	   is	  
controlled	  by	  other	  means.	  Loss	  of	  Myc	  activity	  has	  dramatic	  consequences	  on	  the	  
metabolic	   status	   of	   ES	   cells	   promoting	   their	   entry	   into	   a	   state	   of	   likely	   reversible	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2. Zusammenfassung	  
	  
Pluripotenz	   ist	   definiert	   als	   die	   Fähigkeit	   früher	   embryonaler	   Zellen	   jede	   Zelle	   des	  
Organismus	   bilden	   zu	   können.	   In	   vivo	   besteht	   diese	   Eigenschaft	   im	   Epiblast	   nur	  
vorübergehend,	   während	   sie	   in	   vitro	   durch	   die	   Gewinnung	   von	   embryonalen	  
Stammzellen	   (ES-­‐Zellen)	   auf	   unbegrenzte	   Zeit	   fortbestehen	   kann.	   Die	   zweite	  
Eigenschaft,	   die	   ES-­‐Zellen	   auszeichnet,	   ist	   die	   Selbsterneuerung.	   Diese	   Fähigkeit,	  
weitere	  Stammzellen	  zu	  bilden,	  erfordert	  die	  Koordinierung	  der	  Zellproliferation	  und	  
der	  Wahl	   der	   zellulären	   Identität	   (Orford	   and	   Scadden,	   2008).	   Lange	   Zeit	   wurden	  
murine	  ES-­‐Zellen	  auf	  mitotisch	  inaktivierten	  Fibroblasten	  in	  einem	  Kulturmedium	  in	  
Anwesenheit	   von	   fötalem	   Rinderserum	   und	   dem	   leukemia	   inhibitory	   factor	   (LIF)	  
expandiert.	  Unter	  diesen	  Bedingungen	  sind	  die	  ES-­‐Zellen	  metastabil	  und	  zeigen	  eine	  
Heterogenität	  sowohl	  in	  ihrer	  Morphologie	  als	  auch	  in	  der	  Expression	  von	  wichtigen	  
Pluripotenzfaktoren	  wie	  Oct4	  und	  Nanog	  (Nichols	  and	  Smith,	  2009).	   In	  Medien,	  die	  
Serum	  und	  LIF	  enthalten,	  hängt	  die	  Pluripotenz	  und	  Fähigkeit	  zur	  Selbsterneuerung	  
von	  dem	  Transkriptionsfaktor	  Myc	  ab	  (Smith	  et	  al.,	  2010).	  So	  wurde	  gezeigt,	  dass	  die	  
Expression	   von	   Gata6,	   einem	   Masterregulator	   des	   primitiven	   Endoderms,	   durch	  
Myc-­‐Proteine	   gehemmt	  wird.	  Weiterhin	   kontrollieren	   sie	   den	   Zellzyklus,	   indem	   sie	  
die	   Expression	   der	   mir-­‐17-­‐92-­‐miRNAs	   regulieren.	   Arbeiten	   aus	   der	   Gruppe	   von	  
Austin	   Smith	   konnten	   kürzlich	   zeigen,	   dass	   die	   Kultivierung	   in	   Abwesenheit	   von	  
Serum	   und	  mit	   Supplementierung	   von	   zwei	   Inhibitoren	   (2i	   +	   LIF),	   die	   ES-­‐Zellen	   im	  
naiven	  Zustand	  der	  Pluripotenz	  halten	  können,	  dem	  sogenannten	  „ground	  state	  of	  
pluripotency“.	  Dieser	  Zustand	  zeichnet	  sich	  durch	  eine	  größere	  Übereinstimmung	  zur	  
inneren	   Zellmasse	   der	   Blastozyste	   aus	   (Ying	   et	   al.,	   2008).	   Die	   beiden	   zum	   Einsatz	  
kommenden	   Inhibitoren	   hemmen	   dabei	   den	   Erk-­‐	   sowie	   den	   Glykogen	   Synthase	  
Kinase-­‐3	   (GSK3)	   Signalweg.	   Da	   mit	   verschiedenen	   Kulturbedingungen	  
unterschiedliche	  Transkriptions-­‐	  und	  epigenetische	  Eigenschaften	  in	  Maus	  ES-­‐Zellen	  
einhergehen	   (Marks	   et	   al.,	   2012),	   sollten	   im	   Rahmen	   dieser	   Arbeit	   die	   Expression	  
und	   die	   Erfordernis	   der	   Myc-­‐Proteine	   im	   Zusammenhang	   mit	   dem	   naiven	  
Grundzustand	  der	  Pluripotenz	  untersucht	  werden.	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Zur	  Untersuchung	   der	   c-­‐Myc-­‐Expression	  wurde	   eine	   transgene	   ES-­‐Zelllinie	   erzeugt,	  
die	   anstatt	   im	   endogenen	   c-­‐Myc	   Lokus	   einen	   GFP-­‐c-­‐Myc-­‐Reporter	   besitzt.	   Dabei	  
stellte	  sich	  heraus,	  dass	  unter	  2i-­‐Bedingungen	  das	  c-­‐Myc-­‐Protein	  signifikant	  niedriger	  
exprimiert	   war	   als	   unter	   Serumbedingungen.	   Nach	   conditioneller	   genetischer	  
Deletion	  der	  c-­‐	  und	  N-­‐myc	  gene	  (Doppel-­‐Knockout,	  dKO)	  arretiert	  der	  Zellzyklus	  der	  
ES-­‐Zellen.	   Charakteristischerweise	   geht	   eine	   solche	   Verlängerung	   der	   G1-­‐Phase	  
sowie	   verminderte	   Proliferation	   mit	   der	   Differenzierung	   von	   ES-­‐Zellen	   einher.	   Im	  
Gegensatz	   dazu	   zeigen	   Myc-­‐dKO-­‐ES-­‐Zellen	   überraschend	   einen	   undifferenzierten	  
Phänotyp.	   Dies	   zeigt	   sich	   morphologisch	   durch	   Bildung	   kleiner,	   undifferenzierter	  
Kolonien	   sowie	   durch	   die	   fortwährende	   Expression	   der	   Pluripotenz-­‐assoziierten	  
Faktoren	  Oct4,	  Nanog	  und	  Sox2	  sowohl	  auf	  RNA-­‐	  als	  auch	  auf	  Proteinebene.	  Um	  die	  
molekularen	   Eigenschaften	   von	   Myc-­‐dKO-­‐ES-­‐Zellen	   zu	   untersuchen,	   wurden	  
genomweite	   RNA-­‐Sequenzierungen	   24	   und	   96	   Stunden	   nach	   dMyc-­‐Deletion	  
durchgeführt.	   Die	   Ergebnisse	   legen	   nahe,	   dass	   Myc	   nicht	   ausschließlich	   für	   die	  
Regulation	   der	   Zellzyklusmaschinerie	   verantwortlich	   ist,	   sondern	   zusätzlich	   auf	  
direkte	   und	   indirekte	  Weise	   für	  multiple	   Aspekte	   des	   Zellmetabolismus	   eine	   Rolle	  
spielt.	   In	  Abwesenheit	  von	  c-­‐Myc	  und	  N-­‐Myc	  sind	  Gene	  der	  ribosomalen	  Biogenese	  
sowie	   der	   Protein-­‐	   und	   DNA-­‐Synthese	   stark	   herabreguliert,	   was	   zu	   einem	  
„metabolischen	  Ruhezustand“	  der	  ES-­‐Zelle	  führt.	  
	  Dieser	  metabolische	  Ruhezustand	  der	  ES	  Zellen	  in	  vitro,	  erinnerte	  an	  den	  Status	  	  der	  
embryonalen	   Diapause.	   	   Diapause	   ist	   ein	   wenig	   verstandenes	   Phänomen	   eines	  
reversiblen	   Arrests	   der	   embryonalen	   Entwicklung	   vor	   der	   Einnistung	   in	   die	  
Uteruswand.	   In	   Mäusen	   kann	   es	   durch	   die	   Diapause	   zu	   einer	   verzögerten	  
Implantation	   von	   Embryonen	   kommen,	   wenn	   das	   Muttertier	   noch	   einen	  
vorangegangenen	  Wurf	  versorgt.	  Der	  Vergleich	  mit	  publizierten	  Daten	  	  zur	  globalen	  
Genexpression	   von	   Embryonen	   in	   der	  Diapause	   (Hamatani	   et	   al.,	   2004)	   zeigt,	   dass	  
c/N-­‐Myc-­‐deletierte	   ES-­‐Zellen	   eine	   starke	   Ähnlichkeit	  mit	   der	   ruhenden	   Blastozyste	  
haben.	   Dies	   ist	   charakterisiert	   durch	   die	   reduzierte	   DNA-­‐Synthese	   und	   Zellteilung,	  
niedriger	   metabolischer	   Aktivität	   und	   Aktivierung	   des	   Insulin-­‐Signalweges	   (Given,	  
1988;	  Hamatani	  et	  al.,	  2004).	  
Diese	   Daten	   zeigen,	   dass	   c-­‐Myc	   und	   N-­‐Myc	   in	   Abwesenheit	   von	  
Differenzierungssignalen	  für	  den	  gesamten	  Metabolismus	  und	  Synthesewege	  von	  ES	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Zellen	   verantwortlich	   ist,	   während	   die	   Kontrolle	   der	   Pluripotenz	   durch	   andere	  
Faktoren	   reguliert	   wird.	   	   Das	   Abschalten	   der	   Myc	   Aktivität	   ES	   Zellen	   in	   einen	  
möglicherweise	   reversiblen	   metabolischen	   Ruhezustand,	   	   der	   dem	   Status	   von	  
Diapause	  Embryos	  stark	  ähnelt.	  
Introduction	  
_____________________________________________________________________	  
	   6	  
3. Introduction	  
3.1 Stem	  Cells	  
Stem	   cells	   are	   defined	   by	   two	   main	   properties:	   self-­‐renewal	   and	   capacity	   to	  
differentiate	  into	  more	  mature	  cells	  (Reya	  et	  al.,	  2001).	  	  
Self-­‐renewal	  is	  the	  process	  used	  by	  stem	  cells	  to	  generate	  more	  stem	  cells	  (He	  et	  al.,	  
2009)	  with	  a	  mechanism	  that	  requires	  the	  coordination	  of	  cell	  proliferation	  and	  cell-­‐
fate	  choices	  (Orford	  and	  Scadden,	  2008).	  A	  self-­‐renewing	  stem	  cell	  can	  divide	  either	  
symmetrically	  or	  asymmetrically	  to	  generate	  one	  or	  two	  daughter	  stem	  cells	  with	  a	  
developmental	   potential	   similar	   to	   the	   mother	   cell.	   This	   self-­‐renewal	   ability	   is	  
necessary	  both	  during	  the	  embryonic	  development,	  to	  expand	  the	  number	  of	  stem	  
cells,	  and	  throughout	  the	  adult	   life,	   to	  guarantee	  the	  perpetuation	  of	  the	  stem	  cell	  
pool	  within	  adult	   tissues	   (He	  et	   al.,	   2009).	   Stem	  cells	   are	  able	   to	  differentiate	   into	  
one	   or	  more	   specialized	   cell	   types:	   according	   to	   their	   differentiation	   potential,	  we	  
can	  distinguish	  unipotent,	  multipotent	  or	  pluripotent	  stem	  cells.	  
	  
According	   to	   their	   origin,	   stem	   cells	   can	   be	   categorized	   into	   embryonic	   and	   adult	  
stem	  cells.	  
Embryonic	   stem	   (ES)	   cells	   are	   derived	   from	   the	   inner	   cell	   mass	   (ICM)	   of	   the	  
blastocyst,	   an	   embryonic	   structure	   that	   contains	   pluripotent	   cells	  with	   the	   unique	  
capacity	  to	  differentiate	  into	  all	  the	  tissues	  of	  the	  adult	  organism.	  Although	  ES	  cells	  
are	  not	  identical	  to	  ICM	  cells,	  they	  can	  be	  cultured	  in	  vitro,	  maintaining	  their	  ability	  
to	   differentiate	   into	   all	   lineages	   and,	  when	   injected	   into	   blastocysts,	   they	   re-­‐enter	  
embryogenesis	  and	  participate	  in	  embryonic	  development	  (Nishikawa	  et	  al.,	  2007).	  
Adult	   stem	  cells	  play	   the	  essential	   role	  of	   sustaining	   the	  expansion	  of	  most	   tissues	  
during	  postnatal	  life	  and	  to	  replace	  the	  cells	  lost	  upon	  injury	  (Dor	  and	  Melton,	  2004).	  
These	  stem	  cells	  are	  located	  in	  specific	  tissues	  such	  as	  the	  hematopoietic	  system,	  the	  
intestine	   and	   the	   epidermis,	   and	   lie	   in	   a	   unique	  microenvironment,	   the	   stem	   cell	  
niche,	  that	  controls	  their	  behavior	  and	  provides	  the	  factors	  necessary	  to	  regulate	  the	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Studying	   the	   biology	   of	   both	   embryonic	   and	   adult	   stem	   cells	   is	   essential	   to	  
understand	   the	   mechanisms	   that	   regulate	   self-­‐renewal	   and	   differentiation.	   This	  
knowledge	   holds	   a	   great	   potential	   to	   be	   applied	   in	   cellular	   therapeutics	   for	  
degenerative	  diseases	  (Orford	  and	  Scadden,	  2008).	  
	  
3.2 Embryonic	  stem	  cells	  
3.2.1 The	  origin	  of	  embryonic	  stem	  cells	  
The	   development	   of	   the	   mammalian	   embryo	   begins	   with	   the	   fertilization	   of	   the	  
oocyte	  that	  is	  packed	  within	  the	  zona	  pellucida,	  a	  glycoprotein	  protective	  layer.	  After	  
the	   formation	  of	   the	   zygote,	   a	   sequential	   round	  of	  divisions	  generates	  a	   cluster	  of	  
cells	  known	  as	  blastomeres.	  Some	  of	  these	  cells	  remain	  apolar	  and	  occupy	  the	  inner	  
part	  of	  the	  embryo,	  the	  so-­‐called	  inner	  cell	  mass	  (ICM).	  At	  the	  same	  time,	  polar	  cells	  
surround	   the	   ICM	  and	   form	  an	  outer,	  epithelial	   layer	   termed	   trophoblast	   (Johnson	  
and	  Ziomek,	  1981a,	  b).	  Trophoblast	  cells	  transfer	  fluid	  into	  the	  blastocyst	  to	  form	  a	  
cavity,	  the	  blastocoel,	  and	  after	  cavitation	  the	  cells	  of	  the	  ICM	  develop	  into	  epiblast	  
and	   hypoblast.	   The	   hypoblast	   is	   also	   known	   as	   “primitive	   endoderm”,	   and	   is	   an	  
epithelium	  overlying	   the	  blastocoelic	   surface	  of	   the	   ICM	   (Nichols	   and	  Smith,	  2012)	  
(Figure	   1).	   The	   newly	   formed	   epiblast	   is	   a	   cluster	   of	   10–20	   unspecialized	   cells.	   A	  
single	   mouse	   epiblast	   cell,	   isolated	   at	   this	   stage	   and	   microinjected	   into	   another	  
blastocyst,	  can	  contribute	  to	  all	  lineages	  (Gardner,	  1998).	  Since	  each	  cell	  of	  the	  early	  
epiblast	  is	  potentially	  able	  to	  generate	  the	  entire	  fetus,	  the	  pre-­‐implantation	  epiblast	  
can	  be	  considered	  as	  the	  developmental	  ground	  state	  (Nichols	  and	  Smith,	  2009).	  
	  
In	   1981	  Martin	   Evans	  was	   able	   for	   the	   first	   time	   to	   culture	   pluripotent	   stem	   cells	  
from	   a	   mouse	   blastocyst	   (Evans	   and	   Kaufman,	   1981).	   The	   establishment	   of	   the	  
culture	  conditions	  able	  to	  support	  the	  growth	  of	  these	  embryonic	  stem	  (ES)	  cells	  was	  
the	   result	   of	   more	   than	   20	   years	   of	   research	   on	   pluripotent	   cells	   present	   in	  
malignant	   tumors	   called	   teratocarcinomas.	   In	   1954,	   Stevens	   and	   Little	   established	  
inbred	   strains	   of	   mice	   with	   high	   incidence	   of	   spontaneous	   testicular	  
teratocarcinomas.	   These	   transplantable	   tumors	   originated	   from	   primordial	   germ	  
cells	  of	   the	  fetal	   testes	  and,	  most	   interestingly,	  were	  composed	  of	  several	   types	  of	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embryonic	  and	  adult	  tissues	  foreign	  to	  testes	  (Stevens	  and	  Little,	  1954).	  Barry	  Pierce,	  
in	   1964,	   showed	   that	   the	   transplantation	   of	   single	   cells	   derived	   from	  
teratocarcinomas	   could	   generate	   tumors	   containing	   a	  wide	   range	  of	   differentiated	  
tissues	   (Kleinsmith	   and	   Pierce,	   1964).	   These	   individual	   self-­‐renewing	   pluripotent	  
tumor	   cells	   were	   than	   defined	   embryonal	   carcinoma	   (EC)	   cells.	   In	   1970,	   two	  
independent	  groups	  were	  able	  to	  grow	  EC	  cells	  in	  culture	  (Kahan	  and	  Ephrussi,	  1970;	  
Rosenthal	   et	   al.,	   1970).	   These	   clonally	   isolated	   and	   in	   vitro	   expanded	   EC	   cells	  
retained	   the	   capacity	   to	   form	   teratocarcinomas	  when	   injected	   into	  mice,	   although	  
extensive	  passaging	  dramatically	  reduced	  their	  differentiation	  ability.	  
	  
	  
Figure	   1:	   Lineage	   segregation	   in	   the	   blastocyst.	   The	   late	   blastocyst	   stage	   embryo	   (E4.5)	  
contains	   three	   distinct	   lineage-­‐restricted	   subpopulations:	   the	   trophectoderm,	   which	  
mediates	  implantation	  and	  then	  expands	  to	  form	  the	  placenta;	  the	  primitive	  endoderm,	  that	  
gives	  rise	  to	  the	  yolk	  sac;	  the	  early	  epiblast,	  which	  retains	  pluripotency	  and	  gives	  rise	  to	  all	  
the	   somatic	   tissues	   and	   the	   germ	   cell	   lineage	   of	   the	   embryo.	  Modified	   from	   (Arnold	   and	  
Robertson,	  2009).	  
	  	  
One	  of	  the	  proofs	  of	  the	  enormous	  similarity	  between	  EC	  cells	  and	  early	  embryonic	  
cells	   was	   the	   capacity	   of	   some	   EC	   lines	   to	   participate	   in	   embryogenesis	   (Brinster,	  
1974;	  Papaioannou	  et	  al.,	  1975):	  when	  introduced	  into	  developing	  embryos,	  in	  vitro	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Since	  EC	  cells	  were	  mostly	  aneuploid,	  probably	  as	  a	  consequence	  of	  selection	  during	  
tumor	   growth	   and	   in	   vitro	   passage,	   they	  were	   not	   capable	   of	   proceeding	   through	  
meiosis	  and	  produce	  mature	  gametes	  (Smith,	  2001).	  Therefore	  several	  chimeric	  mice	  
developed	  tumors	  and	  none	  of	  them	  was	  capable	  of	  germ-­‐line	  transmission.	  
	  
In	  1970	  there	  were	  the	  first,	  striking	  observations	  that	  early	  mouse	  embryos	  grafted	  
into	  mice	   giving	   rise	   to	   teratocarcinomas	   (Solter	   et	   al.,	   1970;	   Stevens,	   1970).	   The	  
homology	  of	  EC	  cells	  with	  the	  early	  embryo	  became	  slowly	  clearer	  and	  the	   lessons	  
learned	   from	   EC	   cells	   contributed	   to	   establish	   the	   conditions	   to	   culture	   the	  
pluripotent	  stem	  cells	   from	  the	  embryos.	   In	  1981	  Martin	  Evans,	  Matthew	  Kaufman	  
and	  Gale	  Martin	  were	  able	  for	  the	  first	  time	  to	  culture	  pluripotent	  cells	  directly	  from	  
the	  mouse	   embryos	   on	   a	   feeder	   layer	   of	  mitotically	   inactivated	   fibroblasts	   (Evans	  
and	  Kaufman,	  1981;	  Martin,	  1981),	  known	  to	  support	  the	  efficient	  establishment	  of	  
EC	  cultures	  (Martin	  and	  Evans,	  1975).	  These	   in	  vitro	  cultured	  pluripotent	  cells	  were	  
named	  mouse	  embryonic	  stem	  (ES)	  cells	  and	  retained	  a	  completely	  normal,	  diploid	  
karyotype.	  ES	  cells	  closely	  resembled	  EC	  cells	   in	  morphology,	  growth	  behavior,	  and	  
markers	  expression	  (Smith,	  2001)	  and,	  most	  extraordinary,	  once	   injected	   into	  early	  
mouse	   embryos	   they	   could	   give	   rise	   to	   chimeras.	   Since	   a	   balanced	   set	   of	  
chromosomes	   is	   necessary	   for	   meiosis,	   karyotypically	   normal	   ES	   cells	   could	  
contribute	  to	  all	  the	  tissues	  of	  the	  chimaeras,	  including	  the	  germ-­‐line	  (Bradley	  et	  al.,	  
1984;	  Robertson	  et	  al.,	  1986).	  Since	  the	  establishment	  of	  the	  culture	  conditions	  able	  
to	   support	   their	   growth,	   ES	   cell	   lines	   have	   been	   derived	   from	   pre-­‐implantation	  
epiblasts	  (Evans	  and	  Kaufman,	  1981)	  but	  also	  from	  morulae	  and	  blastomeres	  at	  the	  
eight-­‐cell-­‐stage	  (Tesar,	  2005).	  However,	  until	  now	  there	  is	  no	  evidence	  showing	  that	  
ES	   cells	   isolated	   from	   different	   developmental	   stages	   are	   molecularly	   or	  
phenotypically	   different	   (Nichols	   and	   Smith,	   2012).	   This	   suggests	   that	   embryonic	  
cells	  are	  not	  frozen	  at	  the	  stage	  when	  they	  are	  put	  in	  culture	  but	  they	  may	  continue	  
to	   follow	   a	   developmental	   program,	   and	   progress	   to	   the	   epiblast	   stage	   even	   if	  
isolated	  from	  earlier	  stage	  embryos	  (Nichols	  and	  Smith,	  2009).	  
In	   contrast	   to	   the	   limited	   number	   of	   pluripotent	   cells	   present	   in	   the	   ICM,	   in	   vitro	  
cultured	   ES	   cells	   could	   be	   extensively	   expanded	   and	   manipulated.	   Making	   use	   of	  
homologous	   recombination,	   Oliver	   Smithies	   and	   Mario	   Capecchi	   pioneered	   gene	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targeting	   in	   ES	   cells	   (Capecchi,	   2005;	   Smithies,	   2005):	   they	   showed	   that	   an	  
endogenous	   DNA	   sequence	   can	   be	   exchanged	  with	   a	   very	   similar	   exogenous	   DNA	  
sequence	   to	   introduce	   specific	   genomic	  modifications	   in	   the	   recipient	   cell.	   In	   vitro	  
cultured	  and	  genetically	  modified	  ES	  cells	  opened	  the	  era	  of	  in	  vivo	  mouse	  genetics.	  
	  
3.2.2 ES	  cells	  pluripotency	  
The	   property	   of	   pluripotency	   is	   conferred	   to	   ES	   cells	   by	   the	   expression	   of	   three	  
transcription	  factors	  Oct4,	  Nanog	  and	  Sox2,	  regarded	  as	  the	  intrinsic	  determinants	  of	  
pluripotency.	  These	  proteins	  are	  expressed	  both	  in	  vitro	  in	  ES	  cells	  and	  in	  vivo,	  in	  the	  
ICM	   of	   the	   blastocyst	   (Jaenisch	   and	   Young,	   2008).	   Besides	   this	   core	   regulatory	  
network,	  the	  gene	  expression	  program	  of	  in	  vitro	  cultured	  ES	  cells	  has	  been	  shown	  to	  
more	   broadly	   depend	   on	   signal	   transduction	   pathways,	   chromatin	   regulators,	   and	  
regulatory	  RNAs.	  	  
	  
Intrinsic	  determinants	  of	  ES	  cells	  pluripotency	  
A	   core	   regulatory	   circuit	   consisting	   of	   the	   three	   transcription	   factors	   Oct4,	   Nanog	  
and	   Sox2,	   is	   necessary	   to	   specify	   the	   undifferentiated	   state	   of	   ES	   cells.	   Functional	  
studies	  have	  proven	  that	  these	  transcription	  factors	  bind	  to	  their	  own	  promoters,	  as	  
well	   as	   the	   genes	   encoding	   the	   two	   other	   factors,	   establishing	   an	   autoregulatory	  
circuitry	   (Boyer	   et	   al.,	   2005;	   Jaenisch	   and	   Young,	   2008)	   (Figure	   2)	   which	   might	  
facilitate	  the	  maintenance	  of	  the	  pluripotent	  state	  (Alon,	  2007).	  
	  
	  
Figure	  2:	  Auto-­‐regulatory	  circuitry	  of	  the	  core	  ES	  cells	  pluripotency	  network.	  Oct4,	  Nanog	  
and	  Sox2	  form	  an	  interconnected	  auto-­‐regulatory	  loop,	  binding	  their	  own	  promoters	  and	  the	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Oct4	  is	  encoded	  by	  the	  Pou5f1	  gene	  and	  belongs	  to	  the	  Pit-­‐Oct-­‐Unc	  (POU)	  family	  of	  
homeodomain	  proteins.	  Its	  expression	  is	  restricted	  to	  germ	  line	  cells,	  early	  embryos,	  
ES	   cells	   and	   EC	   cells	   (Okamoto	   et	   al.,	   1990;	   Scholer	   et	   al.,	   1989a;	   Scholer	   et	   al.,	  
1989b).	   In	   vivo,	   Oct4	   is	   necessary	   in	   the	   establishment	   and	   maintenance	   of	  
pluripotency:	  embryos	  lacking	  Oct4	  develop	  to	  the	  blastocyst	  stage,	  but	  the	  cells	  of	  
the	   ICM	   loose	   their	   pluripotency	   and	   differentiate	   into	   trophectoderm.	   For	   this	  
reason,	   ES	   cell	   lines	   lacking	   Oct4	   cannot	   be	   established	   (Nichols	   et	   al.,	   1998).	  
Interestingly,	  altered	  levels	  of	  Oct4	  expression	  can	  lead	  to	  divergent	  developmental	  
programs	   in	   ES	   cells:	   while	   Oct4	   repression	   induces	   loss	   of	   pluripotency	   and	  
differentiation	   to	   trophectoderm,	   less	   than	   two	   fold	   increase	   in	   Oct4	   expression	  
causes	  differentiation	  into	  primitive	  endoderm	  and	  mesoderm	  (Niwa	  et	  al.,	  2000).	  	  
	  
One	  of	  the	  key	  distinguishing	  roles	  of	  Sox2	  appears	  to	  be	  the	  maintenance	  of	  Oct4	  
expression.	   As	   for	   Oct4,	   Sox2-­‐null	   blastocysts	   fail	   to	   form	   a	   pluripotent	   ICM	   and	  
mouse	   ES	   cells	   deficient	   for	   Sox2	   differentiate	   into	   trophectoderm	   (Avilion	   et	   al.,	  
2003).	  Enforced	  expression	  of	  Oct4	  can	  rescue	  the	  differentiation	  phenotype	  of	  Sox	  
deficient	   ES	   cells	   (Masui	   et	   al.,	   2007).	   The	   similarities	   between	   Oct4	   and	   Sox2	  
knockout	  can	  be	  also	  attributed	  to	  the	  synergistic	  action	  of	  these	  two	  transcription	  
factors	  in	  the	  regulation	  of	  several	  ES	  cells	  specific	  genes,	  as	  Fgf4	  (Yuan	  et	  al.,	  1995)	  
and	  Utf1	  (Nishimoto	  et	  al.,	  1999).	  	  
	  
	  After	   more	   than	   10	   years	   of	   studies	   in	   which	   Oct4	   was	   regarded	   as	   the	   “master	  
gene”	   of	   ES	   cells	   pluripotency,	   Nanog	   has	   been	   recently	   recognized	   as	   the	   third	  
member	   of	   the	   core	   pluripotency	   network,	   as	   important	   as	  Oct4	   in	   regulating	   the	  
pluripotent	   state.	   Nanog	   was	   identified	   in	   2003,	   independently	   by	   the	   groups	   of	  
Austin	   Smith	   and	   Shinya	   Yamanaka,	   through	   a	   functional	   screening	   for	   genes	  
conferring	   LIF-­‐independent	   self-­‐renewal	   (Chambers	   et	   al.,	   2003)	   and	   in	   an	   in	   silico	  
differential	   expression	   analysis	   for	   genes	   exclusively	   expressed	   in	   mouse	   ES	   cells	  
compared	  to	  differentiated	  tissues	  (Mitsui	  et	  al.,	  2003).	  Nanog-­‐null	  embryos	  do	  not	  
develop	  beyond	  implantation	  (Mitsui	  et	  al.,	  2003),	  since	  they	  lack	  a	  pluripotent	  ICM.	  
Interestingly,	  in	  vitro	  deletion	  of	  both	  Nanog	  alleles	  in	  ES	  cells	  does	  not	  result	  in	  loss	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of	  pluripotency	  (Chambers	  et	  al.,	  2007).	  Although	  Nanog	  deficient	  ES	  cells	  are	  more	  
prone	   to	   differentiation,	   they	   can	   be	   maintained	   indefinitely	   in	   culture	   and	  
contribute	   to	   somatic	   chimeras	   (Chambers	   et	   al.,	   2007).	   This	   observation	   suggests	  
that	  Nanog	  might	  be	  necessary	  for	  the	  acquisition	  of	  pluripotency,	  but	  is	  dispensable	  
once	  pluripotency	  has	  been	  achieved	  (Chambers	  et	  al.,	  2007;	  Silva	  et	  al.,	  2009).	  
	  
An	  extended	  transcriptional	  network	  for	  pluripotency	  
Although	  Oct4,	  Sox2	  and	  Nanog	  can	  be	  considered	  as	  master	  regulators	  of	  the	  core	  
pluripotency	   network,	   the	   transcriptional	   network	   controlling	   ES	   cell	   pluripotency	  
includes	  several	  more	  factors	  (Yeo	  and	  Ng,	  2013).	  	  
	  
Some	  of	   these	   regulators	  were	   identified	   by	   using	   genome-­‐wide	   RNA	   interference	  
(RNAi)	   screenings	   with	   loss	   of	   pluripotency	   as	   functional	   readout.	   These	   factors	  
include	  Esrrb,	  Tbx3	  and	  Tcl1	  (Ivanova	  et	  al.,	  2006),	   the	  chromatin	  regulators	  Tip60-­‐
p400	  (Fazzio	  et	  al.,	  2008)	  and	  SetDB1	  (Bilodeau	  et	  al.,	  2009),	  and	  other	  important	  ES	  
cells	  transcriptional	  co-­‐factors	  as	  Cnot3	  and	  Trim28	  (Hu	  et	  al.,	  2009)	  and	  Paf1	  (Ding	  
et	  al.,	  2009).	  
	  
More	  regulators	  of	  pluripotency	  were	  identified	  looking	  at	  protein-­‐binding	  partners	  
of	   the	   core	  pluripotency	   factors.	  Using	   affinity	   purification	   and	  mass	   spectrometry	  
approaches,	  several	  Oct4	  and	  Nanog	  associated	  proteins	  were	  discovered	  (Pardo	  et	  
al.,	  2010;	  Wang	  et	  al.,	  2006),	   including	  Sall4	  (Sakaki-­‐Yumoto	  et	  al.,	  2006;	  Wu	  et	  al.,	  
2006;	  Zhang	  et	  al.,	  2006)	  and	  Rif1	  (Loh	  et	  al.,	  2006).	  
	  
Another	  powerful	  tool	  to	  understand	  the	  basis	  of	  the	  pluripotency	  network	  is	  ChIP-­‐
seq	  analysis,	  consisting	  of	  chromatin	   immunoprecipitation	  coupled	  to	  massive	  DNA	  
sequencing.	  This	  technology	  was	  applied	  to	  identify	  promoters	  of	  genes	  targeted	  by	  
the	  core	  pluripotency	  factors	  (Nanog,	  Oct4	  and	  Sox2),	  the	  somatic	  cell	  reprograming	  
factors	  (Klf4	  and	  c-­‐Myc)	  and	  protein-­‐interacting	  partners	  of	  Nanog	  and	  Oct4	  (Dax1,	  
Nac1,	   Zfp1	   and	   Rex1)	   and	   provided	   a	   more	   comprehensive	   overview	   of	   the	  
pluripotency	  network	  in	  ES	  cells	  (Kim	  et	  al.,	  2008).	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Comparison	   of	   promoter	   occupation	   with	   global	   gene	   expression	   analysis	   has	  
revealed	   that	   the	   core	   transcription	   factors	  occupy	  both	   the	  promoters	  of	   actively	  
transcribed	   genes	   necessary	   to	   maintain	   the	   ES	   cell	   state,	   and	   the	   promoters	   of	  
silent	   genes,	   whose	   expression	   would	   promote	   lineage	   commitment	   and	   cell	  
differentiation	  (Boyer	  et	  al.,	  2005;	  Loh	  et	  al.,	  2006)	  (Figure	  3).	  
	  
	  
Figure	  3:	  Model	  of	   the	  ES	   cell	   regulatory	   circuitry.	  Oct4,	  Sox2,	  and	  Nanog	  occupy	  actively	  
transcribed	   genes,	   including	   transcription	   factors	   and	   signaling	   components	   necessary	   for	  
pluripotency.	  At	  the	  same	  time,	  the	  three	  core	  pluripotency	  factors	  also	  occupy	  silent	  genes	  
encoding	  transcription	  factors	  that,	  if	  expressed,	  would	  promote	  ES	  cells	  differentiation	  into	  
different	  lineages.	  At	  this	  latter	  set	  of	  genes,	  RNA	  polymerase	  II	  (pol	  II)	  initiates	  transcription	  
but	  does	  not	  produce	  complete	  transcripts	  since	  the	  polycomb	  (PcG)	  proteins	  prevent	  pol	  II	  
from	   transitioning	   into	   a	   fully	  modified	   transcription	   elongation	   apparatus.	   Adapted	   from	  
(Jaenisch	  and	  Young,	  2008).	  
	  
Although	   the	   transcription	   initiation	   apparatus	   is	   recruited	   to	   the	   promoters	   of	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This	  means	  that	  the	  RNA	  polymerase	  II	   (pol	   II)	  only	  generates	  short	  transcripts	  and	  
pauses	  until	  pause-­‐release	  factors	  and	  elongation	  factors	  allow	  further	  transcription	  
(Young,	   2011).	   In	   ES	   cells	   developmental	   genes	   are	   generally	   organized	   in	  bivalent	  
domains,	  since	  they	  are	  characterized	  by	  nucleosomes	  with	  both	  histone	  H3K4me3,	  
associated	   to	   gene	   activation,	   and	   H3K27me3,	   associated	   to	   gene	   repression	  
(Jaenisch	  and	  Young,	  2008).	  These	  bivalent	  domains	  have	  been	  proposed	  to	  silence	  
developmental	  genes	  while	  keeping	  them	  poised	  for	  activation.	  Poised	  genes	  can	  be	  
rapidly	  activated	  in	  response	  to	  differentiation	  stimuli	  (Bernstein	  et	  al.,	  2006).	  
	  
Extrinsic	  determinants	  of	  pluripotency	  
When	  Martin	  Evans	  isolated	  and	  cultured	  ES	  cells	  for	  the	  first	  time,	  he	  made	  use	  of	  a	  
culture	  medium	  containing	  fetal	  bovine	  serum	  (FBS)	  and	  a	  feeder	  layer	  of	  mitotically	  
inactivated	  fibroblasts	  to	  support	  ES	  cells	  growth	  (Evans	  and	  Kaufman,	  1981).	  Later,	  
the	  medium	  was	  supplemented	  with	  the	  leukemia	  inhibitory	  factor	  (LIF)	  (Smith	  et	  al.,	  
1988;	  Williams	  et	  al.,	  1988)	  identified	  as	  the	  cytokine	  produced	  by	  the	  fibroblasts	  to	  
sustain	   ES	   cells	   self-­‐renewal	   (Niwa	   et	   al.,	   1998).	   Although	   self-­‐renewal	   of	   in	   vitro	  
cultured	  ES	  cells	  apparently	  depends	  on	  exogenous	   signals,	   it	   is	   important	   to	  keep	  
into	   consideration	   that	   the	   requirement	   for	   a	   particular	   signal	   may	   be	   context-­‐
dependent	  (Boiani	  and	  Scholer,	  2005)	  and	  signaling	  pathways	  affecting	  ES	  cells	  may	  
not	  serve	  the	  same	  function	  in	  the	  developing	  embryo.	  	  	  
	  
The	  LIF	  signaling	  cascade	  
LIF	  is	  a	  member	  of	  the	  IL6	  family	  of	  cytokines.	  On	  the	  plasma	  membrane,	  the	  binding	  
of	   LIF	   to	   its	   receptor	   (LIFR)	   causes	   the	   heterodimerization	   of	   the	   receptor	   with	  
another	  transmembrane	  protein,	  the	  glycoprotein-­‐130	  (gp130)	  (Boulton	  et	  al.,	  1994).	  
Upon	  LIF-­‐induced	  receptor	  dimerization,	  the	  intracellular	  domain	  of	  the	  LIFR–gp130	  
heterodimer	   can	   recruit	   the	   Janus	   tyrosine	   kinase	   (JAK)	   (Boulton	   et	   al.,	   1994)	   and	  
become	   phosphorylated,	   functioning	   as	   docking	   site	   for	   the	   signal	   transducer	   and	  
activator	   of	   transcription-­‐3	   (STAT3).	   Receptor-­‐bound	   STAT3	   is	   phosphorylated	   on	  
Tyr705	  by	   JAKs	  before	  dimerizing	  and	  translocating	   to	   the	  nucleus	  where	   it	  acts	   to	  
modulate	   transcription	   of	   target	   genes	   (Boiani	   and	   Scholer,	   2005)	   (Figure	   4).	   The	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treatment	  of	  ES	  cells	  with	  LIF	  also	   induces	   the	  phosphorylation	  of	   the	  extracellular	  
signal-­‐regulated	   protein	   kinases,	   ERK1	   and	   ERK2	   (Burdon	   et	   al.,	   1999b),	   and	  
increases	  the	  activity	  of	  the	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  (Boeuf	  et	  al.,	  
1997).	  
	  
Although	  LIF	   is	  required	   in	  vitro	   to	  derive	  and	  preserve	  ES	  cells	  under	  conventional	  
culture	  conditions	  (in	  the	  presence	  of	  serum),	  it	  is	  not	  clear	  if	  gp130-­‐STAT3	  signaling	  
plays	  an	  analogous	  role	   in	  vivo.	   Indeed,	  mouse	  embryos	   lacking	  gp130	  can	  develop	  
to	   a	   stage	   subsequent	   to	   the	  establishment	  of	   pluripotent	   epiblast	   (Yoshida	  et	   al.,	  
1996).	  This	  observation	  supports	  the	  hypothesis	  that	  alternative	  pathways	  might	  be	  
involved	  in	  maintaining	  pluripotency	   in	  vivo	  and	   in	  vitro.	   Interestingly,	   if	   induced	  to	  
enter	  diapause	  and	  to	  arrest	  at	   the	   late	  blastocyst	  stage,	  gp130	  knockout	  embryos	  
are	   unable	   to	   re-­‐enter	   normal	   development	   (Nichols	   et	   al.,	   2001).	   Therefore,	   the	  
responsiveness	  of	  ES	  cells	  to	  LIF	  may	  have	  its	  origins	  in	  the	  phenomenon	  of	  diapause.	  
	  
Figure	  4:	  Signaling	  pathways	  controlling	  ES	  cells	  pluripotency.	  In	  vitro	  cultured	  ES	  cells	  can	  
be	   exposed	   to	   several	   exogenous	   factors	   that	   are	   involved	   in	   nucleus-­‐directed	   signaling	  
pathways	  and	  modulate	  stem	  cell	  pluripotency.	  The	  leukemia	  inhibitory	  factor	  (LIF)	  exerts	  its	  
effect	   by	   binding	   to	   the	   LIF	   receptor	   and	   activating	   STAT3.	   BMP4	   contributes	   to	   the	   LIF	  
cascade,	  enhancing	  the	  self-­‐renewal	  and	  pluripotency	  of	  ESCs	  by	  activating	  the	  transcription	  
factor	   SMAD4,	   which	   than	   activates	  members	   of	   the	   Id	   (inhibitor	   of	   differentiation)	   gene	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3.2.3 Cell	  cycle	  of	  embryonic	  stem	  cells	  
Cell	  proliferation	  occurs	  through	  a	  series	  of	  events,	  collectively	  named	  as	  “cell	  cycle”.	  
Classically,	   the	   cell	   cycle	   has	   been	   divided	   into	   four	   phases,	   characterized	   by	  DNA	  
synthesis	   (S-­‐phase)	  and	  mitotic	  segregation	   (M-­‐phase),	   separated	  by	  gap	  phases	   to	  
allow	  cell	  growth	  (G1	  and	  G2)	  (Orford	  and	  Scadden,	  2008).	  The	  transitions	  from	  G1	  
to	   S-­‐phase	   and	   from	   G2	   to	   M-­‐phase	   are	   regulated	   by	   the	   presence	   of	   cell	   cycle	  
“checkpoints”	  to	  assess,	  among	  other	  factors,	  the	  integrity	  of	  the	  genome.	  	  
In	  the	  absence	  of	  stimuli,	  cells	  can	  exit	  the	  cell	  cycle	  and	  enter	  a	  quiescent	  state,	  also	  
termed	  G0.	  When	  cells	  are	  stimulated	  by	  mitogenic	  signals,	  they	  enter	  the	  cell	  cycle	  
and	   go	   from	   an	   early	   G1-­‐phase	   to	   a	   late	   G1-­‐phase.	   This	   transition	   is	   also	   called	  
“restriction	   point”,	   which	   represents	   a	   “point	   of	   no	   return”	   since	   cells	   in	   late	   G1-­‐
phase	  become	   independent	  on	  mitogenic	   signals	   to	  proceed	   through	   the	  cell	   cycle	  
(Orford	  and	  Scadden,	  2008)	  (Figure	  5).	  	  
	  
	  
Figure	   5:	   The	   eukaryotic	   cell	   cycle.	  The	  cell	   cycle	  consists	  of	   four	  distinct	  phases	  with	   the	  
aim	  to	  replicate	  and	  transmit	   the	  genetic	  material	   to	   the	  daughter	  cells.	  DNA	  synthesis	   (S-­‐
phase)	   and	   cell	   division	   (M-­‐phase)	   are	   separated	   by	   gap	   phases	   (G1	   and	  G2)	   to	   allow	   cell	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At	   the	  molecular	   level,	   cell	   cycle	   progression	   is	   highly	   regulated	   by	   the	   activity	   of	  
cyclin-­‐dependent	   kinases	   (CDKs)	   and	   cyclins.	   During	   the	   early	   G1-­‐phase,	   mitogens	  
activate	  cyclin	  D	  and	  CDK4	  and	  6,	  which	  drive	  the	  transition	  to	  the	  late	  G1-­‐phase.	  In	  
the	   late	  G1-­‐phase,	   the	   cyclin	   E-­‐CDK2	   complex	   inactivates	   by	  hyperphosphorylation	  
the	  Retinoblastoma	  (Rb)	  protein,	  which	  inhibits	  the	  E2F	  transcription	  factor	  (Hindley	  
and	  Philpott,	  2013).	  At	  this	  point,	  E2F	  can	  up-­‐regulate	  targets	  necessary	  to	  enter	  into	  
the	  S-­‐phase	  (Hindley	  and	  Philpott,	  2013).	  
In	   contrast	   to	   somatic	   cells,	   in	   in	   vitro	   cultured	  mouse	   ES	   cells	   the	   cyclin	   E-­‐CDK2	  
complex	   is	   active	   throughout	   the	   cell	   cycle,	   and	   the	   Rb	   protein	   is	   continuously	  
hyperphosphorylated	  (Burdon	  et	  al.,	  2002;	  Savatier	  et	  al.,	  1994).	  The	  absence	  of	  the	  
restriction	   point	   and	   of	   a	   mitogen-­‐dependent	   early	   G1-­‐phase	   results	   in	   an	  
extraordinary	   rapid	   cell	   cycle	   of	   around	   11-­‐16	   hours	   (Orford	   and	   Scadden,	   2008).	  
Upon	  ES	  cells	  differentiation,	   the	  cell	   cycle	   is	   restructured,	  with	   lengthening	  of	   the	  
G1-­‐phase	  and	  decrease	  in	  rate	  of	  cell	  division	  (He	  et	  al.,	  2009).	  
	  
3.2.4 Maintenance	  in	  culture	  of	  a	  naïve	  state	  of	  pluripotency	  
Cultured	  ES	  cells	  represent	  the	  immortalization	  of	  the	  early	  epiblast	  embryo	  (Nichols	  
and	   Smith,	   2009)	   and,	   retaining	   the	   ability	   to	   differentiate	   into	   all	   lineages,	   they	  
represent	  an	  extraordinary	  tool	  to	  understand	  the	  molecular	  basis	  of	  developmental	  
biology.	  To	  exploit	  the	  full	  potential	  of	  ES	  cells,	  it	  was	  essential	  to	  define	  the	  culture	  
conditions	   able	   to	   stabilize	   them	   in	   a	   state	   that	  more	   closely	   resembles	   the	   naïve	  
state	  of	  pluripotency	  in	  the	  mammalian	  embryo.	  	  
	  
Since	  mouse	  ES	  cells	  were	  first	  described,	  they	  have	  been	  derived	  and	  maintained	  by	  
using	   various	   combinations	   of	   feeder	   cells,	   conditioned	   media,	   cytokines,	   growth	  
factors,	   hormones,	   fetal	   calf	   serum,	   and	   serum	   extracts	   (Ying	   et	   al.,	   2008).	  
Nonetheless,	   ES	   cells	   cultured	   in	   serum-­‐containing	  medium	  are	   exposed	   to	   signals	  
promoting	   their	   differentiation	   and	   therefore	   exhibit	   great	   heterogeneity	   in	  
morphology	  and	  in	  expression	  of	  core	  pluripotency	  factors	  such	  as	  Nanog	  (Chambers	  
et	  al.,	  2007),	  Rex1	  (Toyooka	  et	  al.,	  2008)	  and	  Stella	  (Hayashi	  et	  al.,	  2008;	  Wray	  et	  al.,	  
2010).	  This	  heterogeneity	  suggested	  that	  mouse	  ES	  cells	  grown	  in	  serum	  may	  be	  in	  a	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metastable	  and	  more	  developmentally	  advanced	  state	  that	   is	  not	  representative	  of	  
the	   ground	   state	   of	   cells	   in	   the	   inner	   cell	   mass	   of	   the	   pre-­‐implantation	   embryo	  
(Guenther	  and	  Young,	  2012).	  
	  
Serum	  is	  not	  the	  only	  source	  of	  signals	  driving	  ES	  cells	  differentiation.	  Indeed,	  ES	  cells	  
are	   capable	   to	   induce	   developmental	   pathways	   in	   an	   autocrine	   manner.	   Fgf4	   is	  
expressed	  both	  by	  epiblast	  and	  ES	  cells	  and	  it’s	  a	  strong	  activator	  of	  the	  Erk	  pathway,	  
which	  acts	   to	   induce	  ES	  cells	  differentiation	  (Kunath	  et	  al.,	  2007).	  The	  cytokine	  LIF,	  
which	   promotes	   ES	   cells	   self-­‐renewal	   by	   activating	   the	   transcription	   factor	   STAT3	  
(Niwa	   et	   al.,	   1998)	   also	   stimulates	   the	  MAPK/Erk	   pathway	   (Burdon	   et	   al.,	   1999a).	  
Accordingly,	   genetic	   disruption	   or	   pharmacological	   inhibition	   of	   Erk	   signaling	   can	  
reduce	  differentiation	  in	  ES	  cell	  cultures	  (Burdon	  et	  al.,	  1999a;	  Kunath	  et	  al.,	  2007).	  
Partial	   inhibition	   of	   glycogen	   synthase	   kinase-­‐3	   (GSK3)	   has	   also	   been	   shown	   to	  
enhance	  ES	  cells	  self-­‐renewal	  (Sato	  et	  al.,	  2004;	  Ying	  et	  al.,	  2008)	  primarily	  through	  
stabilization	  of	  intracellular	  β-­‐catenin,	  which	  interacts	  with	  the	  T-­‐cell	  factor	  3	  (Tcf3)	  
and	  blocks	  its	  repression	  function	  on	  the	  pluripotency	  network	  (Wray	  et	  al.,	  2011).	  	  
	  
On	   the	   basis	   of	   these	   observations,	   the	   group	   of	   Austin	   Smith	   has	   shown	   that	  
extrinsic	  stimuli	  are	  dispensable	  for	  the	  derivation,	  propagation	  and	  pluripotency	  of	  
mouse	  ES	  cells	  (Ying	  et	  al.,	  2008)	  and	  naïve	  pluripotency	  can	  be	  established	  in	  vitro	  in	  
a	   serum-­‐free	   culture	   by	   suppression	   of	   differentiation-­‐inducing	   signals.	   The	  
conventional	   ES	   cell	   culture	   medium	   composed	   by	   serum	   and	   LIF	   was	   initially	  
substituted	  by	  a	  combination	  of	  three	   inhibitors,	  known	  as	  “3i”,	  comprising	  an	  FGF	  
receptor	  inhibitor	  (SU5402),	  an	  inhibitor	  of	  MAPK	  kinase	  (Mek)	  1/2	  (PD184352),	  and	  
a	  GSK3	  inhibitor	  (CHIR99021)	  (Ying	  et	  al.,	  2008).	  Since	  the	  FGF	  receptor	  is	  driving	  ES	  
cells	   commitment	   primarily	   via	   the	   Erk	   pathway,	   the	   use	   of	   a	   Mek	   inhibitor	  
(PD0325901)	  eliminates	  the	  need	  to	  block	  the	  FGF	  receptor.	  Hence,	  the	  3i	  medium	  
has	   finally	   evolved	   into	   2i	   (Nichols	   and	   Smith,	   2009;	  Wray	   et	   al.,	   2010).	  Mouse	   ES	  
cells	  grown	  in	  the	  2i	  +	  LIF	  more	  accurately	  represent	  the	  naive	  state	  of	  pluripotent	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The	   exposure	   to	   different	   culture	   environments	   imposes	   distinctive	   transcriptional	  
and	  epigenetic	  properties	  on	  mouse	  ES	  cells	  (Marks	  et	  al.,	  2012).	  Indeed,	  although	  ES	  
cells	   grown	   in	   serum	   and	   2i	   conditions	   have	   similar	   levels	   of	   transcripts	   for	   genes	  
encoding	  key	  pluripotency	  factors	  (Pou5f1,	  Nanog,	  Sox2,	  Esrrb,	  Klf2,	  Klf4,	  and	  Tbx3),	  
cells	  in	  2i	  have	  decreased	  levels	  of	  several	  ectodermal	  and	  mesodermal	  specification	  
genes.	  
	  
3.3 The	  Myc	  family	  of	  transcription	  factors	  
In	  mammals,	  the	  Myc	  family	  of	  transcription	  factors	  comprises	  c-­‐Myc,	  N-­‐Myc	  and	  L-­‐
Myc	  (Adhikary	  and	  Eilers,	  2005).	  c-­‐Myc	  was	  the	  first	  one	  to	  be	  discovered,	  in	  1982,	  as	  
the	  human	  homologue	  of	  the	  oncogene	  v-­‐myc	  of	  the	  avian	  myelocytomatosis	  virus	  
(Vennstrom	   et	   al.,	   1982).	   N-­‐Myc	   was	   identified	   shortly	   later,	   amplified	   in	   several	  
human	  neuroblastoma	  cell	  lines	  and	  tumor	  samples	  (Kohl	  et	  al.,	  1983;	  Schwab	  et	  al.,	  
1983).	  Finally,	  the	  third	  family	  member,	  L-­‐Myc,	  was	  discovered	  for	  being	  deregulated	  
in	   small	   cell	   lung	  cancer	   (Nau	  et	  al.,	  1985).	  Since	   their	  discovery,	   the	  Myc	  proteins	  
have	  been	  implicated	  in	  the	  genesis	  of	  a	  variety	  of	  human	  tumors	  (Meyer	  and	  Penn,	  
2008)	   and	   enhanced	   Myc	   expression	   has	   been	   shown	   to	   contribute	   to	   several	  
aspects	   of	   cancer	   biology	   (Adhikary	   and	   Eilers,	   2005),	   including	   unrestricted	  
proliferation	   (Eilers	   et	   al.,	   1991),	   inhibition	   of	   differentiation	   (Freytag	   and	  Geddes,	  
1992),	  cell	  growth	  (Iritani	  and	  Eisenman,	  1999;	  Johnston	  et	  al.,	  1999),	  vasculogenesis	  
(Baudino	  et	  al.,	  2002),	  reduction	  of	  cell	  adhesion	  (Arnold	  and	  Watt,	  2001),	  metastasis	  
(Pelengaris	  et	  al.,	  2002)	  and	  genomic	  instability	  (Felsher	  and	  Bishop,	  1999).	  
Myc	  expression	  is	  frequently	  deregulated	  in	  tumorigenesis	  (Meyer	  and	  Penn,	  2008).	  
This	  is	  not	  only	  due	  to	  genetic	  changes	  at	  the	  Myc	  locus	  but	  also	  to	  alteration	  of	  one	  
of	  the	  several	  mechanisms	  that	  target	  Myc	  expression	  and	  activity	  at	  transcriptional,	  
post-­‐transcriptional	  and	  post-­‐translational	  levels	  (Levens,	  2003;	  Sears	  et	  al.,	  1999).	  
	  
Functional	  redundancy	  of	  Myc	  family	  members	  
Several	  studies	   indicate	  that	  Myc	  family	  members	  could	  have	  redundant	  functional	  
properties	   during	   the	   early	   stages	   of	   embryogenesis,	   in	   particular	   c-­‐	   and	   N-­‐myc.	  
Indeed,	  knockout	  of	  individual	  Myc	  genes	  is	  only	  lethal	  at	  embryonic	  day	  10	  or	  12,	  as	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a	  consequence	  of	  respectively	  c-­‐myc	  or	  N-­‐myc	  loss	  (Charron	  et	  al.,	  1992;	  Davis	  et	  al.,	  
1993;	  Stanton	  et	  al.,	  1992).	  A	  very	  elegant	  study	  to	  address	  the	  potential	  of	  N-­‐Myc	  to	  
replace	   c-­‐Myc	   was	   performed	   by	   generating	   NCR	   (N-­‐C-­‐Replacement)	   mice,	   where	  
the	  c-­‐myc	  coding	  region	  was	  replaced	  by	  the	  N-­‐myc	  coding	  region	  by	  gene	  targeting	  
(Malynn	   et	   al.,	   2000),	   and	   N-­‐Myc	   protein	   was	   therefore	   expressed	   under	   the	  
regulatory	   elements	   of	   the	   endogenous	   c-­‐myc	   locus.	   Although	   homozygous	   c-­‐
mycNCR/NCR	   mice	   were	   healthy	   and	   fertile,	   they	   presented	   small	   abnormalities,	   as	  
decrease	   in	   total	   body	   weight	   (Malynn	   et	   al.,	   2000).	   Additionally,	   lymphocytes	   or	  
embryonic	   fibroblasts	  derived	   from	   these	  mice	  had	  a	   lower	   response	   to	  mitogenic	  
stimulation,	   demonstrating	   that	   the	   c-­‐mycNCR	   allele	   can	   only	   partially	   compensate	  
the	  loss	  of	  c-­‐myc	  expression	  (Malynn	  et	  al.,	  2000).	  
	  
Gene	  regulation	  by	  Myc-­‐Max	  complexes	  
The	   Myc	   family	   members	   share	   significant	   homology	   in	   their	   genomic,	   RNA	   and	  
protein	  sequences.	  All	  myc	  genes	  consist	  of	  three	  exons,	  of	  which	  only	  exons	  2	  and	  3	  
are	   translated	   and	   encode	   for	   proteins	   that	   function	   primarily	   as	   nuclear	  
transcription	   factors	   (Hurlin,	   2013).	   The	   N	   terminus	   of	   the	  Myc	   proteins	   contains	  
three	  highly	  conserved	  elements,	  known	  as	  Myc	  boxes	   I–III,	  which	  are	  required	  for	  
Myc	  stability	  and	  for	  the	  interaction	  with	  other	  proteins.	  The	  C	  terminus	  consists	  of	  
the	  basic	  region/helix–loop–helix/leucine-­‐zipper	  (BR/HLH/LZ)	  domain	  (Figure	  6).	  
	  
	  
Figure	  6:	  Domains	  of	  Myc	  and	  their	  binding	  proteins.	  The	  three	  Myc	  family	  members	  share	  
at	  least	  80%	  amino	  acid	  sequence	  homology	  in	  the	  functionally	  relevant	  domains	  Myc	  box	  I,	  
Myc	   box	   II	   and	  basic	   region	   helix-­‐loop-­‐helix	   leucine-­‐zipper	   (BR/HLH/LZ).	   These	   regions	   are	  
essential	  to	  mediate	  the	  protein-­‐protein	  interactions	  required	  for	  transcriptional	  regulation	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The	  leucine	  zipper	  domain	  is	  a	  leucine-­‐rich	  protein	  domain,	  present	  in	  a	  large	  class	  of	  
dimeric	   transcription	   factors	   and	  mediates	   interactions	  with	   other	   proteins	  with	   a	  
similar	  domain	  (Adhikary	  and	  Eilers,	  2005).	  
	  
Myc	  can	  both	  activate	  and	  repress	  transcription	  of	   its	  target	  genes	  through	  several	  
mechanisms	  that	  include	  recruitment	  of	  transcription	  factors,	  chromatin	  modulating	  
proteins,	  and	  DNA	  methyltransferases.	  	  
Myc	  does	  not	  bind	  the	  DNA	  on	  its	  own,	  but	  it	  interacts	  with	  a	  partner	  protein,	  Max,	  
through	   the	   shared	   BR/HLH/LZ	   motif	   (Blackwood	   and	   Eisenman,	   1991).	   Max	   is	  
present	   in	   stoichiometric	   excess	   to	   Myc,	   and	   can	   also	   form	   homodimers	   or	  
heterodimers	   with	   several	   related	   proteins,	   known	   as	  Mad1,	   Mad2,	   Mad3,	   Mad4	  
and	  Mnt	   (Adhikary	   and	   Eilers,	   2005).	   All	   the	   dimers	   bind	   to	   the	   DNA	   through	   the	  
same	  E-­‐box	  sequence	   (CAC	  GTG),	  but	  whereas	  Myc-­‐Max	  heterodimers	  activate	   the	  
transcription	   of	   the	   target	   genes	   (Blackwood	   and	   Eisenman,	   1991),	  Mad–Max	   and	  
Mnt–Max	  heterodimers	  repress	  transcription	  (Ayer	  et	  al.,	  1993;	  Hurlin	  et	  al.,	  1997)	  
(Figure	  7).	  	  	  
Myc-­‐Max	  heterodimers	  can	  activate	  the	  transcription	  through	  recruitment	  of	  histone	  
and	  chromatin-­‐modifying	  complexes	  that	  create	  a	  chromatin	  environment	  favorable	  
for	  additional	  factors	  that	  cooperate	   in	  stimulating	  RNA	  polymerase	  activity	  (Figure	  
7).	   Indeed,	  Myc	  has	  shown	  to	  bind	  co-­‐regulatory	  factors,	  such	  as	  TRRAP,	  which	  is	  a	  
core	   subunit	   of	   the	   TIP60	   and	   GCN5	   histone	   acetyltransferase	   (HAT)	   complexes	  
(McMahon	  et	  al.,	  1998)	  and	  other	  HAT	  complexes,	  as	  the	  CreB-­‐binding	  protein	  (CBP)	  
and	   p300	   have	   also	   been	   described	   to	   interact	   with	  Myc	   (Vervoorts	   et	   al.,	   2003).	  
Additionally,	   Myc	   recruits	   the	   INI1	   subunit	   of	   the	   SWI/SNF	   chromatin-­‐remodeling	  
complex	  (Cheng	  et	  al.,	  1999).	  
Myc	  has	  also	  been	  found	  to	  recruit	  the	  cyclin-­‐dependent	  kinase-­‐9	  (CDK9)	  subunit	  of	  
the	   transcription	   elongation	   factor	   b	   (P-­‐TEFb)	   (Kanazawa	   et	   al.,	   2003),	   which	  
phosphorylates	  the	  carboxyl-­‐terminal-­‐domain	  (CTD)	  of	  the	  larger	  subunit	  of	  RNA	  pol	  
II	   and	   is	   critical	   for	   the	   transition	   of	   pol	   II	   into	   a	   mature	   transcription	   elongation	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In	   addition	   to	   its	   ability	   to	   activate	   transcription,	   Myc	   can	   directly	   repress	  
transcription	  of	  around	  10-­‐25%	  of	   its	  targets	  (Patel	  et	  al.,	  2004;	  Zeller	  et	  al.,	  2003).	  
Myc-­‐Max	  heterodimers	  can	  associate	  with	  the	  POZ	  domain/zinc	  finger	  transcription	  
factor	  Miz1	  (Seoane	  et	  al.,	  2001;	  Staller	  et	  al.,	  2001).	  Although	  Miz1	  by	  itself	  acts	  as	  
an	  activator	  of	  transcription,	  Myc-­‐Miz1	  complexes	  can	  repress	  transcription	  of	  Miz1	  
target	  genes,	   including	  cyclin-­‐dependent	  kinase	  inhibitor	  1A	  (Cdkn1a)	  encoding	  p21	  




Figure	   7:	   The	   Myc-­‐Max	   network.	   Myc	   and	   its	   partner	   Max	   regulate	   several	   biological	  
processes	  playing	  an	  essential	  role	  in	  tumorigenesis.	  Myc–Max	  heterodimers	  recruit	  cofactor	  
complexes	   to	  E-­‐box	  sequences	  near	   the	   transcriptional	   start	   site	  of	   target	  genes,	   including	  
proteins	   involved	   in	   chromatin	   remodeling,	   ubiquitylation	   and	   histone	   acetylation.	   Myc	  
cofactors	  include	  the	  cyclin-­‐dependent	  kinase	  9	  (CDK9)	  that	  can	  directly	  phosphorylate	  RNA	  
pol	  II	  and	  enhance	  transcriptional	  elongation.	  Max	  also	  dimerizes	  with	  Mad	  and	  Mnt	  family	  
proteins,	   leading	   to	   recruitment	  of	  a	   scaffolding	  protein	  called	  SIN3,	  which	   in	   turn	   recruits	  
histone	  deacetylases	  (HDACs)	  to	  mediate	  transcriptional	  repression	  of	  genes	  associated	  with	  
E-­‐box	   sequences.	   At	   certain	   promoters,	   Myc	   and	   Max	   interact	   with	   Miz1	   to	   repress	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Myc	  target	  genes	  
Since	  Myc	  was	  identified	  as	  a	  transcription	  factor	  with	  a	  crucial	  role	  in	  tumorigenesis,	  
several	  different	  strategies	  have	  been	  developed	  to	  identify	  its	  target	  genes.	  	  
The	  first	  Myc	  target	  was	  described	  ten	  years	  after	  the	  identification	  of	  human	  Myc,	  
when	  the	  Bishop’s	  group	  developed	  a	  fusion	  of	  the	  human	  c-­‐Myc	  to	  the	  hormone-­‐
binding	  domain	  of	  the	  estrogen	  receptor	  (ER)	  (Eilers	  et	  al.,	  1989).	  Myc–ER	  activation	  
was	   shown	   to	   induce	   quiescent	   cells	   to	   enter	   and	   progress	   through	   the	   cell	   cycle	  
(Eilers	  et	  al.,	  1989)	  and	  alpha-­‐prothymosin	  (Ptma)	  (Eilers	  et	  al.,	  1991)	  and	  ornithine	  
decarboxylase	  1	  (Odc1)	  (Wagner	  et	  al.,	  1993)	  were	  identified	  as	  transcriptional	  Myc	  
targets.	   The	   role	   of	  Myc	   in	   promoting	   cell	   cycle	   progression	   was	   confirmed	   using	  
other	   systems,	   as	   the	  Myc-­‐ERTAM,	   responsive	   to	  4-­‐hydroxytamoxifen	   (Littlewood	  et	  
al.,	   1995),	   and	   Myc-­‐null	   rat	   fibroblasts	   (Mateyak	   et	   al.,	   1997),	   leading	   to	   the	  
identification	  of	  Gadd45a	  as	  a	  target	  of	  Myc	  repression	  (Marhin	  et	  al.,	  1997).	  	  
With	  the	  advent	  of	  the	  microarray	  technology,	  several	  groups	  performed	  large-­‐scale	  
analysis	   to	   identify	  Myc-­‐regulated	  genes.	  Unexpectedly,	   all	   these	   studies	  produced	  
long	   lists	  of	  putative	  Myc	   targets,	   showing	  often	  very	   little	  overlaps	  between	  each	  
other.	   The	   more	   recent	   development	   of	   chromatin	   immunoprecipitation	   assay	  
(ChIP),	   combined	   to	   high-­‐throughput	   array	   technology	   (ChIP-­‐chip),	   or	   with	   high-­‐
throughput	   nucleotide	   sequencing	   (ChIP-­‐PET	   and	   ChIP-­‐seq)	   has	   allowed	   the	  
identification	  of	  the	  true	  Myc	  binding	  sites	  on	  the	  genome	  (Zeller	  et	  al.,	  2006).	  The	  
integration	  of	  these	  data	  with	  expression	  array	  data	  allowed	  the	  development	  of	  a	  
database	  of	  Myc-­‐regulated	   genes	   (http://myccancergene.org)	   and	   the	   visualization	  
of	  the	  complex	  Myc	  regulatory	  network	  (Dang	  et	  al.,	  2006).	  Recent	  estimates	  suggest	  
that	  Myc	  can	  bind	  to	  approximately	  10–15%	  of	  the	  genome	  from	  flies	  to	  humans	  and	  
despite	   the	   functional	   range	   of	   specific	   genes	   altered,	   Myc	   consistently	   affects	  
specific	   classes	   of	   genes	   that	   involve	   metabolism,	   protein	   biosynthesis,	   cell	   cycle	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Figure	  8:	  The	  pleiotropic	  function	  of	  the	  Myc	  family	  members.	  The	  transcription	  factor	  Myc	  
participates	   in	   a	   variety	   of	   cellular	   processes	   by	   regulating	   the	   transcription	   of	   genes	  
involved	   in	   cell	   adhesion,	  differentiation,	   cell	   cycle	   regulation,	  angiogenesis	  and	  apoptosis.	  
Chromatin	  remodeling	  and	  regulation	  of	  ribosome	  biogenesis	  are	  thought	  to	  be	  two	  of	  the	  
mechanisms	  used	  by	  Myc	  proteins	  to	  regulate	  globally	  gene	  expression.	  Adapted	  from	  (van	  
Riggelen	  et	  al.,	  2010).	  
	  
Cell	  cycle	  
The	   genes	   that	   consistently	   emerge	   and	   contain	   E-­‐boxes	   bound	   by	   c-­‐Myc	   in	   ChIP	  
assays	  are	  cyclins	  D1	  and	  D2,	  CDK4,	  and	  cyclin	  B1	  (Bouchard	  et	  al.,	  2001;	  Fernandez	  
et	   al.,	   2003;	   Hermeking	   et	   al.,	   2000;	   Menssen	   and	   Hermeking,	   2002).	   c-­‐Myc	  
represses	  the	  CDK	  inhibitors	  p21	  and	  p15INK4A	  through	  an	  interaction	  with	  the	  Miz-­‐
1	   protein	   at	   the	   core	   promoter	   (Seoane	   et	   al.,	   2001;	  Wu	   et	   al.,	   2003)	   and	   genes	  
involved	   in	   growth	   arrest	   such	   as	   Gadd45	   (Barsyte-­‐Lovejoy	   et	   al.,	   2004)	   and	   Gas1	  
(Lee	  et	  al.,	  1997).	  
	  
Metabolism	  
Myc	  is	  a	  key	  regulator	  of	  many	  pathways	  of	  cell	  metabolism.	  Key	  enzymes	  of	  glucose	  
metabolism,	   such	   as	   enolase	   A,	   hexokinase	   II,	   lactate	   dehydrogenase	   A,	  
phosphofructokinase,	  and	  glucose	  transporter	  I,	  have	  been	  found	  to	  be	  Myc	  targets	  
(Kim	  et	  al.,	  2004;	  Menssen	  and	  Hermeking,	  2002;	  O'Connell	  et	  al.,	  2003;	  Osthus	  et	  
al.,	  2000),	  supporting	  the	  hypothesis	  of	  a	  role	  of	  c-­‐Myc	  in	  enhancing	  glucose	  uptake	  
and	  glycolysis.	  Several	  genes	   involved	   in	  mitochondrial	  biogenesis	  and	  function	  are	  
up-­‐regulated	   in	   response	   to	   c-­‐Myc	   overexpression	   in	   mammalian	   systems	   and	   in	  
Drosophila	   (Morrish	   et	   al.,	   2003;	   Orian	   et	   al.,	   2003;	   Wonsey	   et	   al.,	   2002).	   Iron	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to	   increase	   the	   intracellular	   iron	   pool.	   Ferritin,	   Irp1,	   Irp2,	   and	   the	   transferrin	  
receptor	   (Tfrc1)	   genes	   have	   been	   described	   as	  Myc	   targets	   (Morrish	   et	   al.,	   2003;	  
Orian	  et	  al.,	  2003;	  Wonsey	  et	  al.,	  2002;	  Wu	  et	  al.,	  1999).	  Tfrc1,	  which	  is	  up-­‐regulated	  
by	   c-­‐Myc,	   is	   a	   cell	   surface	   glycoprotein	   that	   transports	   iron-­‐bound	   transferrin	   into	  
the	   cell,	   where	   iron	   is	   then	   incorporated	   into	   enzymes	   that	   catalyze	   energy	  
metabolism	   and	   DNA	   synthesis	   (Dang	   et	   al.,	   2006).	   Nramp1,	   which	   encodes	   a	  
divalent	  cation	  transporter	  and	  removes	  iron	  from	  the	  cytosol,	  is	  repressed	  by	  c-­‐Myc	  
(Bowen	   et	   al.,	   2002).	   Finally,	   several	   genes	   involved	   in	   nucleotide	   synthesis	   and	  
metabolism	  have	  also	  been	  shown	  to	  be	  important	  Myc	  targets	  (Dang	  et	  al.,	  2006).	  
	  
Ribosome	  biogenesis	  and	  protein	  synthesis	  
Ribosome	  biogenesis	   is	   a	   complex	   and	   tightly	   coordinated	  process,	  which	   requires	  
the	   synthesis,	   processing	   and	   assembly	   of	   several	   protein	   and	   RNA	   components	  
(reviewed	  in	  (van	  Riggelen	  et	  al.,	  2010)).	  	  
	  
Structural	   RNA	   components	   of	   the	   ribosome	   comprise	   the	   5S,	   5.8S,	   18S	   and	   28S	  
rRNAs.	  The	  18S,	  5.8S	  and	  28S	   rRNAs	  are	  encoded	  by	   ribosomal	  DNA	   (rDNA)	   in	   the	  
nucleolus,	   where	   RNA	   pol	   I	   transcribes	   a	   single	   47S	   rRNA	   precursor	   (pre-­‐rRNA),	  
which	   is	   then	  processed	  through	  endonucleolytic	  and	  exonucleolytic	  cleavages	   into	  
18S,	  5.8S	  and	  28S	  rRNA.	  The	  5S	  rRNA	  is	  encoded	  in	  chromosome	  regions	  outside	  the	  
nucleolus	   and	   is	   synthesized	  by	  RNA	  pol	   III.	   Ribosomal	   proteins	   are	   transcribed	  by	  
RNA	  pol	  II,	  synthesized	  in	  the	  cytoplasm	  and	  then	  imported	  into	  the	  nucleus,	  where	  
they	  are	  assembled	  into	  small	  and	  large	  ribosomal	  subunits	  (Figure	  9)	  (van	  Riggelen	  
et	   al.,	   2010).	   The	   small	   40S	   ribosomal	   subunit	   contains	   one	   18S	   rRNA	   and	   32	  
ribosomal	   proteins,	   known	   as	   RPS	   proteins.	   The	   large	   60S	   subunit	   is	   composed	   of	  
one	  of	  each	  5S,	  5.8S	  and	  28S	  rRNA	  and	  approximately	  47	  ribosomal	  proteins,	  known	  
as	   RPL	   proteins.	   The	   40S	   and	   60S	   subunits	   are	   then	   exported	   into	   the	   cytoplasm,	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Figure	   9:	  Overview	  of	   the	   ribosome	  biogenesis.	  The	  biogenesis	  of	   the	   ribosomes	  a	  highly	  
coordinated	  process,	   consisting	   in	   the	   synthesis	  and	   import	  of	   ribosomal	  proteins	   into	   the	  
nucleus,	  synthesis	  and	  processing	  of	  ribosomal	  RNA	  (rRNA),	  assembly	  of	  ribosomal	  proteins	  
and	  transport	  of	  the	  mature	  subunits	  into	  the	  cytoplasm.	  Adapted	  from	  (van	  Riggelen	  et	  al.,	  
2010).	  
	  	  
Myc	   directly	   regulates	       the	   expression	   of	   several	   ribosomal	   protein,	   RNA	  
components,	   and	   auxiliary	   factors	   that	   are	   required	   for	   ribosomal	   RNA	   (rRNA)	  
processing,	   ribosome	   assembly,	   export	   of	   mature	   ribosomal	   subunits	   from	   the	  
nucleus	   into	   the	   cytoplasm,	   as	  well	   as	   factors	   that	   control	   the	   initiation	   of	  mRNA	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Figure	   10:	  Myc	   controls	  multiple	   components	   of	   ribosome	  biogenesis.	  Myc	  regulates	   the	  
RNA	   pol	   I-­‐dependent	   transcription	   of	   18S,	   5.8S	   and	   28S	   rRNAs.	   It	   facilitates	   rDNA	  
transcription	   by	   enhancing	   the	   expression	   and/or	   recruitment	   of	   the	   RNA	   pol	   I	   cofactors	  
upstream	  binding	  transcription	  factor	  (UBF)	  and	  selectivity	  factor	  1	  (SL1).	  The	  transcription	  
of	   the	   5S	   rRNA	   and	   tRNA,	   encoded	   on	   chromosome	   regions	   outside	   the	   nucleolus,	   is	  
mediated	  by	  RNA	  pol	  III	  through	  the	  direct	  interaction	  of	  Myc	  with	  TFIIIB.	  Myc	  increases	  the	  
transcription	  of	  many	  RPL	  and	  RPS	  proteins	  and	  translation	  initiation	  and	  elongation	  factors.	  
Myc	  coordinates	  the	  transcription	  of	  genes	  that	  encode	  proteins	  required	  for	  the	  processing	  
of	   rRNA	   precursors,	   contribute	   to	   ribosome	   assembly	   as	   well	   as	   the	   nuclear–cytoplasmic	  
transport	  of	  mature	  ribosomal	  subunits.	  Such	  proteins	  include	  nucleolar	  protein	  56	  (NOP56),	  
block	   of	   proliferation	   1	   (BOP1),	   fibrillarin	   (FBL),	   dyskerin	   (DKC1)	   nucleolin	   (NCL)	   and	  
nucleophosmin	  (NPM1).	  NCL	  binds	  to	  the	  47S	  pre-­‐rRNA	  and	  is	  required	  for	  its	  cleavage	  into	  
18S,	   5.8S	   and	   28S	   rRNA	   in	   the	   nucleolus.	   NPM1	   is	   responsible	   for	   the	   regulation	   rRNA	  
processing,	   ribosomal	   protein	   stability	   and	   transport	   of	   ribosomal	   subunits	   into	   the	  
cytoplasm.	  From	  (van	  Riggelen	  et	  al.,	  2010).	  
	  
The	  role	  of	  Myc	  in	  stem	  cells	  
Making	  use	  of	  gene	  targeting	  in	  mice,	  the	  role	  of	  Myc	  proteins	  in	  development	  has	  
been	  widely	   investigated:	  whereas	  L-­‐myc	  knock-­‐out	  mice	  develop	  normally	  (Hatton	  
et	  al.,	  1996),	  embryos	  lacking	  c-­‐myc	  die	  before	  E10.5	  because	  of	  hematopoietic	  and	  
placental	   defects	   (Dubois	   et	   al.,	   2008;	   Trumpp	   et	   al.,	   2001)	   and	   N-­‐myc-­‐deficient	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al.,	  1992).	  Besides	  their	  role	  in	  development,	  several	  conditional	  genetic	  approaches	  
have	   been	   used	   to	   reveal	   the	   function	   of	   the	   Myc	   family	   members	   in	   stem	   and	  
progenitor	  cells	  (Laurenti	  et	  al.,	  2009)	  (Murphy	  et	  al.,	  2005).	  	  
ES	   cells,	   lacking	   only	   c-­‐myc	   or	  N-­‐myc	   show	  no	   obvious	   phenotype	   (Baudino	   et	   al.,	  
2002;	   Sawai	   et	   al.,	   1991),	   probably	   as	   a	   consequence	   of	   the	   high	   functional	  
redundancy	   between	   these	   two	   family	   members.	   Accordingly,	   deletion	   of	   both	   c-­‐	  
and	  N-­‐myc	   in	  ES	  cells	   cultured	   in	   serum	  +	  LIF	   impairs	  maintenance	  of	  pluripotency	  
and	   self-­‐renewal	   (Smith	   et	   al.,	   2010).	   Indeed,	   under	   these	   culture	   conditions	  Myc	  
proteins	  play	  a	  crucial	   role	   in	   repressing	   the	  expression	  of	   the	  primitive	  endoderm	  
master	  regulator	  Gata6,	  and	  control	  the	  cell	  cycle	  by	  regulating	  the	  mir-­‐17-­‐92	  miRNA	  
cluster	   (Smith	  et	   al.,	   2010).	   In	  hematopoietic	   stem	  cells	   (HSCs),	   c-­‐myc	   controls	   the	  
balance	  between	  hematopoietic	  stem	  cells	  (HSCs)	  self-­‐renewal	  and	  differentiation	  by	  
regulating	   the	   interaction	   between	   HSCs	   and	   their	   niche	   (Wilson	   et	   al.,	   2004).	  
Indeed,	  c-­‐Myc-­‐deficient	  HSCs	  divide	  without	  any	  measurable	  change	  in	  cell	  cycle,	  but	  
fail	  to	  differentiate	  normally	  in	  a	  c-­‐myc	  deficient	  environment	  (Wilson	  et	  al.,	  2004).	  
Interestingly,	  simultaneous	  deletion	  of	  both	  c-­‐myc	  and	  n-­‐myc	  results	  in	  rapid	  loss	  of	  
HSCs,	   due	   to	   impaired	   proliferation,	   differentiation	   and	   apoptosis	   (Laurenti	   et	   al.,	  
2008).	   Finally,	   N-­‐Myc	   loss	   results	   in	   decreased	   proliferation	   and	   increased	  
differentiation	   of	   neural	   precursors	   (Knoepfler	   et	   al.,	   2002),	   demonstrating	   the	  
important	  role	  that	  this	  gene	  plays	  in	  normal	  neurogenesis.	  	  
	  
The	  role	  of	  Myc	  in	  reprogramming	  
Reprogramming	  refers	  to	  the	  process	  of	  altering	  the	  epigenetic	  program	  of	  a	  cell	  to	  
change	   its	   developmental	   potential.	   Converting	   a	   somatic	   cell	   to	   a	  pluripotent	   cell	  
has	   long	   been	   the	   goal	   of	   research,	   reflecting	   the	   enormous	   potential	   that	   such	   a	  
technique	  could	  have	  in	  regenerative	  medicine.	  
In	   1976,	   Miller	   and	   Ruddle	   demonstrated	   that	   thymocytes	   acquired	   pluripotency	  
upon	  fusion	  with	  embryonal	  carcinoma	  (EC)	  cells	  (Miller	  and	  Ruddle,	  1976).	  Indeed,	  
if	  transplanted	  into	  nude	  mice,	  these	  cells	  were	  able	  to	  form	  teratomas	  consisting	  of	  
tissues	   from	   all	   three	   germ	   layers.	   Reprogramming	   has	   also	   been	   achieved	   by	  
transferring	   the	   nucleus	   of	   a	   somatic	   cell	   into	   an	   enucleated	   egg,	   a	   technique	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referred	  to	  as	  somatic	  cell	  nuclear	  transfer	  (SSNT)	  (Wilmut	  et	  al.,	  1997)	  and	  by	  fusion	  
of	  embryonic	  cells	  with	  somatic	  cells	  (Ambrosi	  and	  Rasmussen,	  2005).	  However,	  both	  
strategies	   have	   significant	   drawbacks:	   while	   nuclear	   transfer	   requires	   the	   use	   of	  
oocytes	   and	   is	   highly	   inefficient,	   cell	   fusion	   results	   in	   the	   production	   of	   tetraploid	  
cells	  which	  could	  not	  be	  used	  in	  cell	  replacement	  therapy	  because	  of	  their	  potential	  
tumorigenic	  capacity	  (Ambrosi	  and	  Rasmussen,	  2005).	  	  
In	  2006,	  the	  Nobel	  laureate	  Shinya	  Yamanaka	  demonstrated	  that	  the	  overexpression	  
of	   four	   transcription	   factors	   Oct4,	   Sox2,	   Klf4	   and	   c-­‐Myc	   could	   reprogram	   somatic	  
cells	   to	   induced	   pluripotent	   stem	   (iPS)	   cells	   (Takahashi	   and	   Yamanaka,	   2006).	   iPS	  
cells	  were	  first	  generated	  from	  mouse	  embryonic	  fibroblasts	  (MEFs)	  where	  the	  four	  
transcription	  factors	  were	  introduced	  by	  retroviral	  transfection	  and	  ES-­‐like	  cells	  were	  
selected	   using	   the	   pluripotency-­‐associated	   gene,	   Fbx15	   (Takahashi	   and	   Yamanaka,	  
2006).	   	  Although	   these	  ES-­‐like	   cells	  possessed	  pluripotency,	  as	  assessed	  by	   in	   vitro	  
differentiation	   and	   teratoma	   formation,	   they	  were	   not	   able	   to	   generate	   germ-­‐line	  
competent	   chimeras	   and	   may	   therefore	   represent	   an	   incomplete	   state	   of	  
reprogramming.	  Germ-­‐line	  transmission	  was	  achieved	  later,	  by	  selecting	  iPS	  cells	  for	  
the	   expression	   of	   endogenous	   Nanog	   (Okita	   et	   al.,	   2007)	   or	   Oct4	   (Wernig	   et	   al.,	  
2007),	   reflecting	   the	   requirement	   of	   the	   endogenous	   core	   regulatory	   network	   to	  
establish	  true	  pluripotency	  (Silva	  and	  Smith,	  2008).	  	  
Reprogramming	   is	   a	   gradual	   process	   that	   follows	   a	   defined	   series	   of	   molecular	  
events	   (Brambrink	   et	   al.,	   2008;	   Stadtfeld	   et	   al.,	   2008)	   driving	   the	   repression	   of	  
differentiation-­‐specific	   genes	   and	   the	   activation	   of	   embryonic	   markers	   such	   as	  
alkaline	  phosphatase	  (AP),	  SSEA1	  and,	  in	  later	  stages,	  the	  pluripotency	  genes	  Nanog	  
and	  Oct4.	  Several	  studies	  have	  been	  performed	  to	  understand	  how	  the	  four	  factors	  
orchestrate	  the	  reprogramming	  process	  (Sridharan	  et	  al.,	  2009):	  Oct4	  and	  Sox2	  could	  
act	  by	  promoting	  the	  expression	  of	  the	  endogenous	  Oct4,	  Sox2	  and	  Nanog	  genes	  and	  
activating	   the	   autologous	   pluripotency	   network.	   Once	   active,	   this	   network	   is	  
expected	   to	  be	   self-­‐promoting	   and	   to	   influence	   the	  activity	  of	   target	   genes	  whose	  
expression	   or	   silencing	   is	   critical	   to	   the	   establishment	   of	   pluripotency.	   While	   the	  
function	  of	  Oct4	  and	  Sox2	  in	  ES	  cells	  suggests	  how	  these	  factors	  could	  contribute	  to	  
reprogramming,	  the	  role	  of	  c-­‐Myc	  and	  Klf4	  is	   less	  clear	  (Jaenisch	  and	  Young,	  2008).	  
Interestingly,	  reprogramming	  can	  be	  accomplished	  in	  the	  absence	  of	  c-­‐Myc	  or	  Klf4,	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albeit	   with	   a	   significant	   reduced	   efficiency	   and	   kinetics	   (Nakagawa	   et	   al.,	   2008;	  
Wernig	   et	   al.,	   2008).	   The	   two	   oncogenes	  might	   confer	   somatic	   cells	   the	   immortal	  
growth	   potential	   and	   rapid	   proliferative	   phenotype	   associated	   with	   ES	   cells	  
(Yamanaka,	   2008)	   and	   c-­‐Myc	   overexpression	  might	   promote	   the	   switch	   to	   a	  more	  
open	  chromatin	  state,	  allowing	  the	  reprogramming	  factors	  to	  more	  efficiently	  access	  
genes	   necessary	   for	   reprogramming	   (Yamanaka,	   2008).	   Interestingly,	   the	   group	   of	  
Shinya	   Yamanaka	   has	   reported	   that	   L-­‐Myc	   as	   well	   as	   c-­‐Myc	  mutants	   (W136E	   and	  
dN2)	  with	  lower	  transformation	  activity	  compared	  to	  wild	  type	  c-­‐Myc,	  can	  promote	  
more	   efficient	   and	   specific	   human	   iPS	   cells	   generation	   (Nakagawa	   et	   al.,	   2010).	  
Therefore	   the	   role	   of	   Myc	   in	   reprogramming	   seems	   to	   be	   independent	   on	   its	  
transformation	  property.	  
	  
3.4 Epigenetic	  regulation	  of	  pluripotency	  
Epigenetic	  modifications	  are	  instructions	  that	  are	  imposed	  on	  the	  DNA	  sequence	  to	  
provide	  an	  additional	  level	  of	  gene	  regulation	  (Hemberger	  et	  al.,	  2009).	  	  
	  
	  
Figure	   11:	   Epigenetic	   gene	   regulation	   during	  mammalian	   development.	  During	   the	   early	  
phases	   of	   development,	   DNA	   methylation	   is	   erased,	   pluripotency-­‐associated	   genes	   are	  
expressed,	  while	  developmental	  genes	  are	  repressed	  by	  H3K27me3.	  During	  differentiation,	  
pluripotency-­‐associated	   genes	   are	   repressed	   as	   a	   result	   of	   DNA	   methylation	   while	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As	  development	  and	  differentiation	  proceed,	  the	  cells	  of	  distinct	  organs	  and	  tissues	  
acquire	  specific	  epigenetic	  marks	  and	  possess	  unique	  gene	  expression	  profiles,	  being	  
completely	   identical	   in	   their	   DNA	   sequences.	   In	   mammals,	   the	   most	   important	  
epigenetic	   modifications	   include	   DNA	   methylation	   and	   covalent	   histones	  
modifications	  (Hemberger	  et	  al.,	  2009)	  (Figure	  11).	  
	  
3.4.1 DNA	  methylation	  
DNA	  methylation	  is	  an	  epigenetic	  mark	  that	  refers	  to	  the	  addition	  of	  a	  methyl	  group	  
to	   the	   fifth	   carbon	   of	   the	   base	   cytosine.	   In	   mammals,	   DNA	   methylation	   occurs	  
predominantly	  in	  the	  context	  of	  CpG	  (C	  followed	  by	  G)	  dinucleotides	  and	  is	  catalyzed	  
by	  enzymes	  named	  DNA	  methyltransferases	  (Dnmts).	  	  
	  
Figure	  12:	  Structure	  of	  the	  human	  Dnmts.	  Schematic	  representation	  of	  the	  human	  Dnmt1,	  
Dnmt3a,	   Dnmt3b	   and	   Dnmt3l	   structures	   and	   different	   domains.	   NLS,	   nuclear	   localization	  
signal;	  CXXC,	  cysteine	  rich	  region;	  BAH,	  bromo-­‐adjacent	  homology	  domain;	  PWWP,	  proline-­‐
tryptophan-­‐tryptophan-­‐proline	   domain;	   ADD,	   ATRX-­‐DNMT3-­‐DNMT3L-­‐type	   zinc	   finger	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The	  family	  of	  Dnmts	  includes	  three	  catalytically	  active	  enzymes,	  Dnmt1,	  Dnmt3a	  and	  
Dnmt3b	   and	   their	   close	   homologue,	   Dnmt3l,	   lacking	   catalytic	   activity	   (Meissner,	  
2010).	   Dnmt1	   is	   primarily	   a	   maintenance	   methyltransferase	   that	   preserves	  
methylation	   patterns	   during	   cell	   division.	   During	   S-­‐phase	   it	   localizes	   to	   the	   DNA	  
replication	   foci	   and	   preferentially	   methylates	   hemimethylated	   CpG	   dinucleotides	  
(Denis	   et	   al.,	   2011).	   Dnmt3a	   and	   Dnmt3b	   are	   responsible	   for	   de	   novo	   DNA	  
methylation.	  
	  
All	   the	  Dnmts	  are	  essential	   for	  mammalian	  development.	   Loss	  of	  Dnmt1	   results	   in	  
embryonic	  lethality	  around	  E8.5-­‐9,	  and	  Dnmt1	  mutant	  embryos	  retain	  only	  one-­‐third	  
of	  the	  normal	  amount	  of	  DNA	  methylation	  (Li	  et	  al.,	  1992;	  Meissner,	  2010).	  Dnmt3b	  
mutant	  embryos	  do	  not	  develop	  to	  term	  and	  show	  multiple	  developmental	  defects	  
already	  after	  E9.5	  (Okano	  et	  al.,	  1999).	  Dnmt3a	  knockout	  mice	  die	  around	  1	  month	  
after	  birth	  (Okano	  et	  al.,	  1999),	  while	  homozygous	  Dnmt3l	  mice	  are	  viable,	  although	  
males	   are	   sterile	   and	   heterozygous	   offspring	   of	   homozygous	   females	   die	   due	   to	  
imprinting	  defects	  (Bourc'his	  et	  al.,	  2001).	  Both	  Dnmt3a	  and	  Dnmt3l	  seem	  to	  have	  an	  
essential	   role	   in	   maternal	   imprinting	   (Bourc'his	   et	   al.,	   2001;	   Kaneda	   et	   al.,	   2004).	  
Albeit	   the	   complete	   absence	   of	   CpG	   methylation,	   ES	   cells	   deficient	   for	   all	   three	  
methyltransferases	  Dnmt1,	  Dnmt3a	  and	  Dnmt3b	  are	  able	  to	  self-­‐renew	  and	  maintain	  
the	   molecular	   signature	   of	   pluripotency	   (Tsumura	   et	   al.,	   2006).	   Although	   DNA	  
methylation	   is	   not	   required	   for	   maintenance	   or	   establishment	   of	   ES	   cells	  
pluripotency,	   it	   has	   a	   crucial	   role	   in	   commitment:	   in	   the	   absence	   of	   DNA	  
methylation,	   differentiation	   is	   almost	   completely	   inhibited	   since	   ES	   cells	   fail	   to	  
upregulate	   germ-­‐layer-­‐associated	   markers	   and	   do	   not	   efficiently	   silence	   the	  
pluripotency	  network	  (Jackson	  et	  al.,	  2004).	  	  
	  
Recent	   studies	   have	   shown	   that	   different	   culture	   conditions	   are	   associated	   with	  
profound	  changes	  in	  global	  DNA	  methylation:	  interestingly,	  naïve	  ES	  cells	  cultured	  in	  
2i	   conditions	   are	   characterized	   by	   lower	   expression	   of	   the	   de	   novo	   DNA	  
methyltransferases	  Dnmt3a,	  Dnmt3b	  and	  Dnmt3l	  and	  are	  associated	  to	  global	  DNA	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3.4.2 Histone	  modifications	  
DNA	  is	  packaged	  within	  the	  cell	  in	  a	  structure	  termed	  chromatin.	  The	  nucleosome	  is	  
the	   fundamental	   unit	   of	   chromatin	   and	   is	   composed	   of	   an	   octamer	   of	   four	   core	  
histones	   (H3,	   H4,	   H2A,	   H2B)	   around	   which	   are	   wrapped	   147	   base	   pairs	   of	   DNA	  
(Kouzarides,	  2007).	  The	  core	  histones	  that	  make	  up	  the	  nucleosome	  are	  subject	  to	  a	  
broad	   range	   of	   posttranslational	   modifications	   that	   can	   have	   both	   repressive	   and	  
activating	   functions	   and	   include	   acetylation,	   methylation,	   phosphorylation,	   ADP	  
ribosylation	   and	   ubiquitylation.	   Histone	   modifications	   occur	   at	   specific	   positions	  
primarily	  within	  the	  amino-­‐terminal	  histone	  tails	  (Bernstein	  et	  al.,	  2007).	  Among	  the	  
best-­‐characterized	   mediators	   of	   histone	   modifications	   there	   are	   the	   protein	  
complexes	  of	  the	  polycomb	  (PcG)	  and	  trithorax	  (trxG)	  groups	  (Schuettengruber	  et	  al.,	  
2007),	  catalyzing	  tri-­‐methylation	  of	  histone	  H3	  respectively	  on	  lysine	  27	  (H3K27me3)	  
and	   lysine	   4	   (H3K4me3)	   (Hemberger	   et	   al.,	   2009).	   H3K4me3	   positively	   regulates	  
transcription	  by	  recruiting	  nucleosome	  remodeling	  enzymes	  and	  histone	  acetylases	  
(Pray-­‐Grant	  et	  al.,	  2005;	  Santos-­‐Rosa	  et	  al.,	  2003;	  Sim	  and	  Denlinger,	  2013;	  Wysocka	  
et	  al.,	  2005),	  while	  H3K27me3	  is	  a	  negative	  regulator	  of	  transcription	  since	  it	  induces	  
a	  more	  compact	  chromatin	  structure	  (Ringrose	  et	  al.,	  2004).	  In	  ES	  cells	  several	  genes	  
encoding	   for	   developmental	   transcription	   factors	   are	   associated	   with	   both	   the	  
repressive	  H3K27me3	  and	  with	  the	  active	  H3K4me3	  (Bernstein	  et	  al.,	  2006).	  
This	  particular	  chromatin	  modification	  pattern	  is	  known	  as	  “bivalent	  domain”,	  and	  is	  
thought	   to	   be	   important	   in	   ES	   cells	   to	   silence	   developmental	   genes	  while	   keeping	  
them	  poised	  for	  activation	  (Bernstein	  et	  al.,	  2006).	  
Aim	  of	  the	  thesis	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4. Aim	  of	  the	  thesis	  
	  
The	   main	   goal	   of	   this	   thesis	   was	   to	   elucidate	   the	   role	   of	   the	   Myc	   family	   of	  
transcription	   factors	   in	   naïve	  mouse	   embryonic	   stem	   (ES)	   cells	   cultured	   in	   2i	   +	   LIF	  
medium.	   To	   genetically	   address	   this	   question,	   we	   derived	   ES	   cell	   lines	   carrying	   a	  
Cre/loxP	  system	  to	  conditionally	  delete	  both	  c-­‐myc	  and	  N-­‐myc.	  We	  then	  investigated	  
the	   effect	   of	   Myc	   double	   knock-­‐out	   (dKO)	   on	   self-­‐renewal	   and	   pluripotency	   by	  
analyzing	   the	  cell	   cycle	  profile	  and	   the	  expression	  of	   the	  core	  ES	  cells	  pluripotency	  
factors	  upon	  Myc	  activity	  loss.	  	  Considering	  that	  Myc	  proteins	  can	  influence	  a	  variety	  
of	  cellular	  processes	  by	  globally	  regulating	  gene	  expression,	  one	  of	  our	  aims	  was	  to	  
determine	  the	  molecular	  landscape	  of	  Myc	  dKO	  ES	  cells.	  To	  answer	  this	  question,	  we	  
performed	  whole	   transcriptome	  analysis	  by	  next-­‐generation	  sequencing	   (RNA-­‐seq).	  
Finally,	   to	   compare	   c-­‐Myc	   protein	   expression	   in	   naïve	   ES	   cells,	   cultured	   in	   2i	   +	   LIF	  
medium,	   and	  metastable	   ES	   cells,	   cultured	   in	   serum	  +	   LIF	  medium,	  we	   derived	   ES	  
cells	   from	  mice	   expressing	   a	   c-­‐Myc-­‐GFP	   reporter	   protein	   introduced	   in-­‐frame	   into	  
the	  endogenous	  c-­‐myc	  locus.	  
Results	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5. Results	  
5.1 The	  effect	  of	  Myc	  loss	  in	  naïve	  ES	  cells	  
In	  vitro	  cultured	  ES	  cells	  have	  been	  the	  focus	  of	  an	  enormous	  number	  of	  studies	  to	  
elucidate	   the	  mechanisms	   of	   self-­‐renewal	   and	   pluripotency.	   However,	   ES	   cells	   are	  
derived	  from	  a	  cell	  type	  that	  exists	  only	  transiently	  in	  the	  early	  embryo	  and	   in	  vitro	  
are	   maintained	   in	   an	   artificial	   environment.	   Recent	   studies	   have	   shown	   that	   the	  
conventional	  medium	  used	  to	  culture	  ES	  cells,	  containing	  serum	  and	  the	  cytokine	  LIF,	  
exposes	   these	   stem	   cells	   to	   a	   multitude	   of	   extracellular	   signals	   promoting	   their	  
differentiation.	   ES	   cells	   cultured	   in	   “serum	   +	   LIF”	   are	   therefore	   metastable	   since	  
exhibit	  great	  heterogeneity	  in	  morphology	  and	  in	  the	  expression	  of	  core	  pluripotency	  
factors	  such	  as	  Oct4	  (Nichols	  and	  Smith,	  2009),	  Nanog	  (Chambers	  et	  al.,	  2007),	  Rex1	  
(Toyooka	  et	  al.,	  2008)	  and	  Stella	  (Hayashi	  et	  al.,	  2008;	  Wray	  et	  al.,	  2010).	  Recently,	  
the	   group	   of	   Austin	   Smith	   has	   defined	   a	   new	   culture	   condition	   able	   to	   stabilize	  
mouse	  ES	  cells	   in	  a	  naïve	  state	  of	  pluripotency,	   that	  more	  closely	  recapitulates	   the	  
pluripotent	  state	  in	  the	  early	  mammalian	  blastocyst	  (Leitch	  et	  al.,	  2013;	  Marks	  et	  al.,	  
2012;	   Yamaji	   et	   al.,	   2013;	   Ying	  et	   al.,	   2008).	  Naïve	  ES	   cells	   can	  be	  maintained	   in	   a	  
serum-­‐free	   medium,	   supplemented	   with	   LIF	   and	   in	   the	   presence	   of	   two	   small	  
molecules,	   PD0325901	   and	   CHIR99021,	   inhibiting	   respectively	   MEK	   and	   GSK3β.	  
These	   novel	   culture	   conditions	   are	   therefore	   referred	   to	   as	   “2i	   +	   LIF”.	   The	   role	   of	  
several	   factors	   involved	   in	   ES	   cells	   biology	   has	   been	   studied	   in	   serum-­‐containing	  
cultures.	   Taking	   into	   account	   that	   ES	   cells	   are	   more	   homogenous	   in	   2i	   and	   differ	  
from	  those	  cells	   cultured	   in	   serum	  both	  on	  a	  gene	  expression	  and	  epigenetic	   level	  
(Marks	  et	  al.,	  2012),	  it	  is	  necessary	  to	  re-­‐evaluate	  the	  role	  of	  several	  key	  pluripotency	  
factors	  in	  the	  absence	  of	  differentiation	  signals.	  The	  role	  of	  the	  Myc	  family	  members	  
in	   ES	   cells	   grown	   in	   serum	   +LIF	   has	   been	   broadly	   described.	   Separate	   deletion	   of	  
either	   c-­‐	   or	   N-­‐myc	   seems	   to	   have	   no	   effect	   on	   mouse	   ES	   cells:	   indeed,	   embryos	  
lacking	  either	   c-­‐	  or	  N-­‐myc	  die	   at	   E10.5	  or	   E11.5	   respectively	   (Charron	  et	   al.,	   1992;	  
Davis	   et	   al.,	   1993;	   Sawai	   et	   al.,	   1991;	   Trumpp	  et	   al.,	   2001).	   These	   results	   could	  be	  
explained	   taking	   into	   consideration	   that	   c-­‐myc	   and	   N-­‐myc	   are	   highly	   redundant	  
(Malynn	  et	  al.,	  2000)	  and	  one	  family	  member	  might	  compensate	  the	  absence	  of	  the	  
Results	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other	   in	  ES	  cells.	  Recent	  publications	  have	  shown	  that	   loss	  of	  both	  c-­‐	  and	  N-­‐myc	  in	  
metastable	   ES	   cells	   impairs	   self-­‐renewal	   and	   induces	   rapid	   differentiation	   towards	  
primitive	  endoderm	   (Smith	  et	  al.,	   2010;	  Varlakhanova	  et	  al.,	   2010).	  Elucidating	   the	  
function	  of	  c-­‐	  and	  N-­‐myc	  in	  the	  naïve	  state	  of	  pluripotency	  is	  the	  aim	  of	  this	  project.	  
	  
5.1.1 Derivation	  of	  ES	  cell	  lines	  for	  conditional	  deletion	  of	  c-­‐	  and	  N-­‐myc	  
In	  collaboration	  with	  the	  “transgenic	  service”	  of	  the	  German	  Cancer	  Research	  Center	  
(DKFZ),	  we	  derived	  ES	  cell	  lines	  from	  c-­‐mycflox/flox;	  N-­‐mycflox/flox;	  REYFPflox/flox	  mice.	  	  
The	  REYFPflox	   is	  an	  allele	  reporting	  Cre	  recombinase	  activity	  (Srinivas	  et	  al.,	  2001):	  a	  
loxP-­‐flanked	   stop	   codon	   blocks	   the	   expression	   of	   the	   EYFP	   protein	   and	   upon	   Cre-­‐
mediated	   recombination,	   the	   stop	   codon	   is	   excised,	   resulting	   in	   constitutive	   EYFP	  
expression	   from	   the	   ubiquitously	   active	   Rosa26	   promoter	   (Srinivas	   et	   al.,	   2001)	  
(Figure	  34).	  
E2.5	  days	  morulas	  were	  cultured	   for	   the	   first	   two	  passages	  on	  a	   feeder	   layer	  of	   γ-­‐
irradiated	  MEFs,	  in	  “serum	  +	  LIF”	  medium	  that	  was	  additionally	  supplemented	  with	  
the	   two	   small	   molecule	   inhibitors	   PD0325901	   and	   CHIR99021	   to	   support	   a	   more	  
efficient	   ES	   cell	   derivation.	   Under	   these	   conditions	   we	   generated	   6	   different	  
monoclonal	  ES	  cell	  lines	  where	  both	  c-­‐	  and	  N-­‐myc	  can	  be	  conditionally	  deleted	  in	  the	  
presence	  of	  Cre	  recombinase	  activity.	  These	  lines	  were	  further	  maintained	  in	  serum-­‐
free,	   “2i	   +	   LIF”	   medium.	   Lines	   B8	   and	   D3	   (c-­‐mycflox/flox;	   N-­‐mycflox/flox;	   REYFPflox/flox)	  
were	  used	  to	  investigate	  the	  effect	  of	  both	  c-­‐	  and	  N-­‐Myc	  loss	  on	  ES	  cell	  self-­‐renewal	  
and	  pluripotency.	  The	  genetic	   identity	  of	   these	  ES	  cell	   lines	  was	  confirmed	  via	  PCR	  
(Figure	  15.B).	  	  
	  
5.1.2 Teratoma	  Assay	  
ES	  cells	  are	  by	  definition	  pluripotent,	  since	  they	  are	  capable	  to	  differentiate	  into	  all	  
cell	   lineages	  of	   the	  body.	  The	   teratoma	  assay	   is	  one	  of	   the	  standard	   techniques	   to	  
test	   the	   differentiation	   potential	   of	   embryonic	   stem	   cells.	   Once	   injected	   into	   an	  
immunodeficient	  mouse,	  ES	  cells	  are	  exposed	  to	  a	  complex	  mixture	  of	  factors	  able	  to	  
support	  their	  proliferation	  and	  differentiation	  into	  teratomas,	  non-­‐malignant	  tumors	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comprised	  of	   tissues	  derived	   from	  all	   three	  germ	   layers:	  ectoderm,	  mesoderm	  and	  
endoderm	  (Wesselschmidt,	  2011).	  
In	  order	  to	  prove	  the	  multi-­‐lineage	  differentiation	  capacity	  of	  the	  newly	  derived	  ES	  
cell	   lines,	  we	  injected	  subcutaneously	  2x106	  cells	  into	  immunodeficient	  NSG	  mice.	  8	  
weeks	  after	  injection,	  when	  the	  tumors	  were	  visible	  and	  around	  1.5	  cm	  in	  diameter,	  
the	   mice	   were	   euthanized	   and	   the	   tumors	   surgically	   removed	   and	   processed	   for	  
histopathological	   analysis	   (Figure	   13).	   Hematoxylin	   and	   Eosin	   (H&E)	   staining	   of	  
teratomas	  showed	  that	  ES	  B8	  cells	  were	  able	  to	  differentiate	  into	  skin-­‐like	  structures	  
with	  keratin	  deposition	  (ectoderm,	  Figure	  13.A	  and	  D),	  cartilage	  (mesoderm,	  Figure	  
13.B	  and	  E)	  and	  gastrointestinal	  epithelium	  (endoderm,	  Figure	  13.C).	  
The	   capability	   to	   differentiate	   into	   tissues	   derived	   from	   the	   three	   germ	   layers	  
confirms	  the	  broad	  pluripotent	  potential	  of	  the	  newly	  derived	  ES	  lines.	  	  
	  
	  
Figure	   13:	   Histology	   of	   teratomas	   derived	   from	   c-­‐mycflox/flox;	   N-­‐mycflox/flox;	   REYFPflox/flox	  
mouse	  ES	  cells.	  H&E	  staining	  of	  representative	  structures	  of	  ectodermal	  (A,D),	  mesodermal	  
(B,E)	   and	   endodermal	   (C,F)	   origin	   derived	   from	   teratomas	   developed	   from	   the	   ES	   B8	   line.	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5.1.3 Deletion	  of	  c-­‐myc	  and	  N-­‐myc	  in	  mouse	  ES	  cells	  
The	  schematic	  representation	  of	  the	  strategy	  used	  to	  genetically	  delete	  c-­‐	  and	  N-­‐myc	  
in	  ES	  cells	   is	  shown	  in	  Figure	  14.	  In	  summary,	  the	  cells	  were	  transiently	  transfected	  
with	  the	  pbS513	  plasmid	  (Le	  et	  al.,	  1999)	  expressing	  the	  Cre	  recombinase	  under	  the	  
control	  of	  the	  elongation	  factor	  1-­‐alpha	  (EF1α)	  promoter,	  highly	  active	  in	  mouse	  ES	  
cells.	   The	   REYFPflox	   reporter	   allele	  was	   used	   to	   identify	   those	   cells	   where	   Cre	  was	  
expressed.	   24	  hours	   after	   transfection,	   EYFP+	   cells	  were	   FACS	   sorted	   (Figure	  15.A)	  
and	   cultured	   in	   2i	   +	   LIF	   medium.	   After	   72h,	   more	   than	   120	   single	   colonies	   were	  
mechanically	  picked,	  expanded	  as	  single	  clones	  and	  genotyped	  (Figure	  15.B).	  	  
	  
	  
Figure	  14:	  Experimental	   strategy	   to	  delete	  c-­‐myc	  and	  N-­‐myc	   in	  mouse	  ES	  cells.	  To	  obtain	  
Myc	  dKO	  ES	  cells,	  B8	  and	  D3	  ES	  cells	  (c-­‐mycflox/flox;	  N-­‐mycflox/flox;	  REYFPflox/flox)	  were	  transfected	  
with	  an	  EF1α-­‐Cre	  plasmid	  (pbS513)	  and	  EYFP+	  cells	  were	  sorted	  24	  hours	  after	  transfection.	  
After	  sort,	  single	  ES	  cell	  colonies	  were	  picked,	  separately	  grown	  and	  genotyped.	  Clones	  3,	  4,	  
6	   and	   22	   (c-­‐mycΔ/Δ;	   N-­‐mycΔ/flox)	   were	   than	   transiently	   transfected	   with	   a	   mCherry-­‐Cre	  
plasmid	  to	  express	  the	  Cre	  recombinase	  and	  delete	  the	  last	  N-­‐myc	  allele.	  
	  
All	   the	  clones	  that	  could	  be	  further	  expanded	  had	  only	  partially	  deleted	  myc,	  since	  
they	  were	  always	  carrying	  at	  least	  one	  residual	  N-­‐myc	  or	  c-­‐myc	  allele.	  In	  Figure	  15.B	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clones	  3	  and	  4	  (derived	  from	  the	  D3	  line)	  carrying	  a	  residual	  N-­‐myc	  allele	  (c-­‐mycΔ/Δ;	  
N-­‐mycΔ/flox).	  Clone	  11	  (derived	  from	  the	  D3	   line)	  had	  only	  c-­‐myc	  deletion	  (c-­‐mycΔ/Δ;	  
N-­‐mycflox/flox).	   In	   2i	   +	   LIF	   medium,	   ES	   cell	   lines	   lacking	   both	   c-­‐myc	   alleles	   were	  
morphologically	   indistinguishable	   from	   the	   parental	   lines	   (data	   not	   shown).	   The	  
observation	  that	  it	  was	  not	  possible	  to	  derive	  and	  expand	  ES	  cell	  clones	  in	  which	  the	  
two	  alleles	  of	  both	  c-­‐	  and	  N-­‐myc	  have	  been	  fully	  deleted	  indicates	  a	  strong	  negative	  
selection	  against	  these	  cells.	  
	  
Figure	  15:	  Deletion	  of	  c-­‐myc	  and	  N-­‐myc	  in	  mouse	  ES	  cells.	  B8	  and	  D3	  ES	  cells	  (c-­‐mycflox/flox;	  
N-­‐mycflox/flox;	   REYFPflox/flox)	   were	   transfected	  with	   an	   EF1α-­‐Cre	   plasmid	   (pbS513)	   and	   EYFP+	  
cells	  were	   FACS	   sorted	  24	  hours	   after	   transfection.	  After	   sort,	   single	   ES	   cell	   colonies	  were	  
picked,	   grown	   separately	   and	   genotyped.	   (A)	   Representative	   scheme	   for	   FACS	   sorting	   of	  
EYFP+	  ES	  cells	  24	  hours	  after	  Cre	  induction.	  (B)	  Genotyping	  PCR	  of	  B8	  and	  D3	  ES	  cells	  and	  the	  
clones	   that	   were	   derived	   upon	   Cre-­‐mediated	   myc	   deletion.	   L	   (100	   bp	   DNA	   ladder);	   +	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In	  order	  to	  obtain	  a	  population	  enriched	  for	  Myc	  dKO	  ES	  cells,	  we	  used	  those	  clones	  
carrying	  only	   one	   residual	  N-­‐myc	   allele	   for	   a	   second	   round	  of	   Cre	   induction.	   Since	  
these	  cells	  constitutively	  express	  the	  EYFP	  reporter,	  to	  delete	  the	   last	  N-­‐myc	  allele,	  
clones	   6	   and	  22	  were	   transfected	  with	   the	  mCherry-­‐Cre	  plasmid	   expressing	   a	  Cre-­‐
mCherry	  fusion	  protein	  under	  the	  control	  of	  the	  EF1α	  promoter	  (Figure	  14).	  	  
	  
	  
Figure	  16:	  Deletion	  of	  the	  residual	  N-­‐myc	  allele.	  Clones	  6	  and	  22	  (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox)	  were	  
transfected	  with	  a	  mCherry-­‐Cre	  plasmid	  and	  mCherry+	  (Cre+)	  and	  mCherry-­‐	  (Cre-­‐)	  cells	  were	  
sorted	  24	  hours	  after	  transfection.	  (A)	  Representative	  scheme	  for	  FACS	  sorting	  of	  mCherry+	  
and	  mCherry-­‐	  ES	  cells	  24	  hours	  after	  Cre	  induction.	  (B)	  Immediately	  after	  sort,	  ES	  cells	  were	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Figure	  17:	  mRNA	  expression	  of	  Myc	  homologues	   in	  mouse	  ES	  cells	  upon	  Cre	  mediated	  c-­‐
myc	   and	   N-­‐myc	   deletion.	   Clone	   6	   and	   Clone	   22	   (c-­‐mycΔ/Δ;	   N-­‐mycΔ/flox)	   were	   transiently	  
transfected	  with	   the	  mCherry-­‐Cre	  plasmid.	  24	  hours	  after	   transfection,	  Cre+	  and	  Cre-­‐	   cells	  
were	   FACS	   sorted	   and	   plated	   in	   12-­‐well	   plates	   at	   a	   density	   of	   5x104	   cells	   per	  well.	  mRNA	  
expression	  levels	  of	  c-­‐myc	  (A),	  N-­‐myc	  (B)	  and	  L-­‐myc	  (C)	  relative	  to	  GAPDH	  were	  measured	  by	  
qRT-­‐PCR	  24,	  48	  and	  96	  hours	  after	  transfection	  (N=3;	  mean	  and	  SEM).	  ES	  B8	  (c-­‐mycflox/flox;	  N-­‐
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The	  fluorochrome	  mCherry	  was	  used	  as	  a	  reporter	  of	  Cre	  expression	   (Figure	  16.A).	  
24	   hours	   after	   transfection,	   mCherry	   positive	   (Cre+)	   and	   mCherry	   negative	   (Cre-­‐)	  
cells	   were	   FACS	   sorted	   and	   immediately	   used	   for	   DNA	   isolation.	   Genotyping	   PCR	  
confirmed	   the	   genetic	   deletion	   of	   the	   last	   N-­‐myc	   allele	   in	   the	   Cre+	   populations	  
(Figure	  16.B).	  
	  
To	  confirm	  that	  the	  genetic	  deletion	  of	  myc	  resulted	   in	  the	  down-­‐regulation	  of	  the	  
myc	  mRNA	   transcripts,	  we	   transfected	  clone	  6	  and	  clone	  22	  with	   the	  mCherry-­‐Cre	  
plasmid	  and	  FACS	  sorted	   the	  cells	  24	  hours	  after	   transfection.	  After	   sort,	  Cre+	  and	  
Cre-­‐	  cells	  were	   further	  cultured	   in	  2i	  +	  LIF	  medium.	  RNA	  was	   isolated	  24,	  48	  or	  96	  
hours	  after	  Cre	  induction.	  As	  shown	  in	  Figure	  17.A,	  qRT-­‐PCR	  confirmed	  the	  absence	  
of	   c-­‐myc	   transcripts	   in	   clones	   6	   and	   22	   (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox).	   Compared	   to	   the	   c-­‐
mycflox/flox;	  N-­‐mycflox/flox	  control	  (B8),	  in	  the	  Cre+	  cells	  N-­‐myc	  expression	  was	  strongly	  
reduced	  already	  24	  hours	  after	  transfection	  and	  it	  further	  decreased	  after	  48	  and	  96	  
hours	  (Figure	  17.B).	  As	  a	  compensatory	  effect,	  c-­‐myc	  and	  N-­‐myc	  loss	  also	  resulted	  in	  
a	  2	   to	  3	   fold	  up-­‐regulation	  of	   the	   third	  Myc	   family	  member,	   L-­‐myc,	  96	  hours	  after	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5.1.4 Differentiation	  potential	  of	  c-­‐myc	  KO	  ES	  cells	  
To	  test	  the	  differentiation	  potential	  of	  ES	  cells	  lacking	  both	  c-­‐myc	  alleles,	  we	  injected	  
c-­‐mycΔ/Δ;	   N-­‐mycΔ/flox	   ES	   cells	   subcutaneously	   into	   immunodeficient	   NSG	   mice.	  
Interestingly,	   although	   loss	   of	   either	   c-­‐myc	   or	   N-­‐myc	   has	   been	   reported	   to	   be	  
embryonically	  lethal	  due	  to	  developmental	  defects	  (Charron	  et	  al.,	  1992;	  Davis	  et	  al.,	  
1993;	  Sawai	  et	  al.,	  1991;	  Trumpp	  et	  al.,	  2001),	  we	  observe	   that	  c-­‐myc	  null	  ES	  cells	  




Figure	  18:	  Histology	  of	  teratomas	  derived	  from	  c-­‐mycΔ/Δ,	  N-­‐mycΔ/flox	  ES	  cells.	  H&E	  staining	  
of	   representative	   structures	  of	  ectodermal	   (A),	  mesodermal	   (B)	   and	  endodermal	   (C)	  origin	  
derived	   from	   teratomas	   developed	   from	   the	   Clone	   4	   (c-­‐mycΔ/Δ;	   N-­‐mycΔ/flox).	   Scale	   bars	  
50μm.	  
	  
5.1.5 Cell	  cycle	  profile	  of	  Myc	  dKO	  ES	  cells	  
Mouse	   ES	   cells	   proliferate	   very	   rapidly,	  with	   a	   division	   time	   of	   around	   8-­‐10	   hours	  
(Stead	  et	  al.,	  2002).	  Indeed,	  while	  somatic	  cells	  spend	  the	  majority	  of	  their	  time	  in	  G1	  
phase,	   mouse	   ES	   cells	   are	   characterized	   by	   truncated	   gap	   phases,	   accounting	   for	  
their	   rapid	  cell	   cycle.	  Myc	  proteins	  are	  known	   to	  have	  a	  unique	  and	  crucial	   role	   in	  
promoting	  cell	  proliferation	  (Alevizopoulos	  et	  al.,	  1997;	  Daksis	  et	  al.,	  1994;	  Vlach	  et	  
al.,	  1996).	   Indeed,	  Myc	  has	  been	  shown	   to	   induce	  cell	   cycle	  progression	   through	  a	  
variety	   of	   mechanisms,	   as	   activation	   of	   cyclins,	   inhibition	   cyclin-­‐dependent	   kinase	  
(CDK)	   inhibitors	   and	   inhibition	   of	   cell	   cycle	   checkpoint	   genes	   (reviewed	   in	   (Meyer	  
and	  Penn,	  2008)).	  In	  mouse	  ES	  cells	  cultured	  in	  serum	  +	  LIF,	  lack	  of	  Myc	  disrupts	  their	  
self-­‐renewal	  capacity,	  resulting	  in	  cell	  cycle	  arrest	  (Smith	  et	  al.,	  2010;	  Varlakhanova	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To	  determine	   the	  effect	  of	  Myc	  deletion	   in	  naïve	  ES	   cells,	  we	  performed	  cell	   cycle	  
analysis	  combining	  Ki67	  and	  Hoechst	  staining	  on	  c-­‐mycflox/flox;	  N-­‐mycflox/flox	  (B8)	  cells,	  
c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox	  (clone	  6	  and	  clone	  22)	  cells,	  and	  Myc	  dKO	  ES	  cells	  96	  hours	  after	  
Cre	  transfection	  (Figure	  19.A	  and	  B).	  	  
	  
	  
Figure	  19:	  Cell	   cycle	   analysis	  of	  mouse	  ES	   cells	   upon	   c-­‐Myc	  and	  N-­‐Myc	  deletion.	  Clone	  6	  
and	   Clone	   22	   (c-­‐mycΔ/Δ;	   N-­‐mycΔ/flox)	   were	   transiently	   transfected	   with	   the	   mCherry-­‐Cre	  
plasmid.	  24	  hours	  after	  transfection,	  Cre+	  and	  Cre-­‐	  cells	  were	  FACS	  sorted	  and	  plated	  in	  12-­‐
well	   plates	   at	   a	   density	   of	   5x104	   cells	   per	   well.	   Cell	   cycle	   analysis	   (A,B)	   or	   alkaline	  
phosphatase	  (AP)	  staining	  (C)	  were	  performed	  72	  h	  after	  sort.	  
	  
Exclusive	  deletion	  of	  c-­‐myc	  seems	  to	  have	  no	  influence	  on	  the	  proliferative	  status	  of	  
mouse	  ES	  cells	  (clones	  6	  and	  22)	  as	  a	  consequence	  of	  a	  possible	  compensatory	  role	  
of	  N-­‐myc	   (Figure	  19.A	   and	  B).	   In	   contrast,	   in	  Myc	  dKO	   cells	   (Cre+)	   the	   cell	   cycle	   is	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corresponding	  decrease	  of	  proliferative	  cells	  in	  S-­‐G2-­‐M	  phases	  (Figure	  19.A	  and	  B).	  In	  
agreement	  with	  this	  observation,	  dKO	  ES	  cell	  colonies	  are	  smaller	  in	  size	  as	  observed	  
by	  microscopy	  (Figure	  19.C).	  In	  conclusion,	  our	  results	  indicate	  that	  c-­‐	  and	  N-­‐myc	  loss	  
impairs	  cell	  proliferation	  and	  this	  could	  explain	  the	  failure	  to	  propagate	  dKO	  ES	  cells	  
in	  culture.	  
	  
5.1.6 Pluripotency	  of	  Myc	  dKO	  ES	  cells	  
When	  ES	  cells	  differentiate,	  the	  length	  of	  the	  G1	  phase	  increases	  (White	  and	  Dalton,	  
2005;	  White	   et	   al.,	   2005)	   and	   the	   rate	   of	   cell	   division	   is	   reduced.	   Along	   this	   line,	  
Smith	  and	  colleagues	  observed	  that,	  when	  cultured	  in	  serum	  +	  LIF	  medium,	  Myc	  dKO	  
ES	  cells	  arrest	  proliferation	  and	  rapidly	  undergo	  spontaneous	  differentiation	  towards	  
primitive	  endoderm	  (Smith	  et	  al.,	  2010).	  
	  
Therefore	  we	  tested	  if	  the	  cell	  cycle	  arrest	  caused	  by	  loss	  of	  myc	  is	  also	  associated	  to	  
the	   inactivation	   of	   the	   pluripotency	   network	   in	   the	   naïve	   state.	   Interestingly,	   96	  
hours	  after	  Cre	  induction	  we	  observe	  that	  in	  2i	  +	  LIF	  medium	  Myc	  dKO	  ES	  cells	  form	  
smaller,	   undifferentiated	   colonies	   and	   express	   the	   stem	   cells	   marker	   alkaline-­‐
phosphates	   (Figure	   19.C).	   More	   importantly,	   Myc	   dKO	   ES	   cells	   retain	   protein	  
expression	   of	   the	   pluripotency	   master	   regulator	   Nanog	   (Figure	   20.A	   and	   B)	   as	  
measured	  by	  immunofluorescence	  and	  FACS	  analysis,	  and	  express	  the	  core	  stem	  cell	  
factors	  Oct4	  and	  Sox2	  at	  levels	  similar	  to	  the	  parental	  lines	  (Figure	  20.B).	  	  
	  
Our	  results	  indicate	  that	  c-­‐	  and	  N-­‐myc	  loss	  in	  ES	  cells	  impairs	  proliferation	  but	  it	  does	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Figure	  20:	  Expression	  of	  pluripotency	  markers	   in	  Myc	  dKO	  ES	  cells.	  Clones	  4,	  6	  and	  22	  (c-­‐
mycΔ/Δ;	  N-­‐mycΔ/flox)	  were	  transfected	  with	  the	  mCherry-­‐Cre	  plasmid	  and	  Cre+	  and	  Cre-­‐	  cells	  
were	   sorted	   24	   hours	   after	   Cre	   induction.	   For	   immunofluorescence	   staining	   of	   Nanog	   (A)	  
5x103	  cells	  were	  plated	  on	  chambered	  cover	  glasses	  coated	  with	  MEFs	  and	  stained	  96	  hours	  
after	  transfection.	  For	   intracellular	  FACS	  analysis	  of	  Nanog,	  Sox2	  and	  Oct4	  (B)	  5x104	  sorted	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5.1.7 Expression	  of	  DNA	  methyltransferases	  in	  Myc	  dKO	  cells	  
In	   somatic	   cells,	   during	   each	   round	   of	   DNA	   replication,	   Dnmt1,	   the	   so-­‐called	  
maintenance	  methyltransferase,	  propagates	  the	  methylation	  pattern	  of	  the	  mother	  
cell	  to	  the	  daughters,	  by	  copying	  the	  DNA	  methylation	  information	  from	  the	  parental	  
strand	  of	  DNA	  to	  the	  newly	  synthesized	  strand	  (Bock	  and	  Wutz,	  2013).	  The	  de	  novo	  
methyltransferases,	  Dnmt3a	  and	  Dnmt3b,	  are	  highly	  expressed	  in	  ES	  cells	  cultured	  in	  
serum.	  In	  contrast,	   in	  2i	  conditions,	  where	  ES	  cells	  more	  closely	  resemble	  the	  early	  
mouse	   embryo,	   the	   transcription	   factor	   Prdm14	   down-­‐regulates	   the	   expression	   of	  
the	  de	  novo	  methyltransferases	  leading	  to	  globlal	  DNA	  hypomethylation	  (Grabole	  et	  
al.,	  2013;	  Leitch	  et	  al.,	  2013;	  Yamaji	  et	  al.,	  2013).	  
	  
	  
Figure	   21:	   Expression	   of	   Dnmts	   in	  Myc	   dKO	   ES	   cells.	   Clone	   6	   and	   Clone	   22	   (c-­‐mycΔ/Δ;	  N-­‐
mycΔ/flox)	   were	   transiently	   transfected	   with	   mCherry-­‐Cre	   plasmid.	   24	   hours	   after	  
transfection,	  Cre+	  and	  Cre-­‐	  cells	  were	  FACS	  sorted	  and	  plated	  in	  12-­‐well	  plates	  at	  a	  density	  
of	   5x104	   cells	   per	   well.	   96	   hours	   after	   transfection,	   mRNA	   expression	   levels	   of	   Dnmt1,	  
Dnmt3a,	  Dnmt3a2,	  Dnmt3b	  and	  Dnmt3l	  relative	  to	  Gapdh	  were	  measured	  by	  qRT-­‐PCR	  (N=5;	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Considering	   the	   importance	   of	   these	   methyltransferases	   in	   maintaining	   the	  
methylation	  status	  of	  naïve	  ES	  cells,	  we	  measured	   their	  mRNA	  expression	   levels	   in	  
Myc	   dKO	   cells	   96	   hours	   after	   Cre	   induction.	  We	   found	   that	   in	  Myc	   dKO	   cells	   the	  
levels	   of	   the	   maintenance	   methyltransferase	   Dnmt1	   and	   the	   de	   novo	  
methyltransferase	  Dnmt3b	  were	  unchanged	   (Figure	  21)	  while	  we	  observed	  a	   small	  
increase	  in	  the	  mRNA	  expression	  of	  Dnmt3a	  and	  its	  isoform	  Dnmt3a2.	  Strikingly,	  we	  
find	  that	  Dnmt3l,	  a	  member	  of	  the	  Dnmt	  family	  lacking	  enzymatic	  activity,	  is	  strongly	  
induced	  in	  Myc	  dKO	  ES	  cells.	  
	   	  
Results	  
_____________________________________________________________________	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5.1.8 Global	  gene	  expression	  profiling	  of	  Myc	  dKO	  ES	  cells	  	  
To	   determine	   the	  molecular	   landscape	   of	  Myc	   dKO	   ES	   cells,	   we	   performed	  whole	  
transcriptome	  analysis	  (RNA-­‐seq)	  24	  and	  96	  hours	  after	  Cre	  induction.	  	  
	  
Figure	  22:	  Experimental	   scheme	  for	  RNA-­‐seq	  of	  myc	  dKO	  ES	  cells.	   (A)	  Clones	  6	  and	  22	  (c-­‐
mycΔ/Δ;	   N-­‐mycΔ/flox)	   cultured	   in	   2i	   +	   LIF	   medium	   were	   transfected	   with	   the	   mCherry-­‐Cre	  
plasmid.	  24	  hours	  after	   transfection,	  mCherry+	   (Cre+)	  and	  mCherry-­‐	   (Cre-­‐)	  cells	  were	  FACS	  
sorted	  and	  used	  for	  RNA	  isolation	  (24	  hours	  time	  point),	  or	  were	  plated	  in	  24-­‐well	  plates	  at	  a	  
density	  of	  5x104	  cells/well,	  in	  2i	  +	  LIF	  medium.	  Cultured	  cells	  were	  harvested	  72	  hours	  after	  
sort	  and	  used	  for	  RNA-­‐isolation	  (96	  hours	  time	  point).	  (B)	  B8	  cells	  (c-­‐mycflox/flox;	  N-­‐mycflox/flox)	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These	   two	   time-­‐points	   were	   chosen	   to	   distinguish	   the	   early	   and	   the	   late	   events	  
occurring	  upon	  loss	  of	  myc.	  The	  experimental	  scheme	  used	  is	  illustrated	  in	  Figure	  22.	  
	  
Validation	  of	  the	  RNA-­‐seq	  data	  
In	  order	  to	  validate	  our	  RNA-­‐seq	  data,	  we	  checked	  the	  expression	  levels	  of	  the	  three	  
members	  of	  the	  Myc	  family	  (Figure	  23).	  As	  expected,	  we	  found	  that	  the	  levels	  of	  c-­‐
myc	  transcripts	  were	  significantly	  lower	  (DESeq2;	  p	  adjusted	  value	  <	  0.1)	  in	  all	  the	  c-­‐
mycΔ/Δ;	  N-­‐mycΔ/flox	   samples	  where	  c-­‐myc	  was	  genetically	  deleted.	  Already	  24	  hours	  
after	  Cre	  induction,	  N-­‐myc	  expression	  was	  significantly	  reduced	  in	  the	  Cre+	  samples	  
compared	   to	   the	   Cre-­‐	   and	   the	   parental	   ES	   B8	   line	   (c-­‐mycflox/flox;	   N-­‐mycflox/flox).	   The	  




Figure	   23:	   RNA-­‐seq	   expression	   levels	   of	   the	   Myc	   family	   members.	   Clones	   6	   and	   22	   (c-­‐
mycΔ/Δ;	   N-­‐mycΔ/flox)	   cultured	   in	   2i	   +	   LIF	   medium	   were	   transfected	   with	   the	   mCherry-­‐Cre	  
plasmid.	  24	  hours	  after	   transfection,	  mCherry+	   (Cre+)	  and	  mCherry-­‐	   (Cre-­‐)	  cells	  were	  FACS	  
sorted.	   RNA	  was	   isolated	   24	  hours	   or	   96	   hours	   after	   Cre	   induction.	   ES	  B8	   (c-­‐mycflox/flox;	  N-­‐
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Pluripotency	  
Consistent	  with	  the	  observation	  that	  Myc	  dKO	  ES	  cells	  maintain	  protein	  expression	  
of	  the	  core	  pluripotency	  factors	  Oct4,	  Nanog	  and	  Sox2	  (Figure	  20),	  RNA-­‐seq	  analysis	  
shows	   that	   96	   hours	   after	  Myc	   deletion,	   the	   mRNA	   levels	   of	   these	   genes	   remain	  
unchanged	  (Figure	  24).	  	  
	  
Figure	   24:	   RNA-­‐seq	   expression	   levels	   of	   the	   core	   pluripotency	   factors	   Nanog,	   Oct4	   and	  
Sox2.	  Clones	  6	  and	  22	   (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox)	   cultured	   in	  2i	  +	   LIF	  medium	  were	   transfected	  
with	   the	  mCherry-­‐Cre	  plasmid.	  24	  hours	  after	   transfection,	  mCherry+	   (Cre+)	  and	  mCherry-­‐	  
(Cre-­‐)	  cells	  were	  FACS	  sorted.	  RNA	  was	  isolated	  24	  hours	  or	  96	  hours	  after	  Cre	  induction.	  ES	  
B8	  (c-­‐mycflox/flox;	  N-­‐mycflox/flox);	  NT	  (not	  transfected	  control).	  
Besides	   the	   core	   pluripotency	   factors,	   we	   extended	   our	   analysis	   to	   an	   available	  
published	   pluripotency	   signature	   (Marks	   et	   al.,	   2012)	   including	   additional	   factors	  
known	  to	  play	  a	  role	  in	  ES	  cells	  pluripotency.	  	  
	  
Figure	  25:	  RNA-­‐seq	  expression	  levels	  of	  relevant	  pluripotency,	  self-­‐renewal,	  and	  stem	  cell	  
factors.	  Clones	  6	  and	  22	  (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox)	  cultured	  in	  2i	  +	  LIF	  medium	  were	  transfected	  
with	   the	  mCherry-­‐Cre	  plasmid.	  24	  hours	  after	   transfection,	  mCherry+	   (Cre+)	  and	  mCherry-­‐	  
(Cre-­‐)	  cells	  were	  FACS	  sorted.	  RNA	  was	  isolated	  24	  hours	  or	  96	  hours	  after	  Cre	  induction.	  ES	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Our	   data	   confirm	   that	   several	   categorized	   stem	   cell	   maintenance	   genes,	   as	   Zfp42	  
(Rex1),	  Esrrb,	  Klf2,	  Klf4	  and	  Tbx3,	  are	  transcribed	  to	  similar	  levels	  in	  Myc	  dKO	  ES	  cells	  
compared	   to	   the	   parental	   cell	   line	   (Figure	   25).	   These	   data	   are	   consistent	  with	   the	  
hypothesis	  that	  upon	  loss	  of	  Myc	  cell	  cycle	  arrest	  and	  metabolic	  quiescence	  do	  not	  
impact	  on	  the	  pluripotency	  network.	  
	  
Lineage	  differentiation	  
When	  cultured	  in	  serum	  +	  LIF,	  Myc	  dKO	  mouse	  ES	  cells	  undergo	  rapid	  differentiation	  
towards	   primitive	   endoderm	   (Smith	   et	   al.,	   2010).	   This	   differentiation	   program	   is	  
apparently	   triggered	   by	   the	   increase	   expression	   (40	   fold)	   of	   the	   master	   regulator	  
Gata6	  and	  is	  confirmed	  by	  the	  strong	  induction	  (300	  fold)	  of	  the	  endodermal	  marker	  
Foxa2	  (Smith	  et	  al.,	  2010).	  	  
	  
	  
Figure	   26:	   RNA-­‐seq	   expression	   of	   primitive	   differentiation	  markers	   in	  Myc	   dKO	   ES	   cells	  
grown	   in	  2i	   +	   LIF.	  Clones	  6	  and	  22	   (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox)	  cultured	   in	  2i	  +	  LIF	  medium	  were	  
transfected	  with	  the	  mCherry-­‐Cre	  plasmid.	  24	  hours	  after	  transfection,	  mCherry+	  (Cre+)	  and	  
mCherry-­‐	  (Cre-­‐)	  cells	  were	  FACS	  sorted	  and	  cultured	  in	  2i	  +	  LIF.	  	  RNA	  was	  isolated	  24	  hours	  or	  
96	  hours	  after	  Cre	  induction.	  ES	  B8	  (c-­‐mycflox/flox;	  N-­‐mycflox/flox).	  
	  
Interestingly,	   in	   the	   absence	   of	   differentiation	   cues	   coming	   from	   the	   serum	  
components,	   we	   observe	   only	   a	   small,	   not	   significant	   induction	   of	   the	   endoderm	  
markers	  Gata6	  and	  Foxa2	  (Figure	  26).	  The	  mesodermal	  marker	  Brachyury	  (T)	  is	  also	  
slightly	   but	   not	   significantly	   up-­‐regulated	   in	  Myc	   dKO	   ES	   cells,	   while	   the	   primitive	  
ectoderm	  marker	  Fgf5,	  has	  a	  2	  fold	  induction	  upon	  loss	  of	  both	  c-­‐	  and	  N-­‐Myc	  (Figure	  
26).	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Gene	  expression	  clusters	  upon	  Myc	  deletion	  
For	   the	   analysis	   of	   our	   RNA-­‐seq	   data,	   we	   generated	   gene	   expression	   clusters	   to	  
identify	  genes	  and	  processes	  that	  were	  specifically	  up-­‐	  or	  down-­‐regulated	  upon	  Myc	  
deletion	  (Figure	  27).	  	  
	  
Figure	  27:	  Gene	  expression	  clusters	  of	  genes	  up-­‐regulated	  (dark	  green)	  or	  down-­‐regulated	  
(light	   green)	   in	   the	  different	   sample	   groups.	  24	  hours	  after	   transfection,	  mCherry+	   (Cre+)	  
and	  mCherry-­‐	  (Cre-­‐)	  cells	  were	  FACS	  sorted	  and	  used	  for	  RNA	  isolation	  (24	  hours	  time	  point),	  
or	  were	  plated	  in	  24-­‐well	  plates	  at	  a	  density	  of	  5x104	  cells/well	  in	  2i	  +	  LIF	  medium.	  Cultured	  
cells	  were	  harvested	  72	  hours	   after	   sort	   and	  used	   for	  RNA-­‐isolation	   (96	  hours	   time	  point)	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Since	   we	   included	   several	   controls	   in	   the	   experiment,	   we	   found	   64	   clusters	  
consisting	  of	  all	  different	  possible	  combinations	  of	  up-­‐	  and	  down-­‐regulated	  genes	  in	  
the	   different	   samples	   (Figure	   27).	  Using	   this	  matrix	  we	   could	   exclude	   the	   possible	  
technical	  biases	  introduced	  by	  the	  sorting	  or	  the	  culture.	  	  
In	  the	  following	  analysis	  we	  focused	  on	  clusters	  number	  44	  and	  48,	  including	  genes	  
that	   are	   down-­‐regulated	   24	   and	   96	   hours	   after	   Cre	   induction,	   and	   on	   clusters	  
number	   17	   and	   21,	   including	   genes	   up-­‐regulated	   24	   and	   96	   hours	   after	   Cre	  
induction.	  To	  further	  understand	  the	  overall	  biological	  meaning	  of	  the	  differentially	  
expressed	  genes	  we	  applied	  Gene	  Ontology	  (GO)	  enrichment	  analysis.	  	  
	  
	  
Figure	   28:	   Processes	   down-­‐regulated	   in	   Myc	   dKO	   ES	   cells	   24	   and	   96	   hours	   after	   Cre	  
induction.	  Table	  of	  enriched	  GOs	  grouped	  by	  process	  similarity.	  Ribosome	  biogenesis	  (red);	  
gene	   expression	   (light	   blue);	   metabolism	   (green);	   nuclear	   components	   (yellow)	   and	  
nucleotide	  synthesis	  (purple).	  Left	  column:	  p	  adjusted	  value.	  Right	  column:	  number	  of	  genes	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Processes	  down-­‐regulated	  in	  Myc	  dKO	  ES	  cells	  
GO	   annotation	   enrichment	   analysis	   of	   the	   155	   genes	   belonging	   to	   the	   cluster	   44	  	  
(transcripts	  down-­‐regulated	  upon	  Myc	  deletion	  at	  24	  and	  96	  hours)	  shows	  a	  distinct	  
signature	  in	  processes	  related	  to	  metabolism	  as	  seen	  by	  ribosomal	  biogenesis,	  RNA	  
and	  DNA	  biosynthesis	  (Figure	  28).	  These	  data	  suggest	  that	  Myc	  dKO	  ES	  cells	  enter	  a	  
state	   of	   “metabolic	   quiescence”,	   characterized	   by	   a	   strong	   reduction	   of	   several	  
essential	  metabolic	  activities,	  including	  protein	  and	  nucleotide	  synthesis.	  
	  
Metabolism	  
When	   we	   examine	   the	   cellular	   processes	   that	   are	   altered	   upon	   Myc	   loss,	   cell	  
metabolism	   is	   certainly	   the	   most	   prominent.	   Specifically,	   we	   observe	   that	   in	   the	  
absence	   of	   c-­‐	   and	   N-­‐Myc	   activity	   several	   core	   metabolic	   processes	   are	   down-­‐
regulated,	  including	  ribosomal	  biogenesis	  and	  nucleotide	  synthesis.	  
	  
Myc	  proteins	  have	  been	  described	   to	  be	   involved	   in	  multiple	   aspects	  of	   ribosomal	  
biogenesis	  by	   regulating	   the	  expression	  of	   ribosomal	  proteins	  and	   factors	   required	  
for	  rRNA	  processing,	  ribosome	  assembly,	  export	  of	  mature	  ribosomal	  subunits	  from	  
the	  nucleus	   to	   the	   cytoplasm,	   as	  well	   as	   factors	   controlling	   the	   initiation	  of	  mRNA	  
translation	   (van	  Riggelen	  et	  al.,	   2010).	  Consistently,	  we	   find	   that	   the	  expression	  of	  
several	   genes	   involved	   in	   ribosome	   biogenesis	   is	   reduced	   following	   loss	   of	   Myc.	  
These	   genes	   include	   nucleolin	   (Ncl),	   involved	   in	   the	   cleavage	   of	   the	   47S	   pre-­‐rRNA	  
into	  18S,	  5.8S	  and	  28S	  rRNAs	  (Ginisty	  et	  al.,	  1998),	  the	  ribosome	  biogenesis	  protein	  
Wdr12,	  component	  of	  the	  PeBoW	  complex,	  required	  for	  maturation	  of	  28S	  and	  5.8S	  
ribosomal	  RNAs	  and	  formation	  of	  the	  60S	  ribosome	  (Holzel	  et	  al.,	  2005)	  and	  Rplp0,	  
encoding	  a	  ribosomal	  protein	  component	  of	  the	  60S	  subunit.	  	  
	  
Interestingly,	  the	  eukaryotic	  initiation	  factor	  3a	  (Eif3a),	  component	  of	  the	  eukaryotic	  
translation	   initiation	   factor	   3	   (eIF-­‐3)	   complex,	   is	   also	   down-­‐regulated	   upon	   Myc	  
deletion.	  tRNAs	  are	  essential	  intermediates	  of	  protein	  synthesis,	  since	  they	  translate	  
the	  mRNA	   ribonucleotide	   code	   into	   a	   polypeptide	   sequence.	   tRNAs	   synthesized	   in	  
the	  nucleus	  are	  actively	  exported	  to	  the	  cytoplasm	  by	  specific	  transport	  factors.	  The	  
balance	   between	   nuclear	   and	   cytoplasmic	   pools	   of	   tRNA	   is	   regulated	   by	   nutrient	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availability,	  with	   starvation	  causing	  a	   rapid	  and	   reversible	  accumulation	  of	   tRNA	   in	  
the	  nucleus	   (Neufeld	  and	  Arsham,	  2010).	   Interestingly,	   in	  our	  RNA-­‐seq	  analysis	  we	  
find	   that	   exportin-­‐T	   (Xpot),	   mediating	   the	   nuclear	   export	   of	   aminoacylated	   tRNAs	  
(Kutay	  et	  al.,	  1998),	  is	  also	  downregulated	  in	  dKO	  ES	  cells.	  	  
	  
Following	  Myc	  deletion,	  a	  number	  of	  genes	   involved	   in	  nucleotide	  biosynthesis	  are	  
also	   repressed:	   Gart,	   is	   a	   tri-­‐functional	   purine	   biosynthetic	   protein	   adenosine-­‐3	  
required	  for	  de	  novo	  purine	  biosynthesis	  (Kan	  et	  al.,	  1993);	  Atic,	  encodes	  for	  the	  bi-­‐
functional	   purine	   biosynthesis	   protein	   Purh;	   Aprt,	   is	   an	   adenine	  
phosphoribosyltransferase,	  also	  involved	  in	  purine	  biosynthesis.	  The	  uridine-­‐cytidine	  
kinase	   2	   (Uck2)	   is	   the	   mouse	   homologue	   of	   the	   human	   Uck2	   gene,	   which	  
phosphorylates	  uridine	  and	  cytidine	  to	  uridine	  monophosphate	  (UMP)	  and	  cytidine	  
monophosphate	   (CMP)	   (Suzuki	   et	   al.,	   2004).	   Uck2,	   involved	   in	   pyrimidine	  
ribonucleoside	  biosynthesis,	  is	  also	  down-­‐regulated	  upon	  Myc	  loss.	  
	  
Cell	  cycle	  
In	   agreement	   with	   the	   observation	   that	  Myc	   loss	   induces	   cell	   cycle	   arrest,	   global	  
gene	   expression	   profiling	   of	  Myc	   dKO	   ES	   cells	   shows	   that	   genes	   driving	   cell	   cycle	  
progression	   are	   significantly	   down-­‐regulated	   following	   Myc	   loss	   (Figure	   29).	   This	  
group	   of	   genes	   includes	   E2f3,	   member	   of	   the	   E2F	   family	   of	   transcription	   factors,	  
activating	  genes	  essential	  for	  DNA	  replication	  (Helin,	  1998)	  and	  known	  to	  be	  critical	  
for	  normal	  cellular	  proliferation	  (Humbert	  et	  al.,	  2000).	  Skp2,	  encoding	  the	  S-­‐phase	  
kinase-­‐associated	   protein	   2	   and	   Hmga1,	   encoding	   the	   mobility	   group	   AT-­‐hook	   1	  
protein,	  are	  other	  examples	  of	  genes	  driving	  cellular	  proliferation	  and	  repressed	   in	  
myc	   dKO	   ES	   cells.	   Along	   the	   same	   line,	  well-­‐known	   repressors	   of	   the	   cell	   cycle	   as	  
Gadd45g,	  a	  member	  of	  the	  growth	  arrest	  and	  DNA	  damage-­‐inducible	  protein	  family,	  
and	   Cdkn1c,	   encoding	   the	   cell	   cycle	   inhibitor	   p57,	   are	   strongly	   induced	   96	   hours	  
after	  myc	  deletion.	  Taken	  together	  these	  results	  indicate	  that	  ES	  cells	  strictly	  depend	  
on	  Myc	   expression	   to	   undergo	   cell	   division,	   and	   this	   effect	   is	   independent	   on	   the	  
culture	  conditions.	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Figure	  29:	  Processes	  and	  genes	  down-­‐regulated	  in	  Myc	  dKO	  ES	  cells.	  Functional	  annotation	  
clustering	   of	   differentially	   expressed	   genes	   by	   Gene	   Ontology	   ([GO]	   PANTHER	   [protein	  
analysis	  through	  evolutionary	  relationships])	  analysis.	  
	  
Processes	  up-­‐regulated	  in	  Myc	  dKO	  ES	  cells	  
GO	   annotation	   enrichment	   analysis	   of	   the	   93	   genes	   belonging	   to	   the	   cluster	   21	  	  
(transcripts	  up-­‐regulated	  96	  hours	  after	  Cre	  induction)	  shows	  a	  distinct	  signature	  in	  
processes	  related	  to	  insulin	  signaling	  (Figure	  30).	  	  
	  
Figure	  30:	  Processes	  up-­‐regulated	  in	  Myc	  dKO	  ES	  cells	  96	  hours	  after	  Cre	  induction.	  Table	  
of	  enriched	  GOs	  and	  genes	  functionally	  related	  to	  the	  process.	  P	  adjusted	  values	  are	  shown	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Upon	   Myc	   deletion	   the	   insulin-­‐growth-­‐factor-­‐1	   receptor	   Igf1r	   and	   the	   insulin	  
receptor	  substrate	  proteins	   Irs2	  and	   Irs3,	  are	   induced	  96	  hours	  after	  Cre	   induction	  
(Figure	  31).	  Indeed,	  insulin	  signaling	  is	  one	  of	  the	  most	  significantly	  represented	  up-­‐
regulated	  processes	  (Figure	  30).	  Interestingly,	  the	  Forkhead	  box	  protein	  O3	  (Foxo3)	  
is	  also	  induced	  upon	  loss	  of	  Myc.	  
	  
	  
Figure	  31:	  RNA-­‐seq	  expression	   levels	  of	   factors	   involved	   in	  the	   insulin-­‐signaling	  pathway.	  
Clones	  6	  and	  22	  (c-­‐mycΔ/Δ;	  N-­‐mycΔ/flox)	  cultured	  in	  2i	  +	  LIF	  medium	  were	  transfected	  with	  the	  
mCherry-­‐Cre	  plasmid.	  24	  hours	  after	  transfection,	  mCherry+	  (Cre+)	  and	  mCherry-­‐	  (Cre-­‐)	  cells	  
were	   FACS	   sorted.	   RNA	   was	   isolated	   24	   hours	   or	   96	   hours	   after	   Cre	   induction.	   ES	   B8	   (c-­‐
mycflox/flox;	  N-­‐mycflox/flox);	  NT	  (not	  transfected	  control).	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5.2 Comparison	  of	  ES	  cells	  expressing	  different	  c-­‐Myc	  protein	  levels	  
5.2.1 c-­‐Myc	  expression	  in	  2i	  +	  LIF	  and	  in	  serum	  +	  LIF	  
RNA-­‐seq	  data	  from	  the	  group	  of	  Austin	  Smith	  have	  reported	  that	  c-­‐myc	  mRNA	  level	  
is	  40	  to	  50	  fold	  lower	  in	  2i	  than	  in	  serum,	  and	  N-­‐myc	  and	  L-­‐myc	  expressions	  are	  also	  
reduced	  in	  2i	  (Marks	  et	  al.,	  2012).	  	  
In	  order	  to	  quantify	  c-­‐Myc	  protein	  expression	  in	  the	  different	  culture	  conditions,	  we	  
made	   use	   of	   the	   e-­‐GFP-­‐cMyc	   knock-­‐in	   mice	   generated	   and	   characterized	   by	   the	  
group	   of	   Berry	   Sleckman	   (Huang	   et	   al.,	   2008).	   These	  mice	   are	   carrying	   a	   c-­‐MycGFP	  
allele,	  encoding	  for	  a	  GFP-­‐cMyc	  fusion	  protein	  from	  the	  endogenous	  c-­‐myc	  locus.	  	  
Mice	  homozygous	  for	  c-­‐MycGFP	  are	  viable,	  appear	  normal	  and	  have	  no	  alterations	  in	  
the	  kinetics	  of	  hematopoietic	  differentiation	  or	  immune	  function	  (Huang	  et	  al.,	  2008;	  
Reavie	  et	  al.,	  2010),	  suggesting	  that	  the	  N-­‐terminal	  fusion	  of	  GFP	  to	  c-­‐Myc	  does	  not	  
affect	  c-­‐Myc	  function.	  This	  N-­‐terminally	  tagged	  c-­‐Myc	  protein	  can	  be	  therefore	  used	  
as	  reporter	  of	  c-­‐Myc	  protein	  expression.	  
In	  collaboration	  with	  the	  transgenic	  service	  of	  the	  DKFZ,	  we	  derived	  6	  homozygous	  c-­‐
MycGFP/GFP	  mouse	  ES	  cell	  lines.	  These	  lines	  have	  been	  cultured	  in	  2i	  +	  LIF	  medium	  for	  
several	  passages,	  and	  have	  been	  adapted	  to	  grow	  in	  feeder-­‐free	  conditions,	  on	  0.1%	  
gelatin,	   where	   they	   form	   undifferentiated	   colonies.	   As	   reported	   for	   several	   other	  
mouse	   ES	   cell	   lines,	   in	   serum-­‐containing	  medium	   the	   c-­‐MycGFP/GFP	  ES	   cells	   are	   not	  
able	   to	   sustain	   their	   growth	   in	   the	   absence	   of	   MEFs	   and	   rapidly	   differentiate.	  
Therefore,	  to	  compare	  c-­‐Myc	  protein	  expression	  in	  the	  different	  culture	  conditions,	  
we	  cultured	  c-­‐MycGFP/GFP	  ES	  cells	  on	  a	  feeder	  layer	  of	  MEF	  constitutively	  expressing	  a	  
membrane-­‐targeted	  tdTomato	  fluorescent	  protein	  and	  grew	  the	  cells	  for	  72	  hours	  in	  
2i	  +	  LIF	  or	   in	  serum	  +	  LIF	  medium	  (Figure	  32).	  We	  than	  performed	  FACS	  analysis	  to	  
quantify	  c-­‐Myc-­‐GFP	   levels	  and	  used	  as	  a	  control	   for	  auto-­‐fluorescence	  E14	  ES	  cells,	  
derived	   from	   129/Ola-­‐Hsd	   mice,	   not	   expressing	   the	   GFP	   fluorochrome.	   Our	   data	  
confirm	   that	   c-­‐Myc-­‐GFP	   protein	   expression	   is	   very	   low	   in	   culture	   conditions	  
supporting	   the	   naïve	   state	   and	   it	   strongly	   increases	  when	   ES	   cells	   are	   transferred	  
from	  2i	   to	   serum	   (Figure	  32).	   From	  these	   results	  we	  can	  hypothesize	   that	   c-­‐myc	   is	  
one	  of	  the	  early	  genes	  up-­‐regulated	  upon	  exit	  from	  the	  naïve	  state	  of	  pluripotency.	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Figure	  32:	  Expression	  levels	  of	  c-­‐Myc-­‐GFP	  protein	  in	  2i	  +	  LIF	  and	  in	  serum	  +	  LIF	  medium.	  (A)	  
The	  c-­‐MycGFP/GFP	  ES	  cell	   lines	  C6,	  D7	  and	  E4	  were	  culture	   in	  2i	  +	  LIF	  medium	  or	  serum	  +	  LIF	  
medium	  for	  72	  hours	  on	  tdTomato	  MEFs.	  (B)	  c-­‐Myc	  protein	  levels	  were	  quantified	  by	  FACS	  
analysis	  gating	  on	  PI	  negative,	  tdTomato	  negative	  cells.	  E14	  ES	  cells	  were	  used	  as	  a	  control	  
for	  auto-­‐fluorescence	  (in	  grey).	  
	   	  
5.2.2 Properties	  of	  ES	  cells	  expressing	  different	  c-­‐Myc-­‐GFP	  protein	  levels	  
in	  serum	  +	  LIF	  
In	  order	  to	  define	  the	  properties	  of	  ES	  cells	  cultured	   in	  serum	  +	  LIF	  and	  expressing	  
different	  c-­‐Myc	  protein	  levels,	  we	  FACS	  sorted	  cells	  according	  to	  the	  levels	  of	  c-­‐Myc-­‐
GFP	   expression	   as	   showed	   in	   Figure	   32.	   We	   distinguished	   three	   populations	  
expressing	  high,	  medium	  and	  low	  levels	  of	  c-­‐Myc-­‐GFP	  and	  analyzed	  their	  properties	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Two	  recent	  studies	   from	  the	  groups	  of	  Richard	  Young	  and	  David	  Levens	   (Lin	  et	  al.,	  
2012;	   Nie	   et	   al.,	   2012)	   have	   shown	   that	   c-­‐Myc	   is	   a	   universal	   amplifier	   of	   already	  
active	  gene	  expression	  programs	  and	  cells	  with	  high	  levels	  of	  c-­‐Myc	  are	  bigger	  in	  size	  
and	   produce	   two	   to	   three	   times	   more	   total	   RNA	   compared	   to	   Myc	   low	   cells.	  
According	  to	  the	  published	  data,	  we	  observe	  that	  in	  serum	  +	  LIF,	  c-­‐Mychigh	  cells	  have	  
almost	   twice	   total	   RNA	   content	   compared	   to	   c-­‐Myclow	   cells	   (Figure	   33.A)	   and	   are	  
bigger	  in	  size	  (Figure	  33.B)	  as	  shown	  by	  an	  higher	  forward	  scatter	  (FSC-­‐A).	  	  
When	  we	   looked	   at	   the	   cell	   cycle	   profiles,	   we	   observed	   that	   c-­‐Myc	   protein	   levels	  
correlate	  with	  the	  cell	  cycle	  state	  of	  the	  cells	  (Figure	  32.C	  and	  D),	  with	  the	  c-­‐Mychigh	  
population	  being	  mostly	  in	  S-­‐G2-­‐M	  phases	  and	  the	  c-­‐Myclow	  cells	  being	  in	  G1	  phase	  
of	  the	  cell	  cycle.	  	  
	  
	  
Figure	   33:	   Properties	   of	   ES	   cells	   expressing	   different	   c-­‐Myc	  protein	   levels	   in	   serum	  +	   LIF	  
medium.	  c-­‐MycGFP/GFP	  ES	  cells	  were	  cultured	  for	  72	  hours	  in	  serum	  +	  LIF	  medium	  on	  a	  layer	  of	  
tdTomato	   MEFs.	   The	   cells	   were	   than	   FACS	   sorted	   according	   to	   the	   levels	   of	   c-­‐Myc-­‐GFP	  
expression	  as	  shown	  in	  Figure	  32.	  For	  quantification	  of	  the	  total	  RNA	  content	  (A),	  2x104	  cells	  
from	  each	   population	  were	   FACS	   sorted	   directly	   in	   extraction	   buffer	   for	   RNA	   isolation.	   To	  
evaluate	  size	  differences	  (B),	  FCS	  and	  SSC	  parameters	  were	  assessed	  by	  FACS	  analysis.	  Ki67-­‐
Hoechst	   staining	   was	   used	   to	   profile	   the	   cell	   cycle	   of	   c-­‐Myc-­‐GFPhigh	   and	   c-­‐Myc-­‐GFPlow	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6. Discussion	  
Pluripotency	   in	   the	   early	   embryo	   is	   defined	   as	   the	   capacity	   of	   a	   single	   cell	   to	  
generate	   all	   lineages	   of	   the	   adult	   organism	   (Young,	   2011).	   In	   vivo	   this	   property	   is	  
possessed	   only	   transiently	   by	   the	   cells	   of	   the	   epiblast	   but	   it	   can	   be	   indefinitely	  
“captured”	   in	   vitro	   by	   deriving	   embryonic	   stem	   (ES)	   cells.	   A	   second	   important	  
property	  of	  ES	  cells	  is	  self-­‐renewal,	  defined	  as	  the	  ability	  of	  a	  stem	  cell	  to	  proliferate	  
and	  generate	  one	  or	  two	  daughter	  stem	  cells.	  This	  process	  requires	  the	  coordination	  
of	  cell-­‐cycle	  progression	  and	  cell	  fate	  choices	  (Orford	  and	  Scadden,	  2008).	  
	  
ES	  cell	   lines	  have	  been	  generated	  both	   from	  mouse	  embryos	   (Evans	  and	  Kaufman,	  
1981;	   Martin,	   1981)	   and	   from	   humans	   (Thomson	   et	   al.,	   1998).	   Although	   a	   tissue	  
culture	  source	  of	  human	  pluripotent	  cells	  holds	  a	  great	  potential	  for	  applications	  in	  
basic	  research	  and	  transplantation	  therapies,	  research	  on	  human	  ES	  cells	  generates	  
ethical	  issues	  associated	  to	  the	  use	  of	  human	  embryos	  (Miller	  and	  Bloom,	  1998).	  In	  
2006,	   the	   Nobel	   laureate	   Shinya	   Yamanaka	   observed	   that	   overexpression	   of	   four	  
transcription	   factors,	  Oct4,	  Sox2,	  Klf4	  and	  c-­‐Myc,	   is	   sufficient	   to	  “reprogram”	  adult	  
mouse	   cells	   into	   induced	   pluripotent	   stem	   (iPS)	   cells,	   closely	   resembling	   ES	   cells	  
(Takahashi	  and	  Yamanaka,	  2006).	  The	  four	  Yamanaka	  factors	  were	  later	  shown	  to	  be	  
able	   to	   reprogram	  also	  adult	  human	  dermal	   fibroblasts	   into	   iPS	   cells	   (Takahashi	   et	  
al.,	   2007),	   therefore	   it	   is	   now	   possible	   to	   derive	   human	   pluripotent	   cells	   in	   tissue	  
culture	  not	  only	  from	  limited	  and	  ethically	  challenged	  human	  embryos,	  but	  also	  from	  
adult	  cells	  (Evans,	  2011).	  
ES	   cells	   and	   iPS	   cells	   hold	   great	   promise	   for	   regenerative	   medicine,	   and	   our	  
understanding	  of	  the	  biology	  of	  these	  stem	  cells	   is	   important	  both	  to	  elucidate	  the	  
basis	   of	   embryonic	   development	   and	   to	   improve	  our	   ability	   to	   in	   vitro	  manipulate	  
stem	  cells	  for	  cell	  replacement	  therapy.	  	  
	  
When	  ES	   cells	  were	   cultured	   for	   the	   first	   time,	   they	  were	  expanded	  on	  mitotically	  
inactivated	   fibroblasts,	   in	   a	   culture	   medium	   containing	   fetal	   bovine	   serum	   (Evans	  
and	  Kaufman,	  1981).	  Since	  the	  serum	  components	  represent	  a	  source	  of	  undefined	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signals	   that	   could	   potentially	   promote	   differentiation,	   ES	   cells	   cultured	   in	   serum-­‐
containing	   medium	   have	   been	   shown	   to	   be	   heterogeneous	   in	   morphology	   and	  
expression	  of	  pluripotency	  markers	  as	  Nanog,	  Stella	  and	  Oct4	  (Chambers	  et	  al.,	  2007;	  
Hayashi	  et	  al.,	  2008;	  Marks	  et	  al.,	  2012;	  Nichols	  and	  Smith,	  2009,	  2012).	  Culturing	  ES	  
cells	   in	  serum-­‐free	  medium	  and	   in	   the	  presence	  of	   two	   inhibitors	   (2i)	  of	   the	  MAPK	  
and	   GSK3b	   pathways	   is	   sufficient	   to	   capture	   ES	   cells	   in	   a	   naïve,	   ground	   state	   of	  
pluripotency,	   which	   more	   closely	   resembles	   the	   stem	   cell	   status	   in	   the	   inner	   cell	  
mass	   of	   the	   blastocyst	   (Ying	   et	   al.,	   2008).	   Since	   different	   culture	   environments	  
impose	   distinctive	   transcriptional	   and	   epigenetic	   properties	   on	   mouse	   ES	   cells	  
(Marks	  et	  al.,	  2012),	  it	  appears	  to	  be	  necessary	  to	  re-­‐evaluate	  the	  function	  of	  several	  
regulators	  of	  pluripotency	  under	  2i	  conditions.	  
	  
The	  effect	  of	  the	  simultaneous	  c-­‐	  and	  N-­‐myc	  deletion	  in	  ES	  cells	  cultured	  in	  serum	  +	  
LIF	  has	  been	  recently	  described	  (Smith	  et	  al.,	  2010;	  Varlakhanova	  et	  al.,	  2010).	  Under	  
these	   culture	   conditions,	  Myc	   contributes	   to	   self-­‐renewal	   and	  maintenance	   of	   the	  
pluripotent	  state	  by	  repressing	  the	  endoderm	  master	  regulator	  Gata6	  and	  regulating	  
the	  mir-­‐17-­‐92	  miRNA	  cluster	   (Smith	  et	  al.,	  2010).	  Therefore,	   loss	  of	  both	  c-­‐	  and	  N-­‐
myc	   alleles	   in	   serum	   +	   LIF	   results	   in	   cell	   cycle	   arrest	   and	   spontaneous,	   rapid	  
differentiation	  towards	  primitive	  endoderm.	  We	  know	  from	  recent	  studies	  that	  both	  
feeders	  and	  serum	  are	  sources	  of	  undefined	  signals,	  driving	  mouse	  ES	  cells	  towards	  
metastability,	  therefore	  it	  cannot	  be	  excluded	  that	  the	  effects	  of	  Myc	  loss	  observed	  
in	  serum	  could	  be	  the	  results	  of	  differentiation	  cues	  normally	  absent	   in	  vivo	  during	  
early	  embryogenesis.	  	  
	  
The	  aim	  of	  this	  thesis	  was	  to	  define	  the	  role	  Myc	  family	  members	  in	  the	  maintenance	  
of	  pluripotency	  and	  self-­‐renewal	  of	  naïve	  mouse	  ES	  cells.	  To	  compare	  the	  levels	  of	  c-­‐
Myc	  protein	   in	  naïve	  and	  metastable	  ES	  cells,	  we	  derived	  ES	  cell	   lines	  from	  mice	   in	  
which	   a	   GFP	   gene	   was	   introduced	   in-­‐frame	   into	   the	   endogenous	   c-­‐myc	   locus	   to	  
encode	   for	   a	   c-­‐Myc-­‐GFP	   reporter	   protein	   (Huang	   et	   al.,	   2008).	   Myc	   proteins	   are	  
known	   to	  be	   responsive	   to	   serum	  mitogens	   (Perna	   et	   al.,	   2012)	   and	   FACS	   analysis	  
revealed	   that	   while	   c-­‐Myc	   protein	   expression	   is	   extremely	   low	   in	   naïve	   ES	   cells	  
cultured	  in	  2i	  +	  LIF,	  c-­‐Myc	  is	  strongly	  induced	  upon	  withdrawal	  of	  the	  two	  inhibitors	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and	  addition	  of	  serum.	  This	  observation	  suggests	  that	  c-­‐Myc	  expression	  is	  induced	  in	  
vitro	  during	  the	  earliest	  differentiation	  steps	  of	  naïve	  ES	  cells.	  Interestingly,	  when	  we	  
analyze	  ES	  cell	  that	  have	  been	  cultured	  72	  hours	  in	  serum	  +	  LIF	  medium,	  we	  observe	  
that	   c-­‐Myc-­‐GFP	  high	   cells	   are	  bigger	   in	   size	   and	  have	   an	  RNA	   content	   1.5	   –	   2	   fold	  
higher	  than	  cells	  expressing	  low	  levels	  of	  Myc.	  Additionally,	  ES	  cells	  expressing	  high	  
c-­‐Myc	  levels	  are	  mostly	  in	  S-­‐G2-­‐M	  phase	  of	  the	  cell	  cycle,	  while	  c-­‐Myc	  low	  cells	  are	  
mainly	  in	  G1	  phase.	  	  
	  
To	  genetically	  address	  the	  role	  of	  Myc	  proteins	  in	  the	  naïve	  state	  of	  pluripotency,	  we	  
derived	   ES	   cells	   where	   both	   c-­‐myc	   and	   N-­‐myc	   could	   be	   conditionally	   deleted	   to	  
generate	   Myc	   dKO	   ES	   cells	   (Knoepfler	   et	   al.,	   2002;	   Trumpp	   et	   al.,	   2001).	   An	  
important	  aspect	  to	  take	  into	  consideration	  in	  this	  study	  is	  the	  observation	  that	  Myc	  
family	  members	  could	  have	  redundant	  functional	  properties	  during	  the	  early	  stages	  
of	   embryogenesis.	   Indeed,	   knockout	   of	   individual	   Myc	   genes	   is	   only	   lethal	   at	  
embryonic	   day	   10	   or	   12,	   as	   a	   consequence	   of	   respectively	   c-­‐myc	   or	   N-­‐myc	   loss	  
(Charron	  et	   al.,	   1992;	  Davis	   et	   al.,	   1993;	   Stanton	  et	   al.,	   1992).	   Consistent	  with	   the	  
notion	   of	   functional	   redundancy	   between	   c-­‐	   and	  N-­‐myc,	  we	   find	   that	   c-­‐mycΔ/Δ;	  N-­‐
mycΔ/flox	   ES	   cells	   can	   be	   extensively	   expanded	   in	   vitro	   in	   2i	   +	   LIF	   medium,	   and	  
differentiate	   into	   teratomas	   when	   subcutaneously	   injected	   into	   immunodeficient	  
mice.	  While	  naïve	  ES	  cells	  expressing	  one	  N-­‐myc	  allele	  show	  no	  obvious	  phenotype,	  
ES	  cells	  lacking	  both	  myc	  genes	  (all	  four	  alleles)	  undergo	  rapid	  cell	  cycle	  arrest.	  These	  
data	  suggests	  that	  mouse	  ES	  cell	  proliferation	  strictly	  depends	  on	  Myc	  expression.	  
	  
Myc-­‐dKO	   ESCs	   form	   smaller	   and	   arrested	   colonies,	   but	   unexpectedly	   remain	  
undifferentiated,	  maintaining	  normal	  expression	  of	  alkaline	  phosphatase	  and,	  more	  
importantly,	  of	  the	  core	  pluripotency	  factors	  Oct4,	  Nanog,	  and	  Sox2,	  both	  at	  the	  RNA	  
and	  protein	  level.	  To	  determine	  the	  molecular	  properties	  of	  naive	  Myc	  dKO	  ES	  cells,	  
we	  performed	  whole	   transcriptome	  analyses	  by	  next-­‐generation	   sequencing	   (RNA-­‐
seq)	   24	   and	   96	   hours	   after	   Cre	   induction.	   As	   expected,	   the	   data	   confirmed	   the	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Global	  transcriptome	  analysis	  of	  Myc	  dKO	  ES	  cells	  also	  revealed	  that	  virtually	  all	  the	  
metabolic	   and	   biosynthetic	   aspects	   of	   cellular	   physiology	   were	   robustly	   down-­‐
regulated	  in	  dKO	  ES	  cells.	  These	  include	  cell	  cycle	  activity,	  DNA	  replication,	  ribosomal	  
biogenesis	  and	  DNA	  and	  protein	  synthesis.	  Our	  group	  has	  recently	  described	  the	  role	  
of	   Myc	   proteins	   in	   hematopoietic	   stem	   cells	   (HSCs)	   (Laurenti	   et	   al.,	   2008).	  
Interestingly,	   deletion	   of	   both	   c-­‐	   and	  N-­‐myc	   in	   HSCs	   results	   in	   global	   reduction	   of	  
ribosome	  biogenesis,	  similarly	  to	  what	  we	  observe	  in	  ES	  cells.	  Nevertheless,	  the	  main	  
effect	  of	  Myc	  loss	  in	  the	  hematopoietic	  system	  is	  a	  strong	  apoptotic	  response,	  driven	  
by	   the	   serine	   protease	   Granzyme	   B	   (GzmB),	   resulting	   in	   a	   rapid	   and	   severe	   bone	  
marrow	   failure	   (Laurenti	   et	   al.,	   2008).	   In	   ES	   cells,	   we	   do	   not	   observe	   any	   obvious	  
increase	  in	  apoptosis,	  and	  looking	  at	  their	  gene	  expression	  profile,	  Myc	  dKO	  ES	  cells	  
do	  not	  activate	  any	  apoptotic	  program	  96	  hours	  after	  Cre	  induction.	  All	  together	  our	  
data	  indicate	  that	  the	  overall	  cellular	  and	  molecular	  phenotype	  of	  Myc-­‐dKO	  ES	  cells	  
is	  consistent	  with	  a	  status	  of	  “metabolic	  and	  proliferative	  dormancy”.	  
	  
The	   concept	   of	   dormancy	   is	   not	   new	   to	   the	   stem	   cell	   field:	   recent	   studies	   have	  
shown	  that	  in	  mammals	  several	  adult	  tissues	  contain	  a	  subset	  of	  tissue-­‐specific	  stem	  
cells	  that	  persist	  in	  a	  quiescent	  state	  for	  prolonged	  periods	  of	  time	  and	  proliferate	  in	  
response	   to	   tissue	   damage	   or	   to	   compensate	   for	   tissue	   loss.	   Hence	   stem	   cell	  
quiescence	  is	  a	  poised	  state,	  actively	  maintained	  by	  specific	  signaling	  pathways	  and	  
quiescent	   stem	   cells	   have	   the	   extraordinary	   capacity	   to	   sense	   environmental	  
changes	  and	  are	  ready	   for	   rapid	  activation	   (Cheung	  and	  Rando,	  2013).	   In	   the	  adult	  
mouse,	  for	  example,	  hematopoietic	  stem	  cells	  (HSCs)	  have	  the	  potential	  to	  generate	  
the	   entire	   hematopoietic	   system.	  However,	   during	   homeostasis,	   the	   population	   of	  
HSCs	   harboring	   the	   highest	   self-­‐renewal	   potential	   is	   actually	   slowly	   cycling	   and	  
present	   in	   a	   dormant	   state	   (Foudi	   et	   al.,	   2009;	   Wilson	   et	   al.,	   2008).	   During	  
homeostasis	  signals	  within	  the	  bone	  marrow	  niche	  contribute	  to	  maintaining	  HSCs	  in	  
a	  metabolically	   inactive	   state,	  while	   in	   emergency	   situations,	   in	   response	   to	   stress	  
and	  injury,	  HSCs	  exit	  their	  quiescent	  state	  and	  proliferate,	  to	  efficiently	  and	  rapidly	  
reconstitute	   the	   hematopoietic	   system	   (Wilson	   et	   al.,	   2009).	   Interestingly,	   the	  
comparison	   of	   gene	   expression	   profiles	   of	   different	   types	   of	   adult	   quiescent	   stem	  
cells	  including	  HSCs	  (Forsberg	  et	  al.,	  2010),	  muscle	  stem	  cells	  (MuSCs)	  (Fukada	  et	  al.,	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2007)	  and	  hair	  follicle	  stem	  cells	  (HFSCs)	  (Blanpain	  et	  al.,	  2004),	  shows	  that	  all	  these	  
quiescent	  stem	  cells	  have	  a	  common	  gene	  signature,	  the	  transcriptional	  landscape	  of	  
quiescent	   stem	   cells	   (Cheung	   and	   Rando,	   2013).	   Consistent	   with	   the	   dormant	  
phenotype,	   genes	   that	   are	   involved	   in	   cell	   cycle	   progression,	   DNA	   replication	   or	  
mitochondrial	  functions	  are	  mostly	  down-­‐regulated	  in	  quiescent	  stem	  cells	  (Cheung	  
and	  Rando,	   2013)	   and	   in	  Myc	   dKO	   ES	   cells.	  Genes	   up-­‐regulated	   in	   quiescent	   stem	  
cells	   include	   genes	   encoding	   signaling	   molecules	   involved	   in	   transcriptional	  
regulation	   and	   stem	   cell	   fate	   decisions	   such	   as	   forkhead	   box	   O3	   (Foxo3).	  
Interestingly,	  Myc	   dKO	   ES	   cells	   show	   an	   increased	   expression	   of	   the	   CDK	   inhibitor	  
p57,	   described	   to	   regulate	   dormancy	   of	   both	   HSCs	   and	   neural	   stem	   cells	   (NSCs)	  
(Furutachi	  et	  al.,	  2013;	  Matsumoto	  et	  al.,	  2011).	  p57	  could	   therefore	   function	  as	  a	  
common	  player	  in	  regulating	  stem	  cells	  dormancy.	  	  
	  
In	   almost	   100	   mammalian	   species,	   embryonic	   development	   can	   be	   reversibly	  
arrested	  at	  the	  time	  of	  embryo	  implantation	  (Renfree	  and	  Shaw,	  2000).	  This	  delayed	  
implantation,	  termed	  “diapause”,	   is	  a	  strategy	  to	  enhance	  the	  reproductive	  fitness.	  
Indeed,	   diapause	   length	   is	   regulated	   by	   environmental	   cues,	   such	   as	   light	   and	  
temperature,	   to	   ensure	   the	   most	   optimal	   conditions	   for	   survival	   of	   the	   offspring	  
(Schiesari	   and	   O'Connor,	   2013).	   In	   mice,	   facultative	   diapause	   occurs	   to	   delay	  
implantation	   of	   early	   embryos	   in	   mothers	   still	   feeding	   a	   previous	   litter.	   During	  
diapause,	  mouse	  blastocysts	  enter	  a	  state	  of	  metabolic	  and	  proliferative	  quiescence	  
that	  represent	  the	  dormant	  state	  of	  the	  embryo	  (Hondo	  and	  Stewart,	  2005).	  	  
Strikingly,	   the	   signature	   of	   dKO	   ES	   cells	   maintained	   in	   2i	   medium	   is	   remarkably	  
similar	   to	   an	   expression	   signature	   previously	   reported	   for	   diapause	   arrested	   pre-­‐
implantation	  embryos	  (Hamatani	  et	  al.,	  2004).	  Very	  low	  expression	  of	  processes	  such	  
as	  cell	  division,	  metabolism,	  regulation	  of	  transcription	  and	  translation,	   is	  observed	  
in	  both	  diapause	  embryos	  and	  Myc	  dKO	  ES	  cells.	  	  
	  
The	  diapause	  embryo	  is	  also	  characterized	  by	  high	  expression	  of	  the	  insulin	  pathway,	  
one	   of	   the	   most	   up-­‐regulated	   processes	   in	   Myc	   dKO	   ES	   cells.	   Insulin	   is	   the	   most	  
potent	  anabolic	  hormone	  known.	  It	  stimulates	  the	  cellular	  uptake	  of	  glucose,	  amino	  
acids	   and	   fatty	   acids,	   and	   increases	   the	   expression	   or	   activity	   of	   enzymes	   that	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catalyze	   glycogen,	   lipid	   and	   protein	   synthesis,	   while	   inhibiting	   the	   activity	   or	  
expression	  of	  those	  that	  catalyze	  degradation	  (Saltiel	  and	  Kahn,	  2001).	  Insulin	  is	  also	  
likely	   to	   influence	   insect	   diapause	   (Sim	   and	   Denlinger,	   2013),	   suggesting	   that	   this	  
signaling	  pathway	  has	  been	  evolutionary	  conserved	  for	  diapause	  in	  both	  vertebrates	  
and	   invertebrates.	   Although	   the	   link	   of	   insulin	   pathway	   to	   the	   dormant	   mouse	  
blastocyst	  is	  not	  yet	  clear,	  it	  possibly	  maintains	  the	  embryo	  in	  a	  poised	  state	  that	  is	  
ready	   for	   a	   rapid	   re-­‐activation	   and	   exit	   from	   quiescence	   following	   hormonal	  
stimulation.	  	  
	  
Based	  on	   the	   similarities	  between	   the	  dormant	  embryo	  and	  Myc	  dKO	  ES	  cells,	  our	  
data	  raise	  the	  possibility	  that	  Myc	  activity	  controls	  the	  reversible	  diapause	  arrest	  of	  
early	   embryos.	   However,	   this	   theory	   has	   to	   be	   further	   supported	   with	   additional	  
experiments	  to	  dissect	  the	  mechanism	  linking	  Myc	  activity	  to	  blastocyst	  quiescence	  
and	   re-­‐activation.	   We	   know	   from	   previous	   studies	   that	   successful	   implantation	  
results	   from	  reciprocal	   interactions	  between	  an	   implantation-­‐competent	  blastocyst	  
and	  a	  receptive	  uterus.	  Ovarian	  estrogen	  and	  progesterone	  (P4)	  coordinate	  cellular	  
and	  molecular	  events	  to	  produce	  a	  favorable	  uterine	  environment	  (Hamatani	  et	  al.,	  
2004).	   Among	   other	   factors,	   the	   cytokine	   LIF	   is	   crucial	   for	   uterine	   preparation	   for	  
implantation	  (Wang	  and	  Dey,	  2006).	   In	  mice,	  LIF	   is	  expressed	  first	   in	  uterine	  glands	  
on	   the	   morning	   of	   day	   4,	   and	   then	   in	   stromal	   cells	   that	   surround	   the	   blastocyst	  
during	  attachment	  (Song	  et	  al.,	  2000;	  Stewart	  et	  al.,	  1992).	  This	  transient	  expression	  
of	  LIF	   is	  essential	  for	   implantation:	  females	   lacking	  a	  functional	  LIF	  gene	  are	  fertile,	  
but	   their	  blastocysts	   fail	   to	   implant	  and	  do	  not	  develop.	  The	  blastocysts,	  however,	  
are	  viable	  and,	  when	  transferred	  to	  wild-­‐type	  pseudo-­‐pregnant	  recipients,	  they	  can	  
implant	   and	   continue	   embryogenesis	   (Stewart	   et	   al.,	   1992).	   LIF	   binds	   to	   the	   LIF	  
receptor	  and,	  as	  other	  cytokines,	  to	  gp130.	  Interestingly,	  deletion	  of	  the	  binding	  sites	  
of	   STAT,	   the	   gp130	   signal	   transducer	   and	   activator	   of	   transcription,	   also	   results	   in	  
implantation	   failure	   (Ernst	   et	   al.,	   2001).	  Myc	   has	   already	   been	   identified	   as	   a	   key	  
target	  of	  the	  LIF/STAT	  self-­‐renewal	  pathway:	  murine	  ES	  cells	  express	  elevated	  levels	  
of	  Myc	   and	   following	   LIF	   withdrawal,	  Myc	  mRNA	   levels	   collapse	   and	  Myc	   protein	  
becomes	  phosphorylated	  on	  threonine	  58	  (T58)	  and	  targeted	  for	  GSK3β	  dependent	  
degradation	  (Cartwright	  et	  al.,	  2005).	  Along	  the	  same	  line,	  maintained	  expression	  of	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a	   stable	   Myc	   mutant	   (T58A)	   renders	   ES	   cell	   self-­‐renewal	   and	   maintenance	   of	  
pluripotency	  independent	  of	  LIF	  (Cartwright	  et	  al.,	  2005).	  Therefore	  we	  are	  currently	  
investigating	   the	   hypothesis	   that	   LIF	   produced	   in	   the	   uterus	   might	   induce	   Myc	  
expression	  in	  the	  embryo	  rendering	  it	  competent	  for	  implantation.	  	  
	  
Recent	  publications	  have	  heavily	  questioned	  the	  role	  of	  Myc	   in	  specifying	  a	  certain	  
transcriptional	   signature,	   and	   have	   concluded	   that	   Myc	   simply	   amplifies	   a	  
transcriptional	  program	  that	  completely	  depends	  on	  the	  cell	  type	  and	  its	  status	  (Lin	  
et	  al.,	  2012;	  Loven	  et	  al.,	  2012;	  Nie	  et	  al.,	  2012).	  An	  interesting	  observation	  is	  that,	  
independently	  on	  the	  culture	  conditions,	  mouse	  ES	  cells	  depend	  on	  Myc	  activity	  to	  
enter	  the	  cell	  cycle.	  The	  close	  relationship	  between	  Myc	  and	  mitogenesis	  has	  been	  
extensively	  described	  both	  in	  normal	  cells	  and	  in	  tumorigenesis	  (Dang,	  2012;	  Meyer	  
and	  Penn,	  2008)	  and	  argues	   for	  a	   specific	   role	   for	  Myc	  as	  a	  general	  coordinator	  of	  
cellular	  proliferation	  (Littlewood	  et	  al.,	  2012).	  	  
	  
The	  relationship	  between	  the	  cell	  cycle	  machinery	  and	  the	  pluripotency	  network	  has	  
been	  the	  object	  of	  several	  studies	  but	  whether	  the	  cell	  cycle	  regulators	  can	  influence	  
pluripotency	  and	  differentiation	  is	  still	  not	  clear.	  Our	  data	  suggest	  that	  Myc	  proteins	  
control	  the	  fundamental	  metabolic	  pathways	  of	  mouse	  ES	  cells	  and	  are	  essential	  for	  
cell	  cycle	  progression.	  The	  observation	  that	   loss	  of	  both	  c-­‐	  and	  N-­‐Myc	  only	   impairs	  
cell	   cycle	   without	   disrupting	   the	   core	   pluripotency	   network	   suggests	   that	  
maintenance	   of	   pluripotency	   might	   be	   at	   least	   partially	   independent	   on	   the	  
proliferation	  status	  of	  ES	  cells.	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7. Concluding	  remarks	  and	  outlook	  
	  
The	   results	   reported	   in	   this	   thesis	   suggest	   that	   loss	  of	   both	   c-­‐	   and	  N-­‐Myc	   in	  naïve	  
mouse	   ES	   cells	   induces	   a	   state	   of	   metabolic	   and	   proliferative	   quiescence	   without	  
compromising	  the	  expression	  of	  the	  ES	  cell	  pluripotency	  network.	  	  	  
	  
Although	  Myc	  dKO	  ES	  cells	  do	  not	  activate	  any	  apoptotic	  pathway,	   they	  cannot	  be	  
propagated	  in	  vitro,	  most	  probably	  as	  an	  effect	  of	  the	  metabolic	  and	  cell	  cycle	  arrest.	  
To	   elucidate	   if	   the	   quiescent	   state	   induced	   by	  Myc	   loss	   is	   reversible,	  we	  will	   now	  
induce	   exogenous	   Myc	   expression	   in	   dKO	   ES	   cells	   by	   using	   a	   lentiviral	   inducible	  
system	   or	   by	   direct	   transfection	   of	   c-­‐myc	   mRNA.	   Gene	   expression	   and	   cell	   cycle	  
analysis	  will	  be	  used	  to	  examine	  if	  this	  exogenous	  c-­‐Myc	  activity	  can	  rescue	  the	  Myc	  
dKO	  phenotype.	  This	  would	  also	  demonstrate	  that	  the	  cells	  were	  in	  a	  reversible	  state	  
of	  dormancy	  rather	  than	  in	  an	  irreversible	  cell	  cycle	  arrest.	  
	  
To	   investigate	   if	  Myc	   genes	   are	   the	   genes	   regulated	   in	   vivo	  during	   the	   process	   of	  
diapause,	   we	   will	   experimentally	   inhibit	   embryo	   implantation	   by	   manipulating	  
ovarian	  estrogen	  secretion.	  We	  will	  quantify	  the	  expression	  levels	  of	  the	  three	  Myc	  
family	  members	  in	  normal	  blastocysts,	  diapause-­‐embryos	  and	  re-­‐activated	  embryos.	  
Once	   differences	   in	   Myc	   expression	   will	   be	   confirmed,	   we	   will	   focus	   on	   the	  
identification	   of	   the	   factors	   responsible	   of	   Myc	   regulation.	   Since	   previous	   studies	  
suggest	  that	  Myc	  is	  a	  downstream	  target	  of	  the	  LIF-­‐STAT3	  signaling	  pathway,	  one	  of	  
the	   possible	   candidates	   is	   the	   cytokine	   LIF,	   already	   shown	   to	   be	   essential	   for	  
implantation	  (Wang	  and	  Dey,	  2006).	  
	  
We	   observe	   that	   loss	   of	   Myc	   in	   ES	   cells	   results	   in	   a	   significant	   up-­‐regulation	   of	  
Dnmt3l.	   This	   factor	   has	   been	   recently	   shown	   to	   counteract	   the	   activity	   of	   the	   de	  
novo	  DNA	  methyltransferases	  Dnmt3a	  and	  Dnmt3b	  to	  maintain	  hypomethylation	  at	  
promoters	   of	   bivalent	   developmental	   genes	   (Neri	   et	   al.,	   2013).	   Therefore	   we	   are	  
currently	   performing	   DNA	  methylation	   analysis	   by	   bisulfite	   sequencing	   to	   unravel	  
the	   global	   methylation	   profile	   of	   Myc	   dKO	   ES	   cells	   to	   address	   whether	   the	   de-­‐
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regulation	  of	  Dnmt3l	  is	  causative	  for	  the	  maintenance	  of	  the	  pluripotency	  network	  in	  
Myc	  mutant	  ES-­‐cells.	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8. Materials	  and	  methods	  
8.1 Mouse	  lines	  
Animal	   experiments	   were	   performed	   according	   to	   the	   GV-­‐Solas	   (Gesellschaft	   für	  
Versuchstierkunde).	   Mice	   were	   maintained	   in	   the	   facility	   of	   the	   German	   Cancer	  
Research	  Center	  (DKFZ)	  in	  Heidelberg,	  under	  specific	  pathogen-­‐free	  (SPF)	  conditions	  
and	  housed	  in	  individually	  ventilated	  cages	  (IVC).	  
8.1.1 c-­‐mycflox	  mice	  
The	  c-­‐mycflox	  allele	  was	  generated	  by	  Andreas	  Trumpp	  in	  the	   laboratory	  of	  Michael	  
Bishop	  (Trumpp	  et	  al.,	  2001).	  Two	  loxP	  sites	  flanking	  the	  c-­‐myc	  ORF	  are	  located	  into	  
the	  3’	  untranslated	  region	  and	  into	  the	  intron	  1	  of	  the	  c-­‐myc	  gene.	  With	  the	  use	  of	  a	  
Cre-­‐recombinase,	   the	   c-­‐mycflox	   allele	   can	   be	   converted	   into	   a	   knock-­‐out	   allele	   (c-­‐
mycΔ)	  (Figure	  34).	  
8.1.2 N-­‐mycflox	  mice	  
The	  N-­‐mycflox	  allele	  was	  generated	  in	  the	  laboratory	  of	  Robert	  Eisenman	  by	  inserting	  
loxP	  sites	  5’	  of	  exon	  2	  and	  3’	  of	  exon	  3	  of	  the	  N-­‐myc	  gene	  (Knoepfler	  et	  al.,	  2002).	  
Since	  the	  translational	  initiation	  codon	  of	  N-­‐myc	  is	  located	  in	  the	  second	  exon,	  with	  
the	  use	  of	  a	  Cre-­‐recombinase	  the	  entire	  coding	  region	  of	  N-­‐myc	  is	  floxed,	  and	  the	  N-­‐
mycflox	  allele	  is	  converted	  into	  a	  knock-­‐out	  allele	  (N-­‐mycΔ)	  (Figure	  34).	  
8.1.3 REYFPflox	  mice	  
The	   REYFPflox	   is	   an	   allele	   reporting	   Cre	   recombinase	   activity	   and	   is	   commercially	  
available	  (Srinivas	  et	  al.,	  2001).	   In	  these	  mice,	  a	   loxP-­‐flanked	  stop	  codon	  blocks	  the	  
expression	   of	   the	   EYFP	   protein.	   In	   the	   presence	   of	   Cre	   activity,	   the	   stop	   codon	   is	  
excised,	   resulting	   in	   the	   constitutive	   EYFP	   expression	   under	   the	   Rosa26	   promoter	  
(Figure	  34).	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Figure	  34:	   Schematic	   representation	  of	   c-­‐mycflox,	  N-­‐mycflox	   and	  REYFPflox	  alleles.	  Upon	  Cre	  
expression,	   c-­‐myc	   and	   N-­‐myc	   alleles	   are	   recombined	   and	   deleted	   to	   generate	   double	  
knockout	  cells.	  In	  a	  similar	  fashion,	  the	  stop	  codon	  located	  in	  5’	  of	  the	  EYFP	  gene	  is	  deleted	  
resulting	  in	  constitutive	  EYFP	  expression.	  	  
	  
8.1.4 c-­‐mycGFP	  mice	  
The	  c-­‐mycGFP	  allele	  was	  generated	  in	  the	  laboratory	  of	  Berry	  Sleckman	  (Huang	  et	  al.,	  
2008).	  c-­‐mycGFP	  mice	  express	  a	  GFP-­‐c-­‐Myc	  fusion	  protein	  from	  the	  endogenous	  c-­‐myc	  
locus,	  with	  GFP	  appended	  to	  the	  N	  terminus	  of	  c-­‐Myc.	  
8.1.5 tdTomato	  mice	  
The	  tdTomato	  mice	  were	  generated	  in	  the	  laboratory	  of	  Liqun	  Luo	  (Muzumdar	  et	  al.,	  
2007)	  and	  are	  commercially	  available	  (http://jaxmice.jax.org/strain/007576.html).	  In	  
these	  mice	  a	  membrane-­‐targeted	  tdTomato	  (mT)	  is	  expressed	  in	  all	  tissues	  and	  cell	  
types	  examined.	  When	  bred	  to	  Cre	  recombinase	  expressing	  mice,	  the	  mT	  cassette	  is	  
deleted	  in	  the	  Cre	  expressing	  tissue(s),	  allowing	  expression	  of	  a	  membrane-­‐targeted	  
EGFP	  (mG)	  (Muzumdar	  et	  al.,	  2007).	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In	   this	   thesis	   we	   derived	   MEF	   from	   mice	   homozygous	   for	   the	   tdTomato	   allele	   in	  
order	  to	  separate	  by	  FACS	  sorting	  the	  feeder	  layer	  of	  MEF	  from	  the	  mouse	  ES	  cells.	  
	  
8.2 Cell	  culture	  
8.2.1 Isolation	  and	  culture	  of	  mouse	  embryonic	  fibroblasts	  (MEF)	  
	  
MEF	  Medium	  
DMEM	   	   	   	   	   500	  ml	   	   	   (Gibco,	  11965-­‐092)	  
ES	  cells-­‐tested	  Fetal	  Calf	  Serum	  (10%)	   50	  ml	   	   	   (Gibco,	  10439)	  
Non-­‐essential	  amino	  acids	   	   5	  ml	   	   	   (Gibco,	  11140-­‐035)	  
Pen/Strep	   	   	   	   5	  ml	   	   	   (Gibco,	  15140-­‐122)	  
Glutamine	   	   	   	   5	  ml	   	   	   (Gibco,	  25030-­‐081)	  
	  
MEF	  were	  obtained	   from	  C57BL/6	  mice	   (Harlan).	  After	   removing	   the	  head	  and	   the	  
internal	   organs,	   E13.5	   or	   E14.5	   embryos	   were	   dissociated	   mechanically	   and	   by	  
enzymatic	   digestion	   with	   StemPro-­‐Accutase	   (Gibco,	   A11105-­‐01).	   Cells	   were	   grown	  
for	  3	   to	  4	  passages	  on	  plastic	  dishes	   in	  MEF	  medium.	  For	  use	  as	   feeder	   layers,	   the	  
cells	  were	  mitotically	  inactivated	  by	  exposure	  to	  60	  Gy	  of	  gamma-­‐irradiation.	  
Irradiated	  MEFs	  were	   resuspended	   in	  medium	  containing	  10%	  dimethyl-­‐sulphoxide	  
(DMSO)	   and	   transferred	   to	   cryovials	   (Nunc,	   375418).	   After	   over-­‐night	   storage	   at	   -­‐
80°C,	  cells	  were	  transferred	  to	  liquid	  nitrogen.	  
	  
8.2.2 Derivation	  of	  mouse	  ES	  cell	  lines	  from	  E2.5	  morulas	  
	  
Mouse	   ES	   lines	   were	   derived	   in	   collaboration	   with	   the	   Transgenic	   Service	   Core	  
Facility	  of	  the	  German	  Cancer	  Research	  Center	  (DKFZ).	  6-­‐10	  weeks	  old	  females	  were	  
injected	   intraperitoneally	  with	  7	  U	  of	  pregnant	  mare	  serum	  gonadotrophin	   (PMSG)	  
followed	  by	  7	  U	  of	  human	  chorionic	   gonadotrophin	   (hCG),	   injected	  47	  hours	   later.	  
The	  females	  were	  then	  paired	  with	  males	  and	  checked	  for	  vaginal	  plug	  the	  following	  
morning,	  considered	  as	  0.5	  day	  postcoitum	  (dpc).	  The	  2.5	  dpc	  embryos	  were	  flushed	  
from	  the	  oviducts	  into	  a	  plastic	  dish	  with	  M2	  medium	  (Sigma,	  M7167).	  The	  embryos	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were	  washed	  10x	  in	  M2	  medium.	  To	  remove	  the	  zona	  pellucida,	  the	  embryos	  were	  
incubated	  shortly	   in	  Tyrode’s	   solution	   (Sigma,	  T1788-­‐100ML)	  and	   transferred	  again	  
to	  M2	  medium.	   Finally,	   each	   embryo	  was	   transferred	   to	   a	  well	   of	   a	   96-­‐well	   plate	  
previously	  coated	  with	  a	  layer	  of	  mitotically	  inactivated	  MEF,	  in	  2i	  medium	  plus	  15%	  
FCS.	  
	  
8.2.3 Culture	  of	  mouse	  ES	  cells	  
	  
2i	  +	  LIF	  medium	  	   	   	   	  
Ndiff	  N2B27	  medium	   	   	   500	  ml	   	   (StemCells,	  SCS-­‐SF-­‐NB-­‐02)	  
Pen/Strep	   	   	   	   5ml	   	   (Gibco,	  15140-­‐122)	  
b-­‐Mercaptoethanol	  	   	   	   500	  µl	  	   	   (Gibco,	  31350-­‐010)	  
LIF	  (103	  Units/ml)	   	   	   500	  µl	   	   (Millipore,	  ESG1106)	  
PD0325901	   	   	   	   1	  µM	   	   (StemGent,	  04-­‐0006)	  
CHIR99021	   	   	   	   3	  µM	   	   (StemGent,	  04-­‐0004)	  
	  
Serum	  +	  LIF	  medium	  
KO	  DMEM	  medium	   	   	   500	  ml	   	   (Gibco,	  10829)	  
Pen/Strep	   	   	   	   5ml	   	   (Gibco,	  15140-­‐122)	  
b-­‐Mercaptoethanol	  	   	   	   500	  µl	   	   (Gibco,	  31350-­‐010)	  
LIF	  (103	  Units/ml)	   	   	   500	  µl	   	   (Millipore,	  ESG1106)	  
Glutamine	   	   	   	   5	  ml	   	   (Gibco,	  25030)	  
	  
All	  mouse	  ES	  cell	  lines	  were	  grown	  on	  0.1%	  gelatin-­‐coated	  plates	  (EmbryoMax®	  0.1%	  
Gelatin	   solution,	   Millipore,	   ES-­‐006-­‐B)	   and	   maintained	   at	   37°C	   and	   5%	   CO2	   in	  
humidified	  incubators.	  	  
For	  harvesting,	  cells	  were	  washed	  in	  PBS	  and	  treated	  5	  min	  with	  StemPro-­‐Accutase	  
(Gibco,	   A11105-­‐01)	   detachment	   solution.	   Centrifugation	   steps	  were	   carried	   out	   at	  
800g	  at	  4°C	  for	  5	  minutes.	  Cell	  numbers	  and	  viability	  were	  determined	  using	  a	  ViCell	  
Counter	  (Beckman	  Coulter,	  Brea,	  CA).	  
For	  long-­‐term	  storage,	  ES	  cells	  were	  stored	  in	  liquid	  nitrogen.	  For	  freezing,	  cells	  were	  
harvested	   by	   treatment	   with	   StemPro-­‐Accutase.	   Than	   1-­‐3	   million	   cells	   were	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resuspended	   in	   1	  ml	   of	  medium	   containing	   10%	   dimethyl-­‐sulphoxide	   (DMSO)	   and	  
transferred	  to	  cryovials	  (Nunc,	  375418).	  After	  over-­‐night	  storage	  at	  -­‐80°C,	  cells	  were	  
transferred	  to	  liquid	  nitrogen.	  
	  
8.3 Fluorescence	  Activated	  Cell	  Sorting	  (FACS)	  
FACS	   analysis	   was	   performed	   on	   LSRII	   or	   LSR	   Fortessa	   flow	   cytometers	   	   (Becton	  
Dickinson,	  San	  Jose,	  CA).	  Data	  were	  analysed	  using	  the	  FlowJo	  software	   (Tree	  Star,	  
Ashland,	  OR).	  
	  
8.3.1 Cell	  cycle	  analysis	  
For	   cell	   cycle	   analysis,	   0.5x106	  mES	   cells	  were	   fixed	   by	   incubating	   20	  min	   at	   RT	   in	  
Cytofix/Cytoperm	  buffer	   (Beckton	  Dickinson,	  51-­‐2090KZ)	  and	  washed	   in	  PermWash	  
buffer	   (Beckton	   Dickinson,	   51-­‐2091KZ).	   Intracellular	   staining	   with	   Ki76-­‐Alexa647	  
antibody	  (BD	  biosciences,	  558615)	  was	  performed	  in	  PermWash	  solution	  over	  night	  
at	   4°C.	   Samples	   were	   than	   incubated	   with	   Hoechst33342	   (Sigma,	   H3570)	   for	   10	  
minutes	  and	  the	  acquisition	  was	  performed	  immediately	  after	  washing.	  
	  
8.3.2 Expression	  of	  pluripotency	  markers	  
FACS	   analysis	   for	   the	   mouse	   pluripotency	   factors	   Nanog,	   Sox2	   and	   Oct3/4	   was	  
performed	  using	  the	  BDTM	  Mouse	  Pluripotent	  Stem	  Cell	  Transcription	  Factor	  Analysis	  
Kit	   (Becton	   Dickinson,	   560585)	   according	   to	   the	   manufacturer’s	   instructions.	   In	  
summary,	  1x105	  cells	  were	  harvested	  by	  treatment	  with	  StemPro-­‐Accutase	  and	  fixed	  
for	  20	  min	  at	  RT	   in	  BD	  Cytofix/Cytoperm	  buffer.	  The	  cells	  were	  than	  permeabilized	  
by	  washing	  with	  PermWash	  buffer	  and	  stained	  with	  mNanog-­‐PE,	  Oct3/4-­‐PerCP-­‐Cy5.5	  
and	  Sox2-­‐Alexa	  Fluor®647	  antibodies	  for	  1	  hour	  at	  4°C.	  	  
	  
8.4 Immunofluorescence	  
After	   FACS	   sorting,	   5x103	   mES	   cells	   were	   seeded	   on	   MEFs	   in	   chambered	   cover	  
glasses	  (Lab-­‐Tek	  II,	  Nunc,	  177402)	  coated	  with	  0.1%	  gelatin,	  in	  2i	  +	  LIF	  medium.	  After	  
72	  hours,	   the	   cells	  were	   fixed	  by	   incubating	  15	  minutes	   at	  RT	   in	  4%	  PFA	   (Electron	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Microscopy	  Sciences,	  15713)	  and	  permeabilized	  in	  PBS	  containing	  0.5%	  Triton	  X-­‐100	  
for	  10	  minutes.	  The	  cells	  were	  than	  washed	  three	  times	  with	  PBST	  (0.1%	  Tween	  20	  in	  
PBS)	   for	   5	  min	   at	   RT.	   To	   reduce	  unspecific	   binding,	   the	   samples	  were	   incubated	  1	  
hour	   in	   blocking	   solution	   (0.5	  %	   BSA,	   10%	   goat	   serum,	   0.1%	   Triton	   X-­‐100	   in	   PBS).	  
After	   blocking,	   the	   cells	   were	   incubated	   overnight	   at	   4°C	   with	   the	   anti-­‐Nanog	  
antibody	  (abcam,	  ab80892)	  diluted	  1:150	  in	  blocking	  solution.	  After	  washing	  twice	  in	  
PBS,	   the	   cells	  were	   incubated	   for	   4	   hours	   at	   RT	  with	   the	   secondary	   antibody	   goat	  
anti-­‐rabbit-­‐Alexa	  Fluor	  546	  (Invitrogen,	  A-­‐11035)	  diluted	  1:200	   in	  blocking	  solution.	  
The	  samples	  were	  than	  washed	  twice	  in	  PBS	  and	  stained	  with	  DAPI	  (Sigma,	  D9542)	  
diluted	  1:1000	  in	  PBS.	  DAPI	  was	  incubated	  for	  3	  min	  and	  samples	  were	  washed	  twice	  
in	  PBS.	  The	  slides	  were	  mounted	  with	  Faramount	  (Dako,	  S3035)	  and	  analyzed	  on	  a	  
Zeiss	  Cell	  Observer	  fluorescence	  microscope	  (Carl	  Zeiss,	  Jena,	  Germany).	  
	  
8.5 Alkaline	  Phosphatase	  (AP)	  Staining	  
AP	   staining	  was	   performed	   using	   the	   Stemgent®	   Alkaline	   Phosphatase	   Staining	   Kit	  
(Stemgent,	  00-­‐0055)	  according	  to	  the	  manufacturer’s	  instructions.	  
	  
8.6 Molecular	  biology	  
8.6.1 DNA	  extraction	  
Genomic	  DNA	  was	  isolated	  from	  sorted	  or	  cultured	  cells	  using	  the	  DNeasy	  Blood	  and	  
Tissue	  kit	  (Qiagen,	  69506)	  according	  to	  the	  manufacturer’s	  instructions.	  	  
DNA	  extracts	  from	  mouse-­‐tail	  biopsies	  were	  obtained	  using	  the	  Direct	  PCR	  Tail	  Lysis	  
Reagent	  (Peqlab,	  31-­‐102-­‐T).	  
	  
8.6.2 Genotyping	  PCR	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Allele	   Primer	  Pair	   Primer	  Sequence	   Product	  Size	  
c-­‐myc	  GFP	   cmycGFP	  F1	   AAG	  GGG	  AGT	  GGT	  TCA	  GGA	  TT	   WT:	  290	  bp	  
	   cmycGFP	  F2	   AGC	  AGC	  TCG	  AAT	  TTC	  TTC	  CA	   GFP:	  1000	  bp	  
c-­‐myc	  flox	   5’floxB	   ACA	  ACG	  TCT	  TGG	  AAC	  GTC	  AGA	  GG	   WT:	  320	  bp	  
	   3’floxB	   GCA	  TTT	  TAA	  TTC	  CAG	  CGC	  ATC	  AG	   Flox:	  450	  bp	  
c-­‐myc	  delORF	   cmycdel1	   AAA	  TAG	  TGA	  TCG	  TAG	  TAA	  AAT	  TTA	  GCC	  TG	   KO:	  190	  bp	  
	   cmycdel2	   ACC	  GTT	  CTC	  CTT	  AGC	  TCT	  CAC	  G	   	  
N-­‐myc	  flox/KO	   N-­‐Myc	  1	   GTC	  GCG	  CTA	  GTA	  AGA	  GCT	  GAG	  ATC	   WT:	  217	  bp	  
	   N-­‐Myc-­‐2	   GGC	  ACA	  CAC	  CTA	  TAA	  TCC	  CAG	  CTA	  G	   KO:	  350	  bp	  	  
	   N-­‐Myc	  3	   CAC	  AGC	  TCT	  GGA	  AGG	  TGG	  GAG	  AAA	  GTT	  GAGCGT	  CTCC	   Flox:	  260	  bp	  
REYFP	   Rosa1	  (For)	   AAA	  GTC	  GCT	  CTG	  AGT	  TGT	  TAT	   WT:	  600	  bp	  
	   Rosa2	  (RevEYFP)	   GCG	  AAG	  AGT	  TTG	  TCC	  TCA	  ACC	   RosaEYFP:	  300	  bp	  
	   Rosa3	  (Rev	  WT)	   GGA	  GCG	  GGA	  GAA	  ATG	  GAT	  ATG	   	  
Tomato-­‐EGFP	   Tomato1	   CTC	  TGC	  TGC	  CTC	  CTG	  GCT	  TCT	   WT:	  330	  bp	  
	   Tomato2	   CGA	  GGC	  GGA	  TCA	  CAA	  GCA	  ATA	   Flox:	  250	  bp	  
	   Tomato3	   TCA	  ATG	  GGC	  GGG	  GGT	  CGT	  T	   	  
Table	  1:	  List	  of	  PCR	  primers	  used	  for	  genotyping	  of	  mice	  and	  cells.	  
	  
8.6.3 RNA	  extraction	  
Cultured	  cells	  were	  harvested	  by	  treatment	  with	  StemPro-­‐Accutase	  (Gibco,	  A11105-­‐
01)	   and	   cell	   pellets	   were	   lysed	   in	   50	   μl	   of	   RNA	   extraction	   buffer	   (ARCTURUS®	  
PicoPure®	  RNA	  Isolation	  Kit,	  Life	  Technologies,	  Invitrogen,	  12204-­‐01)	  and	  stored	  at	  -­‐
80°C	   or	   directly	   used	   for	   RNA	   extraction	   using	   the	   ARCTURUS®	   PicoPure®	   RNA	  
Isolation	  Kit,	  according	   to	   the	  manufacturer’s	  protocol	  and	   including	  an	  on-­‐column	  
DNase	  digestion	  (Qiagen,	  79254)	  to	  remove	  genomic	  DNA.	  
	  
8.6.4 Reverse	  transcription	  
Reverse	  transcription	  was	  performed	  using	  the	  SuperScript	  VILO	  cDNA	  synthesis	  kit	  
(Invitrogen,	   11754-­‐250)	   according	   to	   the	   manufacturer’s	   instructions.	   0.1-­‐2	   μg	   of	  
RNA	   were	   used	   as	   template	   and	   cDNA	   was	   diluted	   in	   DNase	   free	   water	   (Gibco,	  
10977)	  and	  used	  for	  qRT-­‐PCR.	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8.6.5 qRT-­‐PCR	  
Real-­‐time	   quantitative	   PCRs	   were	   performed	   using	   the	   ABI	   Power	   SYBR	   Green	  
Master	   Mix	   (Applied	   Biosystems,	   4309155)	   in	   reaction	   volumes	   of	   10	   μl.	   PCR	  
reactions	   were	   run	   on	   a	   Viia7	   machine	   (Applied	   Biosystems)	   with	   the	   following	  
program:	  95°C,	  10	  min;	  50	  cycles	   (95°C,	  15	  sec;	  60°C,	  45	  sec;	  acquisition);	  95°C,	  10	  
sec;	   65°C,	   1	  min;	   0.11°C/s	   up	   to	   95°C	   continuous	   acquisition;	   40°C,	   5	  min.	   Results	  
were	  analyzed	  using	  the	  ViiaTM7	  –software	  1.1.	  	  
	  
Target	   Forward	  Primer	  (5’-­‐3’)	   Reverse	  Primer	  (5’-­‐3’)	  
c-­‐myc	   CAC	  CAG	  CAG	  CGA	  CTC	  TGA	   GGG	  GTT	  TGC	  CTC	  TTC	  TCC	  
N-­‐myc	   CTC	  CGG	  AGA	  GGA	  TAC	  CTT	  GA	   TCT	  CTA	  CGG	  TGA	  CCA	  CAT	  CG	  
L-­‐myc	   CCA	  GCG	  ATT	  CTG	  AAG	  GTG	  A	   TCC	  AGA	  GAT	  CGC	  CTC	  TTC	  TC	  
Nanog	   TTC	  TTG	  CTT	  ACA	  AGG	  GTC	  TGC	   AGA	  GGA	  AGG	  GCG	  AGG	  AGA	  
Oct4	   GTT	  GGA	  GAA	  GGT	  GGA	  ACC	  AA	   CTC	  CTT	  CTG	  CAG	  GGC	  TTT	  C	  
Klf4	   CGG	  GAA	  GGG	  AGA	  AGA	  CAC	  T	   GAG	  TTC	  CTC	  ACG	  CCA	  ACG	  
Rex1	   TCT	  TCT	  CTC	  AAT	  AGA	  GTG	  AGT	  GTG	  C	   GCT	  TTC	  TTC	  TGT	  GTG	  CAG	  GA	  
p57	   TCT	  CGG	  GGA	  TTC	  CAG	  GAC	   ACG	  TTT	  GGA	  GAG	  GGA	  CAC	  C	  
P21	   TCC	  ACA	  GCG	  ATA	  TCC	  AGA	  CA	   GGA	  CAT	  CAC	  CAG	  GAT	  TGG	  AC	  
P27	   GAG	  CAG	  TGT	  CCA	  GGG	  ATG	  AG	   TCT	  GTT	  CTG	  TTG	  GCC	  CTT	  TT	  
P19	   CGG	  TAT	  CCA	  CTA	  TGC	  TTC	  TGG	  AA	   CCG	  CTG	  CGC	  CAC	  TCA	  
Gapdh	   CCC	  ATT	  CTC	  GGC	  CTT	  GAC	  TGT	   GTG	  GAG	  ATT	  GTT	  GCC	  ATC	  AAC	  GA	  
SDHA	   AAG	  TTG	  AGA	  TTT	  GCC	  GAT	  GG	   TGG	  TTC	  TGC	  ATC	  GAC	  TTC	  TG	  
OAZ1	   TTT	  CAG	  CTA	  GCA	  TCC	  TGT	  ACT	  CC	   GAC	  CCT	  GGT	  CTT	  GTC	  GTT	  AGA	  
DNMT1	   TTT	  ACG	  TGT	  CGT	  TTT	  TCG	  TCT	  C	   CAG	  AGA	  CTC	  CCG	  AGG	  ACA	  GA	  
DNMT3a	   AAA	  CGG	  AAA	  CGG	  GAT	  GAG	  T	   ACT	  GCA	  ATT	  ACC	  TTG	  GCT	  TTC	  T	  
DNMT3a2	   ACA	  CAG	  GGC	  CCG	  TTA	  CTT	  CT	   TCA	  CAG	  TGG	  ATG	  CCA	  AAG	  
DNMT3b	   GAA	  CAT	  GCG	  CCT	  GCA	  AGA	   GCA	  CAG	  ACT	  TCG	  GAG	  GCA	  AT	  
DNMT3l	   CGG	  CAC	  CAG	  CTG	  AAG	  GCC	  TTC	  CAT	  G	   AGG	  CAG	  CGC	  ATA	  CTG	  CAG	  GAT	  CCG	  G	  
Table	  2:	  List	  of	  primers	  used	  for	  qRT-­‐PCR	  experiments.	  
	  
All	   primers	   were	   designed	   using	   the	   Roche	   Universal	   Probe	   Library	   Assay	   Design	  
Center.	  c-­‐myc,	  N-­‐myc	  and	  L-­‐myc	  primers	  were	  designed	  by	  Dr.	  Armin	  Ehninger	  and	  
Materials	  and	  methods	  
_____________________________________________________________________	  
	   79	  
were	   validated	   with	   defined	   molecular	   amounts	   of	   template	   DNA	   to	   enable	  
comparative	   quantification.	   GAPDH,	  OAZ1	   and	   SDHA	  were	   used	   for	   normalization.	  
The	  primers	  used	  in	  this	  thesis	  are	  listed	  in	  Table	  2.	  
	  
8.6.6 Cloning	  of	  pBS598	  ef1α	  mCherry-­‐Cre	  plasmid	  
The	   pBS598-­‐ef1α-­‐mCherry-­‐Cre	   plasmid	   (mCherry	   Cre)	   carrying	   the	   mCherry	  
fluorescent	  protein	  in	  frame	  with	  the	  Cre	  recombinase	  has	  been	  generated	  starting	  
from	   the	  pBS598-­‐EF1a-­‐EGFP-­‐Cre	  plasmid	   (Addgene,	   11923).	   This	   plasmid	  has	   been	  
cut	   with	   the	   NcoI	   restriction	   enzyme	   to	   eliminate	   the	   EGFP	   coding	   sequence	   and	  
dephosphorylated	  to	  avoid	  recircularization.	  The	  mCherry	  ORF	  has	  been	  obtained	  via	  
PCR	   using	   the	   pmCherry-­‐NLS	   plasmid	   (Addgene,	   39319)	   as	   template	   and	   the	  
following	  custom	  primers	  carrying	  the	  BspHI	  restriction	  size	  (shown	  in	  bold):	  
mCHERRYup:	  AAATCATGATGGTGAGCAAGGGCGA	  
mCHERRYdw:	  AAATCATGACCTTGTACAGCTCGTCCATGC	  
The	   PCR	   product	   has	   been	   purified	   with	   phenol/chloroform,	   cut	   with	   BspHI,	   gel	  
purified	  and	   ligated	  to	  the	  NcoI-­‐treated	  pBS598-­‐EF1a-­‐EGFP-­‐Cre	  plasmid.	  The	  use	  of	  
the	  BspHI	  enzyme,	  that	  carries	  NcoI	  compatible	  ends,	  has	  been	  necessary	  since	  the	  
mCHERRY	   ORF	   includes	   an	   NcoI	   restriction	   site	   making	   impossible	   a	   direct	   sub-­‐
cloning.	  The	  map	  of	  the	  pBS598-­‐ef1α-­‐mCherry-­‐Cre	  is	  reported	  in	  Figure	  35.	  	  
	  
	  
Figure	  35:	  Map	  of	  the	  pBS598-­‐ef1α-­‐mCherry-­‐Cre	  plasmid.	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8.7 Teratoma	  	  Assay	  
8.7.1. Subcutaneus	  injection	  of	  mES	  cells	  
For	  teratoma	  assay,	  ES	  cells	  were	  harvested	  and	  resuspended	  in	  PBS	  at	  a	  density	  of	  
6x106	  cells/ml.	  3x106	  ES	  cells	  were	  injected	  subcutaneously	  into	  the	  flank	  of	  6-­‐weeks	  
old	   female	   NSG	   immunodeficient	   mice	   (NOD.Cg-­‐Prkdcscid	   Il2rgtm1Wjl/SzJ,	   The	  
Jackson	   Laboratory).	   4-­‐6	   weeks	   after	   injection,	   when	   the	   tumors	   reached	  
approximately	   1.5	   cm	   in	   diameter,	   the	   mice	   were	   sacrificed	   and	   teratomas	   were	  
isolated	  and	  further	  processed.	  
	  
8.7.2. Hematoxylin-­‐Eosin	  (H&E)	  staining	  
After	   surgical	   removal,	   the	   tumors	   were	   fixed	   in	   10%	   buffered	   formalin	   solution	  
(Sigma,	   HT-­‐1-­‐2)	   for	   2	   days,	   at	   4°C	   on	   a	   rotor.	   The	   Tissue-­‐Tek®VIP®6	   was	   used	   to	  
dehydrate	   the	   samples	   by	   sequential	   incubation	   in	   70%	   -­‐	   90%	   and	   100%	   ethanol,	  
followed	  by	  treatment	  with	  xylol	  and	  paraffin.	  Paraffin-­‐embedded	  tissues	  were	  then	  
cut	   in	  4	  μm	  sections	   (Microm	  HM355S	  microtome,	  Thermo	  Scientific	   Inc.,	  Bremen,	  
Germany)	  and	  then	  deparaffinized	  and	  rehydrated	  by	  sequencial	  incubation	  in	  xylol	  
(twice,	  for	  3	  minutes)	  and	  in	  alcohol	  (100%	  -­‐	  95%	  -­‐	  80%	  -­‐	  70%	  and	  50%	  ethanol,	  for	  3	  
minutes	  each).	  The	  samples	  were	  stained	  with	  hematoxylin	  for	  6	  minutes,	  washed	  in	  
water,	  briefly	  immersed	  in	  acidic	  ethanol	  (200	  ml	  70%	  ethanol	  +	  0.5	  ml	  pure	  HCl)	  and	  
then	   counter-­‐stained	  with	   eosin.	  After	   short	   immersion	   in	   95%	  and	  100%	  ethanol,	  
the	  samples	  were	  incubated	  in	  xylol	  for	  15	  minutes	  and	  finally	  embedded.	  After	  air-­‐
drying,	   embedded	   slides	   were	   stored	   at	   room	   temperature	   and	   imaged	   using	   the	  
Leica	  DM	  LB2	  microscope	  (Leica	  Microsystems,	  Germany).	  
	  
8.8 RNA-­‐sequencing	  
8.8.1. Cell	  culture,	  transfection	  and	  FACS	  sorting	  
c-­‐mycflox/flox;	   N-­‐mycflox/flox;	   ROSA-­‐EYFPflox/flox	   ES	   cells	   were	   maintained	   in	   2i	   +	   LIF	  
medium	  for	  more	  than	  10	  passages.	  For	  the	  deletion	  of	  the	  Myc	  alleles,	  1x105	  cells	  
were	   plated	   in	   each	  well	   of	   a	   6-­‐well	   plate,	   pre-­‐coated	  with	   0.1%	   gelatin.	   After	   10	  
hours	  the	  cells	  were	  transfected	  with	  the	  mCherry-­‐Cre	  plasmid	  by	  using	  the	  XfectTM	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Stem	  kit	   (Clontech,	  631321)	  according	  to	  the	  manufacturer’s	   instructions.	  24	  hours	  
after	  transfection,	  ES	  cells	  were	  harvested	  and	  resuspended	  in	  ice-­‐cold	  PBS.	  
Cell	  sorting	  was	  performed	  on	  a	  FACS	  Aria	  II	  or	  FACS	  Aria	  III	  (Becton	  Dickinson,	  San	  
Jose,	   CA)	   at	   the	   DKFZ	   Flow	   Cytometry	   Service	   Unit,	   Heidelberg,	   Germany.	   The	  
following	  sort	  parameters	  were	  used:	  85	  µm	  nozzle;	  maximum	  10,000	  evt/s.;	  45	  psi.	  
Sorted	   cells	   were	   collected	   into	   ice-­‐cold	   PBS,	   span	   down	   and	   seeded	   into	   24-­‐well	  
plates	  at	  a	  density	  of	  5x104	   cells/well,	  or	   resuspended	   in	  100	  μl	  of	  RNA	  extraction	  
buffer	   (ARCTURUS®	   PicoPure®	   RNA	   Isolation	   Kit,	   Life	   Technologies,	   Invitrogen,	  
12204-­‐01)	  and	  stored	  at	   -­‐80°C	  until	   further	  usage.	  Seeded	  cells	  were	  harvested	  72	  
hours	  after	  sort	  for	  RNA	  isolation.	  
	  
c-­‐Myc	  GFP	  ES	   cells	  were	   isolated	   from	  eGFP-­‐c-­‐Myc	  knocking	  mice	   .	   	  Clones	  C6,	  D7	  
and	  E4	  were	  used	  as	  three	  biological	  replicates	  and	  were	  maintained	  for	  more	  than	  
10	  passages	   in	  2i	  +	  LIF	  medium.	  For	  the	  RNA-­‐sequencing	  experiment,	  ES	  cells	  were	  
plated	  at	  a	  density	  of	  0.5x106	  cells/dish	   in	  10	  cm	  dishes	  pre-­‐coated	  with	  tdTomato	  
MEFs,	  in	  2i	  +	  LIF	  or	  serum	  +	  LIF	  medium.	  The	  medium	  was	  freshly	  replaced	  every	  day.	  
72	   hours	   after	   seeding,	   the	   cells	   were	   harvested	   and	   resuspended	   in	   PBS	   at	   a	  
concentration	   of	   10x106	   cells/ml.	   For	   dead	   cell	   exclusion,	   PI	   (Sigma,	   P4864)	   was	  
added	  at	  a	  1:100	  dilution.	  
Cell	  sorting	  was	  performed	  on	  a	  FACS	  Aria	  II	  or	  FACS	  Aria	  III	  (Becton	  Dickinson,	  San	  
Jose,	   CA)	   at	   the	   DKFZ	   Flow	   Cytometry	   Service	   Unit,	   Heidelberg,	   Germany.	   The	  
following	  sort	  parameters	  were	  used:	  85	  µm	  nozzle;	  maximum	  10,000	  evt/s.;	  45	  psi.	  
Sorted	  cells	  were	  collected	  into	  ice-­‐cold	  PBS,	  span	  down	  and	  resuspended	  in	  100	  μl	  
of	  RNA	  extraction	  buffer	  (ARCTURUS®	  PicoPure®	  RNA	  Isolation	  Kit	  (Life	  Technologies,	  
Invitrogen,	  12204-­‐01)	  and	  stored	  at	  -­‐80°C	  until	  further	  usage.	  
	  
8.8.2. Total	  RNA	  isolation	  and	  RNA-­‐sequencing	  
Total	   RNA	   isolation	  was	   performed	   using	   ARCTURUS®	   PicoPure®	   RNA	   Isolation	   Kit	  
(Life	   Technologies,	   Invitrogen,	   12204-­‐01)	   according	   to	   the	   manufacturer’s	  
instructions.	  To	  remove	  genomic	  DNA,	  we	  performed	  a	  DNAse	  treatment	  using	  the	  
RNAse-­‐free	  DNAse	  Set	  (Qiagen,	  79254).	  Total	  RNA	  was	  used	  for	  quality	  controls	  and	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for	   normalization	   of	   starting	   material.	   For	   the	   Myc	   dKO	   RNA-­‐seq,	   cDNA-­‐libraries	  
were	  generated	  with	  10	  ng	  of	  total	  RNA	  using	  the	  SMARTer™	  Ultra	  Low	  RNA	  Kit	  for	  
Illumina	  Sequencing	  (Clontech)	  according	  to	  the	  manufacturer’s	  indications.	  Of	  note,	  
12	  cycles	  were	  used	  for	  the	  amplification	  of	  cDNA.	  Paired-­‐end	  adaptors	  were	  applied	  
to	   each	   population.	   100	   bp	   reads	   sequencing	   was	   performed	  with	   the	   HiSeq2000	  
device	  (Illumina)	  and	  three	  samples	  per	  lane.	  
	  
8.8.3. Processing	  of	  RNA-­‐seq	  raw	  data	  
Bioinformatic	   analysis	   of	   the	   RNA-­‐seq	   data	   was	   performed	   by	   Alejandro	   Reyes	  
(EMBL,	   Heidelberg).	   Read	   fragments	   were	   aligned	   against	   the	   mouse	   reference	  
genome	   GRCm38	   from	   ENSEMBL	   release	   69,	   using	   GSNAP	   (version	   2012-­‐07-­‐20).	  
Splitted	   alignments	   were	   allowed	   for	   exon-­‐exon	   junctions.	   Only	   uniquely	   aligned	  
fragments	  were	  considered	  for	  further	  analysis.	  For	  each	  gene,	  the	  number	  of	  read	  
fragments	  was	  calculated	  using	  htseq-­‐count.	  The	   likelihood	   ratio	   test	   from	  DESeq2	  
was	   used	   in	   order	   to	   test	   for	   differential	   expression	   in	   any	   of	   the	   conditions.	   The	  
variance	   stabilizing	   transformation	   from	   DESeq2	   was	   used	   to	   make	   the	   data	  
homoscedastic	   through	   the	   dynamic	   range.	   A	   background	  matched	   for	   expression	  
strength	   with	   the	   differentially	   expressed	   genes	   was	   generated	   to	   avoid	   any	   bias	  
associated	   to	   expression	   strength	   in	   further	   testing.	   The	   variance	   stabilized	   data	  
were	  considered	  in	  order	  to	  group	  the	  differentially	  expressed	  genes	  by	  their	  relative	  
expression	   level	   compared	   to	   the	  mean	  expression	  across	   all	   the	   conditions.	  Gene	  
Onthology	   enrichment	   tests	   were	   performed	   compared	   to	   the	   background	   genes	  
using	  a	  Fisher’s	  exact	  test.	  Multiple-­‐testing	  correction	  was	  done	  with	  the	  Bonferroni-­‐
Hochberg	   method.	   Principal	   component	   analysis	   and	   hierarchical	   clustering	   were	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9. 	  Abbreviations	  
	  
2i	   	   two	  inhibitors	  
3i	   	   three	  inhibitors	  
AP	   	   alkaline	  phosphatase	  
BMP	   	   bone	  morphogenic	  protein	  
BSA	   	   bovine	  serum	  albumin	  
cDNA	   	   complementary	  DNA	  
CDK	   	   cyclin	  dependent	  kinase	  
ChIP	   	   chromatin	  immunoprecipitation	  
CHIR	   	   CHIRON99021	  
dKO	   	   double	  knock-­‐out	  
DMSO	   	   dimethyl	  sulphoxide	  
DNA	   	   deoxyribonucleic	  acid	  
Dnmt	   	   DNA	  methyltransferase	  
Dpc	   	   days	  post	  coitum	  
EC	   	   embryonal	  carcinoma	  
ER	   	   estrogen	  receptor	  
ERK	   	   extracellular	  receptor	  kinase	  
ES	   	   embryonic	  stem	  
FACS	   	   fluorescence	  activated	  cell	  sorting	  
FCS	   	   fetal	  calf	  serum	  
FGF	   	   fibroblast	  growth	  factor	  
FGFR	   	   FGF	  receptor	  
FITC	   	   fluorescin	  isothiocyanate	  
GAPDH	  	   glyceraldehyde-­‐3-­‐phosphate	  dehydrogenase	  
GFP	   	   green	  fluorecent	  protein	  	  
GSK3b	   	   glycogen	  synthase	  kinase	  3b	  
H&E	   	   hematoxylin	  and	  eosin	  
hCG	   	   human	  chorionic	  gonadotrophin	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HSCs	   	   hematopoietic	  stem	  cells	  
ICM	   	   inner	  cell	  mass	  
IL-­‐6	   	   interleukin	  6	  
iPS	   	   induced	  pluripotent	  stem	  
JAK	   	   janus	  activated	  kinase	  
Klf	   	   Kruppel-­‐like	  family	  
LIF	   	   leukaemia	  inhibitory	  factor	  
MAPK	   	   mitogen	  activated	  protein	  kinase	  
MEFs	   	   mouse	  embryonic	  fibroblasts	  
mRNA	   	   messenger	  RNA	  
PBS	   	   phosphate	  buffer	  saline	  
PCR	   	   polymerase	  chain	  reaction	  
PD	   	   PD0325901	  
PcG	   	   polycomb	  
PI	   	   propidium	  Iodide	  
PI3K	   	   phosphatidylinositol	  3-­‐kinase	  
Pol	   	   polymerase	  
PMSG	  	   	   gonadotrophin	  	  
qRT-­‐	  PCR	   quantitative	  real-­‐time	  PCR	  
RNA	   	   ribonucleic	  acid	  
RNA-­‐seq	   RNA-­‐sequencing	  
RNAi	   	   RNA-­‐interference	  
siRNA	   	   short	  interfering	  RNA	  
SSNT	   	   somatic	  cell	  nuclear	  transfer	  
STAT	   	   signal	  transducer	  and	  activator	  of	  transcription	  
trxG	   	   trithorax	  
wt	   	   wild	  type	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10. Contributions	  
	  
The	  c-­‐mycflox/flox;	  N-­‐mycflox/flox;	  REYFPflox/flox	  and	  c-­‐mycGFP/GFP	  embryonic	  stem	  (ES)	  cell	  
lines	  were	  generated	  by	  Frank	  van	  der	  Hoeven	  (DKFZ,	  Heidelberg)	  and	  myself,	  in	  the	  
transgenic	  service	  unit	  of	  the	  German	  Cancer	  Research	  Center.	  	  
	  
Dr.	   Sandro	   Altamura	   (MMPU,	   Heidelberg)	   and	   Dr.	   Larissa	   Carnevalli	   (HI-­‐STEM,	  
Heidelberg)	  contributed	  to	  the	  project	  with	  scientific	  support,	  useful	  discussions	  and	  
technical	  advises.	  
	  
Dr.	   Nina	   Cabezas	   (DKFZ,	   Heidelberg)	   provided	   scientific	   support	   for	   the	   RNA-­‐
sequencing.	   Alejandro	   Reyes	   (EMBL,	   Heidelberg)	   performed	   the	   bioinformatic	  
analysis	  of	  the	  data.	  
	  
Dr.	   Sandro	   Altamura	   (MMPU,	   Heidelberg)	   cloned	   the	   pBS598	   ef1α	   mCherry-­‐Cre	  
plasmid,	  provided	  the	  E14	  ES	  cells	  and	  critically	  reviewed	  this	  thesis.	  
	  
Cell	  sorts	  were	  performed	  in	  collaboration	  with	  Gelo	  de	  la	  Cruz	  and	  Ann	  Atzberger	  at	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me	  during	  these	  years.	  Knowing	  how	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   always	   see	   the	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   and	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   encouragement	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   given	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strength	   to	   go	   through	   the	   toughest	   moments.	   Thanks	   for	   believing	   in	   me	   much	  
more	  than	  I	  do.	  You	  became	  a	  crazy	  little	  nerd	  …	  ehm	  …	  scientist	  in	  the	  last	  years	  and	  
you	   now	   have	   all	   you	   need	   to	   succeed.	   Thanks	   for	   developing,	   together	   with	  
Alejandro,	  the	  RNA-­‐seq	  analysis	  tools	  that	  will	  allow	  several	  projects,	  including	  mine,	  
to	  move	  forward	  J.	  Ti	  voglio	  davvero	  tanto	  bene	  J.	  
	  
Aine,	  my	  crazy,	  Irish	  friend.	  Thanks	  for	  letting	  me	  in	  your	  wonderful	  word.	  I	  still	  think	  
sometimes	  that	  you	  might	  not	  exist	  in	  reality,	  and	  you	  are	  rather	  the	  figment	  of	  my	  
imagination.	  Thanks	  for	  the	  long	  chats,	  the	  Aperol,	  the	  muesli	  and,	  of	  course,	  thanks	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for	  your	   true	   friendship.	   I	  wish	  you	  and	  Andrew	   to	  write	   together	  your	  passionate	  
and	  romantic	  novel	  J.	  
	  
Elisa	   E,	   I	   am	   really	  happy	  you	  chose	   to	   join	  our	   lab:	   you	  brought	  a	   lot	  of	  new	  and	  
positive	  energy.	  Thanks	  for	  your	  HUGE	  support	  while	  I	  was	  writing	  my	  thesis	  J.	  You	  
are	   a	   great	   friend	   and	   a	   valuable	   scientist	   that	   will	   soon	   “swim”	   in	   an	   ocean	   of	  
sequencing	  data:	  cancer	  will	  have	  no	  secrets	  for	  you	  any	  more!	  Good	  luck	  for	  your	  
Postdoc.	  
	  
Daniel	  K,	  thanks	  for	  being	  the	  founder	  the	  “Omics”	  group	  and	  for	  making	  me	  feel	  a	  
bit	   part	   of	   it.	   It’s	   been	   a	   pleasure	   sharing	   with	   you	   so	  many	   thoughts	   about	   life,	  
future	   and	  dreams.	   Thanks	   for	   your	   rational	   advises	   and	   for	  being	   so	  German	  and	  
Mediterranean	  at	  the	  same	  time:	  you’ve	  learned	  definitely	  the	  best	  of	  both	  cultures	  
J.	  I	  am	  sure	  a	  great	  future	  is	  waiting	  for	  you.	  
	  
Little	   Lisa,	   thanks	   for	   being	   so	   genuine	   and	   cheerful	   and	   for	   sharing	   with	  me	   the	  
Trumpp	  PhD	  life.	  Always	  remember	  our	  song.	  Never	  forget	  you	  are	  a	  smart	  student	  
and	  try	  to	  find	  in	  yourself	  the	  confidence	  (or	  just	  give	  me	  a	  call).	  Good	  luck	  with	  your	  
PhD:	  especially	  now	  that	  you	  are	  also	  a	  “Myc”	  scientist,	  I	  am	  pretty	  sure	  you’ll	  do	  a	  
great	  thesis	  J.	  Thanks	  also	  for	  translating	  to	  German	  the	  summary	  of	  this	  thesis.	  
	  
Anja	  S,	  thanks	  for	  being	  such	  a	  shiny	  person.	  It	  was	  fantastic	  to	  share	  with	  you	  the	  
first	  years	  of	  my	  PhD.	  As	  I	  have	  always	  told	  you,	  I	  am	  sure	  there	  are	  more	  southern	  
genes	   in	  your	  DNA	  than	  you	  might	   think.	  You	  will	  be	  an	  amazing	  mother	  and	   I	  am	  
sure	   that	  you	  will	   also	  make	  a	  brilliant	   career.	   I	  wish	  all	   the	  best	   for	  you	  and	  your	  
little	  Greek-­‐German	  family.	  
	  
I	   also	  need	   to	   thank	  all	   the	  people	   that	  have	  directly	  and	   indirectly	   contributed	   to	  
this	   thesis.	   A	   big	   thanks	   goes	   therefore	   to	   all	   the	   technicians	   of	   HI-­‐STEM	   for	   the	  
incredible	  work	  they	  are	  doing	  to	  keep	  the	  lab	  running.	  Meli,	  you	  will	  always	  be	  my	  
little	   mum.	   It	   was	   fantastic	   working	   with	   you.	   You	   have	   two	   beautiful,	   smart	  
daughters	  and	  I	  am	  sure	  they	  will	  give	  you	  lots	  of	  reasons	  to	  be	  proud.	  Don’t	  worry	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about	   the	   future:	   it	  will	   bring	   you	   the	  happiness	   you	  deserve.	  Katja,	   thanks	   for	   all	  
your	  valuable	  help	  during	  these	  years.	  You	  are	  an	  amazing	  technician	  and	  we	  grew	  
and	  learned	  a	  lot	  together.	  I	  wish	  you	  all	  the	  best	  with	  your	  working	  and	  private	  life.	  
Corinna,	  you	  have	  been	  a	  great	  teacher	  and	  you	  will	  always	  be	  my	  reference	  for	  the	  
mouse	  surgery.	  Daniel	  B,	  you	  are	  an	  incredibly	  smart	  student	  and	  I	  am	  sure	  we	  will	  
enjoy	  working	  together	  in	  the	  next	  months.	  	  MariaJo,	  it	  was	  great	  fun	  working	  with	  
you,	   even	   if	   only	   for	   a	   little	   while.	   I	   wish	   you,	   Andrea	   and	   Leo	   a	   wonderful	   life.	  
Sandra,	  thanks	  for	  titrating	  liters	  and	  liters	  of	  antibodies	  for	  us,	  always	  keeping	  a	  big	  
smile.	  Andrea	  K,	  thanks	  for	  the	  wonderful	   job	  in	  coordinating	  the	  technicians	  team	  
and	  for	  being	  one	  of	  the	  main	  columns	  of	  the	  Trumpp	  lab.	  Thanks	  to	  Anja	  and	  all	  the	  
animal	  caretakers	  of	  the	  T137	  room:	  much	  of	  the	  research	  of	  the	  Trumpp	  lab	  would	  
not	  be	  possible	  without	  you.	  
	  
Gelo,	  Jens,	  Ann,	  Klaus	  and	   Steffen,	  you	  always	  made	  me	  feel	  welcome	   in	  the	  core	  
facility.	  Thanks	  for	  sharing	  with	  me	  both	  the	  secrets	  of	  flow	  cytometry	  and	  several,	  
incredible	  cooking	  recipes.	  You	  made	  all	  the	  hours	  I	  spent	  sorting	  really	  a	  great	  time.	  
	  
Thanks	  to	  Frank	  van	  der	  Hoeven	   for	  helping	  me	  to	  derive	  the	  ES	  cells:	  the	  work	  of	  
this	  thesis	  would	  not	  have	  been	  possible	  without	  your	  contribution.	  Thanks	  to	  Austin	  
Smith,	  for	  directing	  the	  research	  of	  this	  thesis	  without	  being	  fully	  aware	  of	  this	  role.	  
Talking	   to	   you	   during	   several	   conferences	   around	   the	   world	   has	   been	   incredibly	  
inspiring.	  A	  big	  thanks	  goes	  also	  to	  the	  Utikal	  group	  for	  making	  me	  feel	  valuable	  and	  
part	  of	  their	  team.	  
	  
Thanks	   to	   Marina	   and	   Erika	   for	   taking	   care	   of	   us	   J.	   Without	   your	   help	   in	  
coordinating	   our	   work,	   our	   lives	   would	   be	   an	   incredible	   mess.	   Thanks	   for	   always	  
being	  so	  supportive	  and	  for	  doing	  such	  an	  amazing	  job!	  
	  
Thanks	  to	  all	  the	  former	  members	  of	  HI-­‐STEM	  and	  to	  the	  current	  members	  of	  Mick,	  
Marieke,	  Thordur,	  Martin	  and	  Christoph’s	  groups:	  I	  wish	  you	  all	  to	  make	  this	  unit	  a	  
successful	  and	  collaborative	  environment	  where	  passion	  for	  good	  science	  is	  the	  one	  
and	  only	  thing	  that	  matters.	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I	   want	   to	   thank	  ALL	  my	   “Heidelberger	   Friends”	  who	   became,	   during	   these	   years,	  
more	  than	  a	  family.	  I	  have	  seen	  many	  of	  you	  leaving	  for	  new	  adventures	  and	  more	  
people	  have	  joined	  our	  team.	  Thanks	  for	  all	  the	  love	  you	  keep	  giving	  me	  and	  for	  the	  
great	  moments	  we	  spent	  together.	  
	  
Sandro,	  dedico	  a	  te	  questa	  tesi,	  per	  tutta	   la	   forza	  che	  sei	  riuscito	  a	  darmi	   in	  questi	  
anni	  ...	  per	  la	  pazienza,	  i	  weekend	  e	  le	  notti	  trascorsi	  insieme	  nel	  Trumpp	  lab	  …	  per	  
tutto	  quello	  che	  mi	  hai	  insegnato	  nella	  vita	  e	  nel	  lavoro.	  Per	  l’amore	  che	  mi	  dimostri	  
continuamente,	  in	  un	  milione	  di	  modi	  possibili.	  Grazie.	  
	  
Alla	  mia	   famiglia,	   per	   avermi	   sempre	   sostenuto	   ed	   aver	   sempre	   creduto	   in	  me.	   E’	  
difficile	   riuscire	   a	   vivere	   lontano	   da	   voi	   e	   da	   Napoli.	   A	   nonno	   Gaetano,	   e	   a	   tutto	  
l’amore	  ed	  il	  sostegno	  che	  mi	  dara’	  sempre.	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